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Abstract
The preference for open disclosure of a terminal diagnosis has become
widespread in western societies. Disclosure practices are influenced and
shaped by medical culture, the organisation of medicine and cultural and
social expectations of the medical management of dying. In the literature
clinician’s performance of telling bad news to patients and their families
is positioned within an array of expectations and critique. Within this
are theories and commentaries on the motivations of physicians and the
degree to which they still determine when and how much information on
a terminal diagnosis is communicated. Yet little is known of the clinicians
experience presenting a life threatening diagnosis to their patient. This
research looks beyond the mechanisms of communicating bad news to
examine how clinicians manage, cope and sustain their emotions over
cumulative experiences of telling bad news to patients.
Method: A qualitative study drawing on symbolic interactionist
framework the research explores clinicians’ experiences of disclosing a
terminal diagnosis or prognosis to their patients and families. Semi-
structured interviews were conducted with five clinicians from a range
of medical specialities in New Zealand. Narrative analysis of the data
revealed the practice and processes of disclosing a terminal diagnosis
to a patient are more nuanced and less distinct from an absolute of
truth-telling or not. Balancing hope and honesty, clinicians communicate
bad news to patients generally over a long period of testing, diagnosis,
treatment and retesting. Consequently the experience for the clinician
is mediated and managed through this trajectory of care. Positioned to
negotiate an orderly and medically managed dying process with their
patients, there is a risk clinicians can be demoralised when disruptions
to the expected response to care occurs. Recognising broader societal
responsibilities to consider the position of clinicians who act on our behalf




In February 2013, my father received test results that indicated a possible
change in the status of the prostate cancer he had been diagnosed with, and
treated for, over the previous seven years. He was angry because despite
his requests, regular tests had not been considered necessary by his GP. The
change in diagnosis, from an illness he was told would be unlikely to end his
life before the natural course of old age, to the likelihood of dying within a
few years, was confirmed during an appointment with an oncologist.
In the process of this being disclosed to my parents something happened.
Two people in their early eighties, who felt let down by their GP, were in
the difficult retelling of this diagnosis to family over the coming days, able to
articulate a high level of trust and a certain intimacy befitting a long term
relationship with the oncologist. Initially, I was focused only on the prognosis
and what the journey ahead would mean for us. Then as I spent time with my
parents and witnessed their re-telling of this story to close friends, I noticed
how often the experience of the disclosure with the oncologist was mentioned.
Their experience was critical to their re-ordering of the future.
I became intrigued with how such devastating news had been communi-
cated to two people who clearly had expectations of a lot more living to do.
Disclosing the diagnosis had not thwarted their sense of a future. Rather it
had been re-adjusted, so hope for more living and a carefully managed end was
facilitated by the plan of action confidently offered by the oncologist. Their
deep sense of trust that his care was authentic ran counter to my expecta-
tions of how they, as aged people in a busy oncology department, would be
treated. Assured of the care and the plan ahead, we were all able to salvage
and re-order our hopes for more time with minimal suffering.
Over the course of my father’s illnesses the relationship with his oncolo-
gist was challenged as his trust in the care pathway offered was constantly
renegotiated, most critically when treatments failed. Exacerbated by the dis-
ruption of lumpy and insensitive transitions to and from palliative care, his
GP and oncology registrars, my father’s trust in a medically determined future
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6 CHAPTER 1. PREFACE
waned. Finally, in the unexpectedly abrupt and difficult dying phase when
his illness veered off course, the trust was lost. Two weeks before his death
he mustered the strength to accept further radiation treatment suggested by
his oncologist. When he arrived he discovered his oncologist was schedule to
attend another clinic. I watched my father physically diminish from what my
parents described as ‘blow’.
I knew then he didn’t come for the treatment. It was something else.
Perhaps he was seeking reassurance or an understanding he could trust this
man to provide? Maybe there was more; perhaps he had something to ask or
say? Characteristically though, I do know my father would have wanted to
shake his hand, look him in the eye and say thank you and goodbye for the
last time. That was his gift. Maybe that was all he wanted to do.
I wondered what it was like for his oncologist to be in this relation-
ship repeatedly with the countless patients in his waiting room who all bore
startlingly similar characteristics. I wondered if, or how he would know my fa-
ther had died. What would it mean for him when in many respects biomedicine
had failed to deliver on the plan? I recalled the exultation experienced when
initial treatments were deemed successful and I questioned if endings were
avoided because the confrontation with death when there was nothing more
that could be offered might be awkward or even unbearably difficult. I began
to consider how clinicians navigate, negotiate and cope with this most critical
process, that situates them so intimately with another person’s reconciliation
with death.
My experiences with my father ran parallel to, and directly influenced,
the development of the research project for this thesis. Originally expecting
an extended ‘terminal’ future, I had anticipated completion of this research
long before his death. On reflection, had that occurred, I may have missed
the gift he gave me in dying as he did. Throughout this research process I
have thought about his journey, contemplating what happened, in between
the beginning and end, and what could be different.
Chapter 2
Introduction
Disclosing a terminal diagnosis or prognosis to their patients, clinicians have
been described as intermediaries or “master of ceremonies” to the transition
from health to life-threatening illness and for some, death (Boland 2013, p.
230). Clinicians must bear the burden of witnessing the suffering of others
on a daily basis, in a culture where emotional stoicism is expected and little
support is available to discuss feelings such as loss and grief. It is easy to forget,
in the blame and critique of their performances disclosing a life-threatening
diagnosis or prognosis, clinicians also suffer:
“Through their willingness to be present to us in our most vulnera-
ble moments they are forever scarred with our pain–a pain that we
the healthy want to deny or at least keep at arm’s length (Hauerwas
in Chapple, 2010, p. 226).”
The expectation of medical professionals to distance us from death, through
cure or producing pain-free, peaceful death could be considered a way of cop-
ing with the more recent preference for open-awareness of death and dying.
We may want to know if we have a life-threatening diagnosis but we also want
to believe in the possibility of the ideal good death promulgated in hospice
discourses.
As such, the disclosure of a life-limiting illness situated within this cultural
and social landscape of paradoxical expectations, is a sociological event. At
the threshold of the illness trajectory for dying patients, it is interesting that
clinicians’ experiences of disclosure, specifically in New Zealand, have been
largely under-researched.
The purpose of this thesis is to locate experiences of five New Zealand
clinicians from different medical specialties in the cultural and social context
of the medical management of death and dying by drawing on data gathered
through semi-structured interviews. In light of ongoing criticism in much of
the patient literature, I am interested in how clinicians orient themselves to
the disclosure experience and cope with their role of telling bad news.
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When I asked how clinicians experienced disclosing a a life-limiting illness
to a patient their first response was to talk of when they would or would not be
doing this, and then who would be, and why. When I asked clinicians what it
was like to tell someone there was nothing more that could be done for them,
invariably I heard a resolute denial: “I don’t.” Why? Because drawing on
their medical construc there was always something more that could be done for
the patient. Working from this angle responses to my questions led to stories
of diagnosis that dominated the disclosure experiences over the trajectory of
care for patients.
I argue that disclosure of life-threatening illness or prognosis is more than
telling a patient the results of a diagnosis. The focus of disclosure invari-
ably turns to what next? Clinicians are tasked with “brokering” the patients’
engagement in the medical management of their illness which follows (Tim-
mermans 2005, p. 993). Scripts informed by professional and social expecta-
tions determine what is able to be brokered by the clinician. Professionally
clinicians’ belief in the orthodox medicine they can offer and expectations of
patients to accept treatment and care within this paradigm informs how dis-
closure processes are managed. Always having something more to offer their
patient and anticipating patients will always accept these offerings also es-
tablishes expectations more broadly in society. Clinicians are positioned to
stave off death, or deliver a peaceful, pain free death though this is largely
dependent on the patient adopting the role of the valiant warrior, fighting to
the end against death. Patients who consider alternative approaches to dying
disrupt these social scripts, threatening the orderly and managed approach to
life-threatening disease.
When negotiations fail and the patient rejects their care, or their bodies
are unable to be managed, clinicians do report experiencing a sense of failure.
How clinicians are positioned to manage the disclosure of a life threatening
diagnosis or prognosis to their patients and the negotiation of care to follow
is the focus of this research.
Road Map to Thesis
Consequently a series of questions emerge: what influence does medical cul-
ture have on the clinicians’ experiences and what is their awareness of these
influences in the context of the disclosure process? How do clinicians manage
the presentation of a life threatening diagnosis or prognosis to their dying
patients? What emotions do they experience and how do they deal with the
feelings that emerge from this situation? How much of their experiences are
influenced and shaped by social and cultural expectations of the medical man-
agement of death and dying? How much do these expectations constrain and
enable clinicians in how they can care for their patients?
The rationale and methods used to investigate the clinicians’ experiences
of disclosure is outlined in the methodology chapter which follows, along with
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a discussion on the challenges and limitations of these research processes. The
methodology chapter is followed with a review of the relevant literature, organ-
ised to represent thematically relevant debates and dichotomies of disclosure I
draw on in the analysis. To augment this context I continue with biographies
of each clinician who generously contributed to this research. These biogra-
phies act as a backdrop as the reader and transition into the fourth chapter,
which offers an analysis of three clinicians’ experiences of diagnosis and dis-
closure. Understanding clinicians’ experiences from their respective position
along the trajectory of medical care informs their responses to the experience.
Frequent exposure and expectations of good survival outcomes, mediates the
clinicians experiences and often turns the patient’s focus from the risk of dying
toward the fight for survival.
Diagnosis is the starting point for clinicians to establish their orientation
to disclosure. Diagnosis also illustrates the temporal ordering of disclosure to-
ward a trajectory of care where the clinician always has ‘something more they
can do’. At times offering a certain predictable order to the disclosure experi-
ence, the findings suggest regularity and routine facilitate the clinicians’ pre-
sentation of their professional identities to patients in the clinical encounter.
In Chapter 5 I explore the influence of medical culture on the clinicians’
experiences of disclosure through the analysis of another three of the clin-
icians’ narratives. These narratives bring to the fore powerful discourses of
clinicians’ responsibility to do no harm to their patient. Adhering to this ethos
extends to managing their own emotional responses to patients lest they up-
set or surprise them with their own feelings of loss or sadness. Clinicians are
also taught to control their emotional responses lest this interferes with their
clinical judgement.
However the uncertainty of how patients will respond emotionally, physi-
cally and intellectually emerges when clinicians talk about more challenging
experiences in Chapter 6. I explore how in these situations, when the clini-
cians’ actions are halted or fail to achieve the expected outcome, their perfor-
mance is disrupted and narratives of failure emerge. This raises questions of
how clinicians can be supported to care for their patients and be permitted
to respond with other scripts.
In the concluding chapter I bring together the pieces of stories interspersed
in the clinicians’ narratives as exemplars of Frank’s (2004) concept of medical
generosity. From these narratives I came to see that the responsibility to give
permission for them to fail, to speak from other scripts, to grieve, and to
socialise newly trained doctors to a “remoralized” ethic of care lies with us all
(Frank 2004, p. 25). In this way we can all forgive ourselves when we “cannot





The decisions that shaped how this research project was identified, designed
and executed had their genesis in the personal experiences of witnessing my
father’s relationship with his oncologist. There was a personal motivation
driving my interest. The choice to pursue research that sought to explore how
consultants involved in end-of-life care in New Zealand experience disclosing
a terminal diagnosis, reflects my belief that knowledge is not objective but
rather constructed, shaped and informed from the experiences of both the
research participant(s) and the researcher.
Visits to the oncologist with my parents allowed me an insight into a
process of end-of-life care that I had not known and which ran counter to
my pre-formed expectations of the patient-doctor relationship. In my own
sense-making of these experiences I sought understanding and context from
the research literature of how doctors experience what was for my family,
a significant relationship into the unknown; the trajectory of a terminal ill-
ness. Reviewing the literature initially generated a wealth of material on the
patient’s experience of receiving a terminal diagnosis, or what is frequently
referred to as ‘bad news’, however, there was little reference to the doctor’s ex-
perience of giving the news. Although it appeared little was known about the
physicians’ experiences in the literature, much had been discussed in relation
to their communication style and most of this negatively.
I was seeking an understanding of what it was like for them to tell an-
other person their life may end sooner than they had expected. I sought to
understand how they experienced this and why. This led to the physicians’
meaning–making of the experience of disclosing a terminal diagnosis within
this shifting social context becoming the focus of my research.
Developing an understanding of what it might mean to be a doctor experi-
encing the processes of disclosure did not assume there was a hypothesis to be
tested, or that a body of knowledge about their experience existed that could
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be tested with the New Zealand doctors I recruited to the research. Rather,
the research was approached from the position that this knowledge would be
constructed from the lived experiences of the doctors and co-constructed from
my actions and reflexivity as the researcher interpreting and analysing these
accounts.
What I learned was the inherent limitations of seeking to uncover and
reveal the personal experiences of research participants as an outsider to the
medical profession within the constraints of a small research project. I also
learned the value methodological challenges offer to furthering my understand-
ing of what it means to do social research.
This chapter outlines the research design used to guide the sociological
exploration of how doctors in New Zealand experience the process of disclos-
ing a terminal diagnosis to their patients. Elements of the research design
are presented beginning with the approach to the research that led to the
selection of the methodology underpinning how the research was conducted.
It follows with discussion of collecting and analysing the data and concludes
with a section on the methodological considerations, including limitations of
the research project. Interwoven in the presentation of the mechanics of the
research process are examples from my journal of the reflexive experience of
‘doing’ social research that generated personal and pragmatic dilemmas.
Approach
Given the nature of the research question and the scarcity of literature from
the experience of New Zealand consultants, it made sense to use a qualitative,
rather than a quantitative or mixed-method approach, to develop a rich ac-
count of their experiences and from this identify themes of how meaning gets
made in the New Zealand context.
Applying an interpretative-constructivist approach to this issue was ap-
propriate as little exploratory research had been done that considered the
consultants’ experiences. In this way, I used an inductive reasoning approach
to the research design and sought to develop an understanding of these expe-
riences from what the research participants shared.
This approach premises the relationship of the researcher and the research
participants as actively constructing shared understandings. Acknowledging
the researcher’s role in these co-constructions I learned how significant my own
subjectivity was on the research process. I formulated a research question
to understand an experience in my own life, and using Interpretative Phe-
nomenological Analysis (IPA) as the research methodology thought I could
probe deeply into the experiences of the research participants.
What emerged from the data I collected was not the deeply personal ma-
terial I had expected. After months analysing the data trying to locate the
insider’s perspective of the consultants’ experiences of disclosure, I became
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lost. With the department’s support I was offered a change in supervision
and with that, an understanding of the methodological issues inherent in how
I had approached the research question. A shift in perspective allowed me to
work with the data I had in front of me. With consideration and understand-
ing of the methodological limitations of IPA for this research project I drew on
symbolic interactionism to align the analysis more closely to the data. I was
able to retain the focus on the experience of a phenomenon and the meanings
ascribed to the experience but with less grand claims to understanding what
it is like to live in the consultants’ worlds.
I realised I could not access the consultants’ inner worlds. My analysis
could only be based on what consultants said to me about their experiences
and the constructions or interpretations as social, rather than psychological
entities, we both made of the phenomenon of disclosing a life-limiting diagnosis
and prognosis to a patient. This change of approach and the implications




Initially, when I began to consider the research project, I was attracted to
grounded theory as it aligned to my approach that knowledge is constructed,
allows for inductive enquiry, and gives voice to the participants being re-
searched. Within the multiple perspectives of grounded theory I orientated
to the constructivist position primarily because this approach provides a de-
parture from the direction of the classical interpretation of the methodology
that seeks to identify and explain patterns of behaviour abstracted from the
research data (Charmaz 2006). The focus of this research was to explore ex-
periences and interpret the meaning-making of those experiences so if there
was no discernible ‘pattern of behaviour’ emerging that did not mean that the
research findings were less valid.
The more constructionist approach to grounded theory is concerned that
seeking to identify and conceptualise behaviour patterns from the data analysis
risks losing the voice of the research participants (Charmaz 2006). Research-
ing experiences from an interpretative-constructivist position steered me away
from abstracting behaviour patterns, causality and I thought, seeking to dis-
cover truth(s).
However, this did not mean I wanted to simply engage in a descriptive
story-telling of the experiences of the clinicians. Rather I wanted to develop
an interpretative account of what it is to be having these experiences and how
this contributed to a sociological understanding of the phenomenon.
To develop a rich, detailed, qualitative account of how clinicians experience
disclosing a life-limiting illness to their patients I wanted to understand how
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they felt about the phenomena and then situate their accounts in the social
and political shifts influencing ‘truth-telling’ in the broader realm of medicine.
It was also likely that consultant specialists and mid-career clinicians would
not only have had more opportunity to experience these disclosures but may
also be experiencing this within a wider range of medical specialties given the
increasing rates of co-morbidities associated with longer life-spans.
At the time, the question and challenge was how I would recruit the req-
uisite number of consultants to meet the expectations of data saturation us-
ing grounded theory in the timeframe available to complete a Master’s thesis.
Conservative estimates for data saturation were a minimum of fifteen to twenty
participants with the potential for more if new data was still adding insights
to the investigation. Because of the nature of the research focus, it was an-
ticipated that it may be difficult to recruit large numbers of consultants in
New Zealand willing to participate in multiple rounds of data collection given
constraints on time.
Facing the likelihood of only being able to recruit a small sample of clini-
cians bought to the fore some of my underlying assumptions about the validity
of the research. I reconciled that generalisability was not an aim. Instead the
aim was to develop a detailed analysis of experiences and how these may have
changed over the consultants’ medical careers.
Interpretative Phenomenological Analysis
In discussions with my supervisors, they suggested Interpretative Phenomeno-
logical Analysis (IPA) as a more suitable methodology. Although IPA origi-
nates from health psychology and is focused on individual experience, rather
than social context, there was confidence it was possible to adapt this approach
toward a sociological analysis (Smith 2011).
With its roots in symbolic interactionism and phenomenology, IPA allows
for meaning to be explored from an interpretative-constructivist paradigm
(Smith 1996). Understanding people’s lived experience and the individual
meaning they attach to their experience is the central focus of IPA. Like phe-
nomenology, IPA is concerned with an individual’s perception and also recog-
nises the importance of the interaction of the researcher and the research par-
ticipant from which meaning occurs (McPherson, Wilson, and Murray 2007;
Smith, Larkin, and Flowers 2009). From a symbolic interactionist perspective,
those meanings are only “obtained from a process of interpretation” (Smith
1996, p. 263).
Data collection methods are selected to support this approach (Starks
and Trinidad 2007; Smith, Larkin, and Flowers 2009). Smith et al. (2009)
also suggest that an ideal sample size for a small research project such as a
masters’ thesis, is no more than three to allow for a thorough analysis of each
interview transcript and “say something in detail about the perceptions and
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understandings of this particular group” (Smith, Larkin, and Flowers 2009, p.
55).
Importantly, I was attracted to IPA because it sought to get an “insider
perspective” on an individual’s experiences by generating rich, in-depth de-
scriptions for analysis (Smith, Larkin, and Flowers 2009, p. 150). I anticipated
using an IPA approach would enable me to uncover and reveal the nuances
and complexities of the clinicians’ experiences of telling patients they had a
life-limiting diagnosis or prognosis from the interviews I conducted and the
analysis that followed (Smith, Larkin, and Flowers 2009).
Finally, IPA offered a sense-making of its own through the ongoing process
of self-reflexivity using techniques such as journaling and bracketing to capture
my presuppositions (Smith, Larkin, and Flowers 2009). These practices helped
me to reconcile my doubts about the overt influence I may have on the research




In using IPA I was seeking an understanding of the clinicians’ experiences
to analyse how they make meaning of disclosure situations. Data collec-
tion methods called for a particularly small sample size to produce a “suf-
ficiently penetrating analysis” (Smith, Larkin, and Flowers 2009, p. 57). IPA
tends toward sampling a more homogeneous group through purposive sam-
pling (Smith, Larkin, and Flowers 2009). The group targeted for recruitment
in this research was medical consultants that have had or are currently in-
volved in, aspects of end-of-life care. This was to provide some homogeneity
in terms of experiences in their career as medical students and as mid-career
consultants.
It was agreed I would try to recruit four to six participants from a range of
medical specialties to explore the issues for consultants who may be engaged
at different stages and times in the process of disclosing a terminal diagnosis
to their patients. This included consultants within academia and medical
institutions.
The sample was not specifically orientated to achieving a gender, age or
ethnic balance, as statistically overall in New Zealand medical specialities are
largely comprised of European males aged between 50 and 54 years, with the
exception of general practice where women are more evenly represented at
45% in this speciality (Medical Council of New Zealand 2012). Largely these
statistices were reflected in the sample for this research. Five participants,
one woman and four men from specialities in palliative care, oncology, surgery
and general practice were interviewed. Although information on age was not
solicited, each participant offered an indication of their age in the context of
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discussing experiences over the life of their careers. Based on this information
the range of ages was approximated at between fifty and sixty-five years.
Homogeneity in ages was anticipated because the research targeted consultants
who were likely to have well-established careers with considerable experience
of end-of-life care and also aligns to the statistical profile of specialists in New
Zealand (Medical Council of New Zealand 2012).
Recruitment Process
Recruiting research participants commenced by making contact with people I
knew personally who were medical professionals and inviting them to partic-
ipate in the research. Unsure of their response because of the research focus
it was deeply encouraging to receive an immediate and positive response to
the invitations. The first interview was quickly confirmed and then a meeting
with the second recruit to reconnect and discuss the research prior to schedul-
ing an interview was organised. At that meeting the recruitment effort was
bolstered by an unsolicited offer of assistance to provide introductions to col-
leagues that would likely agree to participate in an interview. This version
of ‘snowballing’ where parties are invited to pass on information about the
research to potential participants of their acquaintance was identified as part
of the recruitment strategy early on. However, I had not anticipated offers of
support immediately (Atkinson and Flint 2003). Buoyed by this response I
held back from implementing the cold-calling technique of approaching con-
sultants I didn’t know via email or phone to introduce myself and the research
project.
The early and unanticipated momentum of recruitment informed my ex-
pectation that further participants would be confirmed in a similar time frame.
However, this was an expectation that proved to be unrealistic and challenging
throughout the recruitment process. Understandably consultants are dealing
with competing priorities and communications were frequently delayed. At
the same time as I was recruiting participants my father’s illness progressed
unexpectedly such that maintaining recruitment activities became onerous.
Consequently the momentum of the recruitment was disrupted as study was
suspended. After a break of four months, I reengaged with the recruitment.
This time the pressure on the snowballing technique intensified after several
attempts at cold-calling failed to generate any responses. I went back to the
first two participants for assistance and again was provided with support and
introductions. One of these resulted in the confirmation of another interview
in four weeks and the other a phone call agreeing to an interview with the
time to be agreed via email.
In the interim the second interview was held which along with the first
interview, referenced the role of General Practitioners (GPs) in the diagnosis
process with patients. In selecting the sample group, GPs had been considered
less integral to the disclosure process with an assumption that medical spe-
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cialists would most likely determine and communicate diagnosis directly with
patients. This was an assumption that was challenged by the data from the
first two interviews and as such, warranted the inclusion of GP’s experiences
in the research data. Delays in recruiting participants proved advantageous in
this instance because it provided time and flexibility to reconsider the sample
criteria against this new information and make the decision to include GPs.
Again, I relied on personal networks to assist with successfully recruiting a
GP to participate in the research.
Following the completion of four interviews I became concerned that the
fifth interview may not proceed as I had not succeeded in confirming an ap-
pointment for the interview. Although the target number of participants of
between four and six meant it was acceptable to complete the fieldwork with
four interviews, the inclusion of another consultant’s experience from a dif-
ferent medical speciality temporarily allayed an underlying concern about the
data I was collecting for the interrogative analysis that lay ahead. Unable to
draw a line under the recruitment phase proved distracting and disconcerting
while shifting to the next stages of analysis. Hence it was a moment of relief
when the fifth interview was finally scheduled providing closure on the recruit-
ment phase and perspective on the need to be patient, resilient and tenacious
as a social science researcher.
Data Collection
Smith, Larkin, and Flowers (2009) suggest that to develop a detailed exam-
ination of how people understand and make sense of things requires flexibil-
ity with the data collection methods and as such, suggests the use of semi-
structured interviews. Given the type of information sought from the inter-
views was a narrative description by consultants of how they experience and
make sense of disclosing a terminal diagnosis to their patients, this method was
used to generate much of the data. Semi-structured interviews also align to the
constructivist approach as there is the opportunity for reciprocity to develop
with the researcher and participant and to acknowledge the co-construction
of data and meaning-making (Creswell 2009).
Research Questions
A schema of research questions was developed in preparation for the inter-
views. I found this process difficult as every draft I produced had traces of
my presuppositions with questions that assumed the process of disclosure was
difficult or problematic, leading to anguished meaning-making for the consul-
tants. I sought assistance from my supervisors and trialled the questions with
a friend but throughout my journal entries the research questions remained
an unresolved issue. Should I be consistent and ask the same questions? How
much did this approach risk guiding the interview away from the elusive reve-
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lations I thought I should be uncovering? This is evidenced in a journal entry
following the third interview I wrote:
In the interview I was conscious of questions I had asked in the
other two interviews and thinking I should follow a consistent for-
mat but it didn’t flow that way. Each interview has been so dif-
ferent from each other and my expectations that I am still left
feeling like I’m not doing it right and anxious that I may have
missed opportunities to get to the ‘good stuff’ (Journal entry, 9
May, 2015).
In the end I used the schema mostly as a framework for each interview
though many times the interview veered off in other directions. Prior to each
interview, I reviewed the questions against the material I had, to identify pos-
sible gaps that could be included in subsequent interviews. Each interview
was different and unique. Some shared a rhythm that intensified as the con-
versation moved toward the personal, while one was determinedly impersonal
as my journal entries reflect:
Kept feeling like I was being prevented from asking more than
the superficial - answers were repetitive and stayed within a small
radius of work. Am I asking the right questions? (Journal entry,
5 March, 2015).
This interview we got into the experiences pretty quickly which
gave it a different momentum. It seemed more intense and personal
(Journal entry, 8 April, 2015).
Interviews varied in length, averaging 90 minutes with the exception of
the first interview which was over two hours. All of the interviews took place
in workplaces scheduled in between and after, the intensity of clinics, ap-
pointments, meetings and emergencies. I was acutely aware that my presence
represented a significant disruption to an already overfull day and wanted to
ensure I minimised the toll this took on the participant. I always arrived
punctually, got better at time-keeping and monitoring for shifts in the dy-
namic that indicated I may be labouring an issue. I found at the conclusion
of each interview there was a process of re-orientating again to the role of
researcher and making sense of being an outsider to the participant’s world.
Following each interview, I transcribed the audio-recordings and individual
transcriptions were made available to each research participant to confirm ac-
curacy and provide an opportunity to make modifications if they wished to do
so. Pseudonyms were used to protect the identities of all research participants
and all other identifiers were protected, including location. Any identifying
information captured in the audio-recordings and transcription was excluded.
Returning the transcripts to each participant facilitated a further opportunity
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to thank participants for their time and support of the research following the
interview, affecting in part a closure to the fieldwork. Only one participant
returned their transcript which had extensive track changes to both clarify
the meaning of what they had said and how it was said, editing out many
instances of repeated words and turns of phrase.
Reflexive Practice
The complex and nuanced relationship as researcher to the participant mak-
ing sense of their meaning-making proved demanding and engaging throughout
each stage of the research process. Drawing on the Heideggerian phenomeno-
logical approach, Larkin, Watts, and Clifton (2006, p. 108) suggest that at-
tempts to show the research participant “on its own terms” divorced from
any preconceptions, assumptions or expectations will fail. This is because the
researcher, like the participant, as “a ‘person-in-context’ (and hence an ob-
server, indelibly situated within the meaningful world that we observe) we can
never fully escape the ‘preconceptions’ that our world brings with it” (Larkin,
Watts, and Clifton 2006, p. 108).
Throughout the research process I kept a research journal. As much as
possible, I wrote freely about my experiences, fears, questions and understand-
ings. For example, very early into the research process I was questioning the
methodological approach:
I’m reading Smith et al., (2009) to understand more of IPA. I am
supposed to be looking at the everyday, phenomena, and I am
unsure if this is the right methodology for this research question.
Is it only a phenomenon for me? What if clinicians don’t see it as
a phenomenon? Why do patients report it as a significant event?
A single event? (Journal entry, 12 June 2013).
Again, in the following journal extract I was projecting my own sense of
disclosure as an intimate process, perhaps as I had experienced it with my
father, on to the research agenda:
The thing that has intrigued me for so long with this issue is a sense
of intimacy that I get from considering being witness to someone
on their journey to death entering this space with a patient that
is exclusive and so othering. Yes, we are all going to die but no
one can know what it feels like to be told unless it is happening to
them (Journal entry, 19 June 2013).
I used the discipline of writing a journal initially to try to identify and
bracket off assumptions such as this, particularly prior to interviews and im-
mediately following them. I found it helpful to journal these thoughts, not to
counter them but to identify their potential to impact on the research process
20 CHAPTER 3. METHODOLOGY
and situate them within this “hermeneutic circle” (Smith, Larkin, and Flowers
2009, p. 35). The following journal extract provides a good example of this:
Dr X moved directly and quickly into recalling her first experience
with a dying patient as a student nurse and in the telling of this
story her Christian faith was declared. It was unexpected and
I was unsure if this was something she may have expected me to
share given my connection with her niece. I now wonder if perhaps
I could have pursued this but clearly felt compelled not to engage
with this in the interview perhaps some fear on my part early into
the interview that I didn’t know what I was engaging with also
wondered if this was testing my response, would it be assumed
that a fellow Christian would respond differently (Journal entry, 8
April, 2014).
IPA emphasises what is referred to as a “double hermeneutic”; that is
essentially a two stage interpretation “as the participants are trying to make
sense of their world; the researcher is trying to make sense of the participants
trying to make sense of their world” (Smith et al. 2009, p. 53). At times
this spiralled into a helix of sense-making of my sense-making of the research
participants’ sense-making:
It seems the diagnoses process provides the mechanism for inter-
preting and making sense of experiences of patients and clinician’s
responses to that. The clinician is making sense of the patient’s
sense-making through a diagnosis process and the patient is re-
making sense from the clinician’s sense-making and is renegoti-
ating/continually re-establishing own sense of self/security. I am
making-sense of their sense-making of this (Journal entry, 10 July,
2014).
Finally, the reflexive process of journaling was helpful throughout the re-
search process but came to the fore as a link back to the research process
following disruption and in the shift to narrative analysis. Recording the
challenges I experienced in the research facilitated an understanding of the
methodological issues I faced; at times acting as the missing pieces in the
puzzle in my own research narrative.
Analysis
IPA Analysis
The process of IPA analysis outlined by Smith, Larkin, and Flowers (2009)
was used to guide how I analysed the data gathered. Drawing on a phe-
nomenological perspective, I wanted to understand what it is like from the
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consultants’ point of view; specifically what it means ‘to take their side’ and
also simultaneously work with the data to critically examine what is going on
that the research participant may not be consciously aware of (Smith, Larkin,
and Flowers 2009, p. 36). The IPA researcher is encouraged to take another
stance, this time stepping outside of the participant’s shoes to stand to one
side and question what is being said (Smith, Larkin, and Flowers 2009, p. 36).
I focused on identifying themes from the data to give voice to each con-
sultant’s experience of this phenomenon. A “detailed case-by-case analysis of
individual transcripts” was conducted, commencing with a preliminary anal-
ysis of the first interview transcript through reading, listening and re-reading
the transcript many times to become deeply familiar with the research partic-
ipant’s account and ensure their voice was present with each reading (Smith,
Larkin, and Flowers 2009, p. 55). Alongside this process I continued to reflect
on my responses to the transcripts that may be influencing the analysis:
I am not sure if I am coding things under the right categories
of linguistic, descriptive and conceptual. I find myself reacting
personally to things I am reading, particularly when I hear them
as egotistical or paternalistic. I know this is my influence on the
script. I need to put that aside and really try to hear what he is
saying is important to him (Journal entry, 2 April, 2014).
On the second and subsequent readings coding or “initial noting” of de-
scriptive and linguistic comments was sequentially entered in columns adjacent
to the text (Smith, Larkin, and Flowers 2009, p. 88). This was followed by a
shift to the interpretative process of “conceptual coding” that Smith, Larkin,
and Flowers (2009, p. 88) describes as “a move away from the explicit claims
of the participant ... toward the participant’s overarching understanding of
the matters that they are discussing”. Again, my journal entry reflects the
shift this process fostered in my analysis from the example above:
I am hearing more of what it is to be him rather than how it is for
me to listen to him (Journal entry, 14 April, 2014).
The preliminary analysis was then abstracted and clustered into high level
themes representing meaningful units relevant to the research focus (Smith et
al. 2009).
Approaching this method of analysis for the first time I found the sug-
gestions for physically cutting and sorting themes on pieces of paper and
assembling them in large envelopes unusual but because I was new to IPA I
decided to try this hands-on method. With themes written on paper stuck to
walls, arranged, revised, assumptions tested and revised again, the depth of
data and power of the interpretative analysis of that data became apparent.
Looking for relationships across themes became a creative endeavour through
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the act of interpreting and identifying connections, then rearranging themes to
identify insights into other levels of possible meanings. In part, that creativity
was facilitated by what Larkin, Watts, and Clifton (2006, p. 114) describe as
IPA’s “epistemological openness” that allows the researcher to draw upon a
considerable ‘interpretative range’. This range encourages the researcher to
“explore and innovate in terms of organizing the analysis” that opens up mul-
tiple possibilities for interpreting and drawing out meaning (Smith, Larkin,
and Flowers 2009, p. 96). I drew on discursive, temporal and cultural elements
as well as looking for patterns in frequency of repetition to try to push beyond
the antecedent descriptive stage (Smith, Larkin, and Flowers 2009, p. 98).
Continuing the analysis of single transcripts in isolation of each other
proved challenging as there was a strong tendency to want to identify patterns
between interview data. To mitigate the risk that prematurely conceptualis-
ing themes across each transcript might result in overlooking critical data I
staged each transcript analysis with interviewing, transcribing and writing.
The end result of this stage was five large envelopes; one for each inter-
view, with a list of themes pasted on the front spread across a large table
to commence the next stage of looking for connections across the interviews.
Smith, Larkin, and Flowers (2009, p. 96) encourage the researcher to “eye-
ball” lists of themes suggesting that “some themes will act as magnets, pulling
other themes towards the”. Walking around the table seeing the themes as a
whole body of data for the first time; some connections were more immedi-
ately apparent whereas others did repel, seemingly polarised. As this process
of analysis evolved new themes were added to a tentative master table of
themes and then successive themes modified, developed and combined into
categories. This produced an awareness of what had come before to an extent
that “convergences and divergences” from these themes became apparent in
subsequent transcripts (Smith, Larkin, and Flowers 2009, p. 73).
To ensure interpretations were valid I implemented a continuous process of
comparing themes and categories across transcripts (Smith et al. 2009). This
iterative process also required checking my own “sense-making” against what
the research participant had actually said (Smith, Larkin, and Flowers 2009,
p. 72). When the detailed analysis was completed, a process of prioritising
the themes followed to inform the construction of the final table of ‘super-
ordinate themes’ with related themes and excerpts from participants ‘nested’
under them (Smith, Larkin, and Flowers 2009, p. 101). These themes were
then used to develop an emergent thematic analysis to inform the expansion
of the analysis for the writing phase (Smith, Larkin, and Flowers 2009).
Smith, Larkin, and Flowers (2009, p. 36), draw on Ricoeur’s interpretative
position as an example of a double hermeneutic operating in IPA that required
moving beyond empathetically “representing what the participant would say”
toward a hermeneutics of suspicion to take a look at them from “another
angle”. The thematic analysis I had developed did not seem to do this and
I felt I lacked the ability to find IPA’s middle ground of a hermeneutics of
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questioning to extend my analysis of what the consultants were saying (Smith,
Larkin, and Flowers 2009, p. 36).
I returned to the literature on IPA and read a paper by Prunella Gee,
a PhD candidate supervised by Jonathon Smith, one of the authors of the
text on IPA I had followed (Gee 2011). Documenting the process of following
the methodological steps outlined in the text to her study of male retirement
patterns, Gee’s experiences provided a pragmatic example. Her commitment
to thoroughness in the analysis process and recommendation to first time
users to follow the road map in the book “because it lays bare the skeleton”
to identifying emergent themes renewed my resolve to keep analysing (Gee
2011, p. 21). This is evident in an extract from my journal where I thought I
needed to uncover what was unknowable even to the research participant:
This is possibly what I was battling in the interview to get beyond
this confidence, find a crack, something that revealed self-doubt or
moments where his convictions failed him (Journal entry, 20 April,
2014).
In fear of being too descriptive and failing to bring forth the deeper mean-
ings from what the consultants had said of their experiences I moved the
interpretation further away from empathy trying to emulate a psychological
interpretation of the consultants’ experiences.
A Shift in Supervision and Analytical Framework
I felt increasingly out of my depth and at my supervisors’ suggestion, tried
writing a case study descriptively and interpretatively. I lost my way only
to discover I was still making too many assumptions and somewhat pejora-
tively. When I tried again with greater empathy, the feedback was I had lost
interpretation.
With a change in supervision I came to understand the methodological
limitations of applying IPA to this research question. Crucially, I realised my
attempts to get an insider perspective with a small sample of medical profes-
sionals adept at managing people entering their world were highly unlikely to
succeed. Why would they tell me, an outsider, in a fleetingly brief encounter,
their innermost thoughts? Reconciling this limitation helped ease the sense
of failure I experienced with the data I had generated and the subsequent
analysis.
Symbolic Interactionism
Given IPA has symbolic interactionism in its roots, I was encouraged to con-
sider the thematic analysis from this perspective. Switching the framework
for analysis from IPA to symbolic interactionism addressed the pressure I felt
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to present an insider’s perspective and as a result I began to build confidence
in the themes I had originally identified.
I returned to the transcripts, this time captivated by the stories of disclo-
sure experiences some of the consultants had shared with me. Reading Plum-
mer (1995, p. 23) view of stories as the interactions between the “producers”
(tellers) and “consumers” (listeners, audiences, readers) told in different ways
in different contexts, gave me the confidence to work with the stories I had.
He poses several questions to consider in the sociological analysis of stories,
challenging analysis to move beyond the focus on the formal structure of text
to consider the social role of stories (Plummer 1995, p. 19). Like Plummer
(1995) I was interested in why I was told a particular story, how the story was
told, the strategy of the story teller, for instance in managing impressions and
the link between the story and wider social context where these stories may
perpetuate dominant discourses of medical professionalism.
Atkinson (1997, p. 328) points to the “centrality of narrative” to the cul-
ture of medicine, highlighting the significance of a wide range of medical nar-
ratives, from case studies and patient records to the tradition of narrating
orally medical instruction and opinion. He suggests “telling the case is a
powerful mechanism for enactment of professional work” and takes place re-
peatedly in daily medical practice as doctors engage with colleagues, formally
and informally to discuss patients (Atkinson 1997, p. 328). The consultants’
stories provided access to understanding how their meaning-making of the
disclosure to a patient is constructed and interpreted through medical social-
isation. Stories are often valued for their uniqueness and rarity and who tells
the story in medical culture is hierarchically determined revealing how power
is perpetuated as Atkinson (1997, p. 329) judiciously suggests:
“Senior physicians have reserved rights to tell particular kinds of
stories . . . to tell personal stories of professional experience and
can claim the floor to do so before an audience of peers and ju-
niors.”
In medicine, doctors also tell their patients’ stories in presentations, case
histories and other narrative performances (Atkinson 1997). The confidence
and skill in recalling detailed stories was a feature of the consultants’ nar-
ratives. This led me to Goffman’s (1959) dramaturgical analysis of social
interaction as a performance and the medical encounter with their patient the
“front stage” for disclosing a life-limiting diagnosis.
Clinicians are expected to perform in specific ways that are socially con-
gruent with ascribed understandings in medical culture. Therefore the pre-
sentation of a diagnosis to their patients is a performance of each clinician’s
interpretation of ‘doing’ medical professionalism. They must deliver the pre-
sentation with the authority required for the patient to accept the diagnosis
as legitimate to ensure the treatment and care they can offer will be followed.
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In this respect the consultants’ narratives of their disclosure of a life-limiting
diagnosis to a patient can be considered as the site where identities, roles and
responsibilities are created, negotiated and managed (Lehn and Gibson 2011).
At the same time I read Arthur Frank’s (2004) book, The renewal of gen-
erosity: illness, medicine, and how to live. Here I found themes of demorali-
sation and the transformation to caring relationships through generosity that
resonated with some of the consultants’ stories. I was able to reconnect empa-
thetically with the consultants’ experiences. I could hear stories of resistance,
when generosity had been extended despite professional pressure, and shift
from a psychological analysis of personality type to a social analysis of the
impact of medical socialisation, norms and expectations on the consultants’
experiences.
Drawing on Foucault, Holstein and Gubrium (2009, p. 162), describe a
“disciplinary gaze” as a particular way of seeing the world which results in
“characteristic narratives, leading participants to story things in special ways”.
Through the consultants’ “disciplinary gaze” their narratives of the disclosure
of a life-limiting illness to a patient was embedded within, and informed by,
the culture of medicine (Holstein and Gubrium 2009, p. 162). Initially I
had interpreted the response from some consultants to the question of when
they “tell” as deliberately obtuse and one of my early themes was “Where is
the telling?” When I reconsidered this in the context of the characteristics
of disciplinary narratives I could understand the importance of locating the
disclosure experience within the temporal trajectory of a patient’s illness and
the consultant’s own position in the structures of organisational health care
to their meaning-making.
In this way, the analysis of consultants’ experiences shifted from the psy-
chological to the social, cultural and professional context in which they, and
I, came to understand the disclosure experience.
Narrative Analysis of the Clinicians’ Perspectives
Although there is much debate over what a narrative is, I have, like Riessman
(2008, p. 7), used the term interchangeably with story, to mean the first-person
account of the consultants’ experiences of disclosure. Locating narratives in
research interviews is not uncommon as respondents will sometimes order
their experiences into long stories (Riessman 1993, p. 3). However, stories
told in interviews are not always clearly demarcated with more commonly
used “entrance and exit talk” such as “that reminds me of a story” (Riessman
1993, p. 17). The issue for the researcher is deciding where the narrative
begins and ends.
Exploring the typology of narrative analysis to identify how I should make
this decision I looked to Riessman (1993, 2008) who provides theoretical and
practical guidance building on the work of Gee (1986) and Gee (1991), Mishler
(1986) and William and Waletzky (1967). Riessman emphasises there is “no
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one method” she uses in narrative analysis and encourages a blurring of the
boundaries to look not just at the linguistic form of texts and the thematic
content but how, and why, the respondent selected this story and organised it
in this way (Riessman 1993, p. 5).
The process of narrative analysis is slow and painstaking “requiring at-
tention to subtlety: nuances of language, audience, organisation of text, local
contexts of production, and the circulating discourses that influence what can
be narrated, and how” (Riessman 2008, p. 18). Interestingly, Smith, Larkin,
and Flowers (2009, p. 106) claim a “strong intellectual connection with various
forms of narrative analysis” and cite Riessman’s work as an example of the
shared emphasis on the personal and meaning-making through the analysis
of the lived experience and relationship to personal identity in the telling of
a story. In this respect I was able to draw on the themes I had identified in
the IPA analysis that emerged from the linguistic, temporal and contextual
coding of individual transcripts.
For example, initial readings of the data I had gathered appeared domi-
nated by the process of diagnostic actions. I had written of this in my research
journal though had discarded this as too descriptive in later analysis:
There has been something in the tone of each interview that has
felt like a clinical synopsis/description and I haven’t been able to
fully identify what that is other than referencing Mischler’s “voice
of medicine” - clipped and rapid intonation with a sense of listing
things off and a need to get numbers, dates, times, actions identi-
fied quite explicitly. Perhaps the consultants I am interviewing are
responding to and interpreting the research question as a problem,
requiring diagnosis (Journal entry, 16 April, 2014).
Returning to the diagnosis process I began extracting excerpts from often
long narratives and informed by Gee’s (1986) poetic representation of lan-
guage, broke each story into parts. When I broke the stories into stanza-like
forms of only a few lines each, other readings and interpretations emerged.
I then worked from Riessman’s (1993) process to look at how each story was
organised using Labov’s (quoted in Riessman, 1993) framework of narrative
analysis. This process involved identifying elements Labov considers part of
a well-formed story including:
Abstract – an initial clause in a story that summarises what is to follow
Orientation – provides information on time, place, characters
Complicating Action – sequence of events
Evaluation – significance and meaning of the action, attitude of the
narrator
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Resolution – what finally happened
Coda – returns the narrative to the time of speaking
Not all of the stories had these elements and I was concerned this rendered
the selection of narratives flawed. Riessman (1993) however, counters Labov’s
claims of the function of these elements to a story, suggesting there are few
rules for partitioning parts of interviews that “feel like narrativizations” (p.
60). I was heartened by this and able to move on to look beyond the structure
to question why the stories were told the way they were, what discourses they
drew on and what the story was seeking to accomplish.
Deciding which stories to select, where to break the story into parts and
in some instances, deciding where to end the story made my interaction with
the text visible. I was conscious that extracting the clinicians’ stories from
the wider narrative risked isolating the meaning from the context of the con-
versation. To re-situate the excerpts I provided either a brief synopsis of the
question and context that each clinician was responding to or included my
voice in the text.
Employing this hybrid of narrative analysis styles I was able to work dy-
namically, shifting attention between the structure of the story, to particular
linguistic features, such as verb tense, key words, repetitions, hesitancies and
turns of phrase and then to the broader social context.
In this way, I was alerted to both the form and the content of the consul-
tants’ stories and could abstract themes while preserving the narrative detail
(Riessman, 2008). From this analysis the consultants’ experiences of disclos-
ing a life-limiting illness or prognosis to their patients emerged as more than
just ‘telling bad news.’
Methodological Considerations
Limits to Accessing Clinician’s Inner Worlds
Larkin, Watts, and Clifton (2006, p. 104) highlight the potential difficulties in-
herent in the IPA researcher seeking to offer an ‘insider’s perspective’ agreeing
with Smith (2006) that access to the participants experience “is both partial
and complex”. Access, according to Smith, Larkin, and Flowers (2009, p. 53)
“depends on, and is complicated by, the researcher’s own conceptions; that
are necessary to “make sense of that other personal world”.
In many ways I had set myself up to fail. Clinicians learn how to manage
their emotions, present themselves as empathetic, and to protect their patients
from any overtly emotional responses they may have. I had no more right to
accessing their inner worlds than their patients yet I had expected to gain
entry.
Although I had indicated and prepared for 60–90 minute interviews, in
the first interview I felt I had lost control and did not know how to keep the
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interview on track. The following excerpt from the transcript illustrates the
types of tensions that emerged:
“Jo: For you though, that role though of being the doctors in end
of life care, moving from that role of curing to not being able to
heal ...
Dr K: Well it’s interesting because cure would be the medical word
for making the cancer or disease go away. Heal, and there’s lots of
literature, people will feel healed even though they’re dying. There’s
a great gospel song Maryann Williams, ”When the doctor gives up
the healing begins”, that’s the lyric. So the word heal is actually
has a much, much, more broader meaning. It doesn’t necessarily
mean cure or even live. So that will come out in your literature.
Jo: Yes
Dr K: If it hasn’t, you’ll find that that word ’heal’, people will feel
healed if they’re dying.
Jo: Though interesting that lyric is when the doctor gives up?
Dr K: The healing begins
Jo: Where does that leave you as a doctor?
Dr K: Well it’s another one of the things when I’m teaching about
communication to junior doctors there’s a few things I really talk
about. If you mean death say death . . . ”
I expected I could, with enough time and a flexible structure, encour-
age participants to reveal their innermost thoughts about their experiences
to me. This assumption that research participants’ inner-most private expe-
riences can be accessed during an interview is challenged by Atkinson (1997,
p. 327) in his critique of research where narratives are regarded as “offering
privileged access to personal experience”. Furthermore, the assumption in
IPA that what participants say of their experience provides insights into their
“psychological worlds” led me away from the socio-cultural contexts of these
experiences (Todorova 2011, p. 37). Although there have been calls to include
these contexts in IPA analysis, I believe the considerable skill and experienced
guidance required is a barrier for a master’s thesis (Todorova 2011).
Power and Positionality ‘Interviewing Up’
Perhaps another limitation to using IPA as an early researcher was the pres-
sure experienced interviewing a small number of participants. It seemed there
was little room for error with only four to six participants to interview and
yet I had no previous experience conducting social science research interviews.
This pressure was exacerbated by the thought of entering the world of senior
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medical professionals and asking them to talk openly about potentially diffi-
cult, troubling and personal experiences.
I was unprepared for the negotiation of power and my overall sense of
powerlessness in the interview process. To say that I overcame this would be
untrue, however, I did adjust by using this pressure to prepare well, listen
intensely and tap into the assumptions I was bringing to the process through
journaling and in discussions with my supervisors:
I felt there was no research question to be answered, it felt irra-
tional, wrong to be asking, prying into a closed world; “we have
this sorted.” Of course why did I think any differently, how else
can you do this job? (Journal entry, 15 March, 2015).
In some ways it also eased my apprehension that the first interview se-
cured through the recruitment process was with a medical practitioner who
was known to me. Similarly, the second interview I conducted was with a
consultant I knew personally. However, knowing the research participants
brought other challenges as I was conscious of the shift from social conversa-
tion to a more one-sided narrative that needed to occur and mindful in that
process that I was probing into aspects of their lives not previously disclosed.
Contrasted with subsequent interviews where I had no previous connection to
the participant, the negotiation of roles was more pronounced.
Frequently reference was made to the literature on various subjects and
statistical data related to outcomes, treatments, prognosis and patients. This
left me wondering where I was placed by the participants who were all suc-
cessfully positioned in the hierarchical organisation of medicine and for some,
also academia.
Reflecting on my journal entries I was aware that questioning my position-
ing in this context manifests my own preconceptions and latent beliefs that
ascribe status to medical professionals, in particular consultants, because their
work saving lives is more important:
Conducted the fourth interview today and I still feel unsure I have
gathered what I expected to, or what I need. The interview was
at the hospital and again this context made me very aware of
the limited time the consultant had available and the other, more
pressing and important demands on them. Am I just overly sen-
sitive to this? It brought into question my legitimacy researching
medicine from outside of the institution and in addition, wanting
to traverse territory that is quite possibly well-hidden even inside
the institution (Journal entry, 30 April, 2014).
Along with the tellers or performers of stories, Plummer (1995, p. 21)
identifies the “coaxers, coachers and coercers” who “probe, interview, and
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interrogate”. Doctors are one example, as are social researchers. Then there
are the consumers, readers and listeners who interpret and make sense of the
stories.
In these interviews I was coaxing the ‘coaxer’ and also the audience con-
suming the story. I was aware of occupying multiple roles in constructing the
stories that emerged. The power dynamics shifted accordingly. I had little
control over where and when interviews took place, how I was positioned by
the consultants’ and how this determined how they would answer the questions
I asked.
However through the analysis process the power I had to interpret and
represent the consultants’ experiences was marked and at times, disconcert-
ing. This experience was eloquently articulated in the following excerpt from
Plummer (1995, p. 21):
“Sometimes people hear so lightly what others say so intensely, and
sometimes people hear so intensely what others say so lightly.”
During the analysis process I questioned if what I had heard intensely, for
example in the stories of the diagnosis process, was relevant to the disclosure
experiences when for the consultants’ this was often presented as routine.
Similarly I could see times when they were hearing intensely, as if on guard,
to what I had said lightly as this transcript extract shows:
“Jo: So when you are called in an advisory capacity are you there
to manage the conversation with the patient and the family or has
that already happened?
Dr: Well, it depends. Can you clarify what you mean by “manage
the conversation?””
The experience of interviewing into this profession was challenging and at
times, frustrating yet it has strengthened my resolve to pursue opportunities
to continue research with clinicians. The barriers to entry are significant but
I believe there is value in hearing their voice in qualitative research given the
often negative representations of clinicians in much of the patient literature.
Outsider to the Medical Profession
Clearly not an insider to the medical profession I had a more acute awareness
of being distinctly outside of this population (Dwyer and Buckle 2009). I
questioned if the experiences consultants shared would have been restrained,
modified, or even withheld if there was a sense of ‘reputation’ or ongoing
professional relationship to be considered. Equally, I am aware of, and have
empathy for, the professional management of me as an ‘outsider’ to the con-
sultants’ world.
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Pragmatics determined the interviews were located in medical environ-
ments, often with unavoidable interruptions from phone calls and knocks at
the door. When interviewing participants I knew personally, this environment
facilitated a distinct and necessary boundary between social and professional
worlds. It also sharply contextualised my position as a non-medical person
who despite my own experiences of hospital care could not access the unique
and complex, micro society of the hospital.
This experience generated insights into my role in relationship to the re-
search participant from an insider/outsider perspective. Being outside of the
medical profession was both an advantage and disadvantage. At times in an
interview I wondered if some information was withheld or restrained because
I was not identified by the participant as a medical professional with whom
they may have a sense of a shared social reality that could engender profes-
sional trust. For example I would become aware of a hesitation when technical
aspects of patient care were being referred to and at others, a flicker of frus-
tration if I sought clarification on the way care was structured or pain relief
was negotiated.
The second interview brought into question more acutely the credibility
of researching from outside of the institution of medicine and using a qualita-
tive, rather than a positivist/empirical approach that is common to medical
research. This time I had to reorient to the person I knew socially as the
person-in-their-context that favoured a clinical approach to their meaning-
making of the diagnosis process.
Conversely, I considered the times I occupied an outsider status afforded
insights that I may not have been sensitive too if I was researching from within.
This was particularly apparent in my observations of the medical environments
where all of the interviews were conducted and the way the participants inter-
acted with their highly familiar territory. Stark differences were apparent in
the public, private and hospice offices and waiting rooms, from the intensity
of fluorescent lights highlighting blemished walls and battered metal furniture
to bird-song both real and piped softening the harsh realities of the cancer
embodied in the buildings. I waited alongside the patients and was greeted
then ushered into an office or treatment room much as they would be. In all
but one of the interviews, the room was furnished with a desk and adjacent
to the desk, three chairs in a row from which I was invited to select one to sit
in.
What appeared a routine and unremarkable practice presented immediate
dilemmas for interviewing because it wasn’t apparent that we could face each
other whichever chair I selected. Also I needed proximity to place the audio
recorder in position but if I sat too close would this assume an intensity
or encroachment given I wanted to elicit fairly personal information in their
‘professional’ space? Equally, selecting a seat at the end of the row may
indicate I was deliberately distancing myself from the participant. Each time
I did end up selecting the seat closest to the desk though it never became
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routine or comfortable and I frequently observed participants moving in to
face me, or around to their desk, or further away, in tune with the information
being shared and the questions I was asking.
Another advantage of researching from the outside was the latitude this
granted to ask questions that may have been considered naive, ill-informed or
confronting if I was a medical colleague. Unsurprisingly, this was easier for
me with the participants that I had no previous connection with, although
all of the research participants engaged deeply with the research questions
in the interviews. This level of engagement was rewarding for an early re-
searcher although access to their worlds was always limited by the power of
the participants’ position in relation to my own, as an outsider (Merriam et al.
2001).
Limitations of the Research
Disruption to the Research Process
With the progression of my father’s illness I found I was researching an is-
sue that was unexpectedly unfolding before me. I needed to reorient to the
realities that research, like work, is managed in the context of everyday life
and acknowledge that while I was an insider to the diagnosis process with
my father, I was an outsider to what it meant to be the person diagnosed.
Having conducted one interview and in the process of scheduling another, I
knew that if I continued with the interviews there was a risk my quest to
understand, prepare for and make-sense of, the personal vortex I had entered,
would lead interviews off-course. I had already become that carer, referred to
with disdain in the first and subsequent interviews I conducted, questing for
information on all the wrong search engines and had unconsciously expanded
my literature review to include end-stage prostate cancer. With my super-
visors’ guidance and support, I received approval to suspend study for four
months. The disruption meant I lost some continuity in the recruitment phase
and experienced an extended period of data collection.
Sample Size and Bias
Limited access to the research participants and the constrictions on the time
they had available was a barrier to including follow-up interviews in the re-
search design. The analysis has been limited to data collected from single
interviews only where repeated interviews may have facilitated an opportu-
nity to develop a deeper knowledge of the participant and to test and refine
the analysis.
The small sample size (n=5) of the research project is a limitation to the
generalisability of the research findings. Broader representation of gender,
ethnicity, age and medical specialties was not possible in a small sample size
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and therefore limited the analysis. Relying largely on a snowball method of
recruitment meant the sample was strongly biased toward participants with
professional interconnections. In some instances, the selection of participants
was influenced by other participants identifying who they knew and/or who
they thought would be a suitable research participant.
Ethical Considerations
A formal application was prepared and submitted to the University of Can-
terbury Human Ethics Committee for approval. Preparing the application
provided an opportunity to consider the potential ethical implications of this
research and identify strategies to mitigate these. I prepared an information
sheet and consent form as part of the application outlining the nature of the
research, an indicative interview schedule of questions and the time required
for the interview.
An important ethical consideration was the potential risk that research
participants may experience some emotional distress because they would be
engaging in a reflexive process about their professional experiences disclosing
a terminal diagnosis. There existed the possibility that in some instances
participants, when recalling experiences or specific situations with patients,
may identify or reflect on aspects of the process that didn’t go well. To manage
this potential risk I ensured the information sheet clearly communicated the
focus of the research interview so participants had time to gauge their comfort
with the process and self-select on this basis. I also offered to meet or call
to discuss the research in more detail so that participants could ask questions
directly. Three participants who had been referred to me accepted this offer
facilitating an additional stage to the consent process that allowed them to
consider the research and the researcher independently of the recruitment
process. These discussions were predominantly focused on the participant
ascertaining the relevancy of their experiences to the research and the logistics
of scheduling the interview.
Should participants have experienced distress in the interview, I planned
to pause the interview and offer to re-continue or if required, re-scheduled
the interview when the research participant was ready. However in all of the
interviews it was apparent that the participants had considered the issues and
their experiences beforehand; selecting anecdotes that were reflective but not
deeply distressful.
Confidentiality was another significant ethical consideration with this re-
search notably because of the small research sample and cohort. New Zealand
is a relatively small country with a correspondingly small number of medi-
cal specialists and as such, identities of research participants may have been
more readily identifiable. Assuring participants of confidentiality in this con-
text was paramount to ensuring participants were confident that they could
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disclose any information about their experiences without perceiving the pro-
cess could harm their individual professional standing and more broadly the
medical profession. To achieve confidentiality all potential identifiers were
removed from the research including names, references to family members,
geographical location, specific medical speciality and place of employment.
Furthermore, any anecdotal references to patients, their families and other
health professionals used to illustrate the participant’s experiences, were also
removed. Returning the interview transcriptions to the participants to review
also allowed time to redress any topics covered and withdraw any informa-
tion. Participants were advised of their right to withdraw from the research
at any time providing an additional mitigation strategy should participants
experience discomfort with the interview or reviewing the transcription.
Electing to research in an aspect of end-of-life care that was germane to my
life also presented ethical concerns in terms of the risk I could experience per-
sonal distress hearing the information and experiences consultants recounted
in the interviews. Not only would this be distressing for the participants if
I was noticeably upset during an interview, it may manifest more subtlety
impacting the ability to establish an appropriate research relationship. These
risks were discussed with my supervisors at the formative stages of the research
and meetings were scheduled prior to interviews, allowing time to reflect and
prepare. Simultaneously, the journaling process was employed to foster a self-
reflexive process to identify less discernible issues. These strategies were highly
effective and along with the decision to suspend studying minimised the risk
of personal harm.
Conclusion
I embarked on a research project with expectations of getting participants
to reveal to me, and possibly for the first time, themselves, deeply personal
revelations of their experiences. While I can reflect on this at the conclusion
of the journey and question my naivety, I can see that my starting point
facilitated the most significant learning in the thesis process. Perhaps because
I learn best by doing I had struggled to connect with methodological course
material. Daunted by the myriad of approaches and over eager to get on with
the business of doing research, I hoped to figure things out as I went along.
Consequently, I have faced numerous methodological challenges. I have
also learnt first-hand that social research does not happen in a vacuum and
while challenging on many levels, it has been integral to developing an under-
standing of both the practice and theory of learning what it means to engage
in qualitative research. It is from these experiences; pivotal to my research
journey and the research findings presented in the following chapters, that I




There is a largely critical body of literature detailing negative patient and
allied health professionals’ experiences and perceptions of truth-telling(Parker
et al. 2001; Schofield et al. 2001; Salander 2002; Schofield et al. 2006). Situated
within a complex realm of narratives in the literature that both glorify and
demonise the medical profession, the physician is asked to negotiate the pre-
conceptions and expectations of the patient to deliver a message that confirms
their death is imminent. The clinical encounter is viewed by Charon (2001,
p. 1900) as the site of a complex interplay of individual needs and socially
constructed responses where “granting tonic authority to its physicians while
regarding them with chronic suspicion, the public commands physicians to
understand and treat disease while doing no harm.”
To understand the practice of disclosure by physicians with their patients
I begin with the wider shifts in cultural and social expectations of medicine’s
management of death and dying. What emerges from the literature is the
practice and processes of disclosure cannot always be considered as distinct
acts of telling the truth or not. With the social and cultural expectations
that it is the physician who is responsible for the disclosure of a diagnosis
or prognosis, it remains in their remit to judge what to say and when. As
a consequence, the influence of medical culture on how the responsibility of
disclosure is interpreted, managed and enacted by physicians is integral to this
analysis.
The influence of medical culture on physicians’ experience of disclosure
is followed by a discussion of the process and experience of disclosure as a
single moment of telling or occurring over a longer process. Diagnosis is the
critical process of the disclosure of a terminal diagnosis or poor prognosis.
The processes involved in reaching a terminal diagnosis is managed within the
structure of medical specialities. This can mean for some physicians there will
be longer therapeutic relationships with their patients while for other physi-
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cians, the relationship will cease when curative treatment is no longer possible.
For both the physician and the patient, disclosure processes are shaped by the
organisation of medical care and this can mediate as well as exacerbate their
respective emotional responses and adjustment to the diagnosis or prognosis.
Physicians’ experiences of disclosing a terminal diagnosis or poor progno-
sis to their charges has been underresearched, despite ongoing calls for such
research to be done (Klenow and Youngs 1987; Dickson et al. 2002; Grassi
et al. 2000). In addition much of the physician situated research is generated
from quantitatively orientated perspectives such as surveys and as such the
physician’s voice is largely unheard (Dickinson and Tournier 1994; Dickson
et al. 2002; Dimoska et al. 2008). Drawing on the literature that considers the
potential impact on physicians of working with patients who are dying and
the disclosure process, I then look at how this can translate into what Frank
(2004, p. 86) Frank refers to as a “demoralization of medicine”.
Too Tell or Not to Tell
Although over time the preference for open-disclosure has become wide-spread
in western societies, the practice of full disclosure is less distinct. In this sec-
tion I argue that framing disclosure as truth-telling or lying over-simplifies
this nuanced and complex process. Disclosure does not occur in a “cultural
vacuum” and needs to be considered in a broader context of social and cul-
tural influences to understand why physicians may choose to manage how
much a patient is told and when. I consider the historical, technological and
demographic changes influencing the shifting boundaries of death and dying.
Alongside these changes social scripts of ideal deaths have emerged. Troubled
by an increased reliance on medicine and the moral imperative to preserve the
sanctity of life at all costs, I conclude from the literature that boundaries of
truth-telling in disclosure are not always indubitable.
Historical Shifts Influencing the Disclosure of Dying in
Western Societies
The decision to disclose a terminal diagnosis or prognosis to a patient, has
plagued medicine for centuries and has been the subject of philosophical, moral
and ethical debates that Sokol (2006a, p. 632) suggests frequently position
doctors as the “masters of equivocation”. In his historical analysis of the shift
in medicine in western society1. Sokol (2006a, p. 632) asserts the disclosure
1Though the focus of this research is practices of disclosure in a western society, there is a
body of literature referencing the cultural differences in disclosure preferences and practices
(Sokol 2006a; Wood, McCabe, and Goldberg 2009; Zier et al. 2012; Carrion 2010; Martis
and Westhues 2013; Arbabi et al. 2014) including China and America (Xue, Wheeler, and
Abernethy 2011), Asian patients in New Zealand hospital settings (Windsor et al. 2008)
and older people with a later-life disability in the US (Ahalt et al. 2012). However Nie
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of a terminal diagnosis or prognosis remains a contentious issue with many
of the ethical considerations for and against “benignly intended deception” as
relevant to the debate today as it was centuries ago. The ethos of preventing
harm that underlies this discourse of medical care is applied by proponents
on both sides of the disclosure versus non-disclosure debate.
Some of the literature on the disclosure debate references its genesis to
the time of Hippocrates in 400BC who wrote of his concerns to physicians
about the risk that patients will “take a turn for the worse” if told their
illness would result in death (Krisman-Scott 2000; Sokol 2006a, p. 48). The
practice of concealing the prognosis to patients was widespread throughout the
nineteenth and early twentieth century though, according to Krisman-Scott
(2000, pp. 48–49), some physicians had begun experimenting and reporting
on their positive experiences with truth-telling to their patient.
The shift toward more open disclosure in predominately western societies
decades later is discussed in the literature with reference to numerous sur-
veys of patients and physicians during the 1950s and 1960s (Field and Copp
1999; Krisman-Scott 2000; Gordon and Daugherty 2003; Sokol 2006a). Data
generated from patient surveys conducted in the 1960s in the United States
indicated an overwhelming support for full disclosure of information; however
surveys of physicians at the same time were less consistent (Krisman-Scott
2000; Sokol 2006a). Some physicians reported lying to the patient about their
prognosis in the terminal stages of cancer, in contrast to the results of another
study where the majority of surgeons disclosed a full account of the cancer
diagnosis (Krisman-Scott 2000; Sokol 2006a).
Sociologically, the work of Glaser and Strauss (1965) on awareness contexts
and dying trajectories reflects the growing interest in death and dying in
academic research at this time. Focusing on interactions with dying patients
and medical practitioners where there was a practice of non-disclosure, Glaser
and Strauss (1965, p. 64) identified ways patients and medical staff engaged
in what they termed the “ritual drama of mutual pretense”. The tactics
employed by staff to hide the truth and counter tactics used by patients to try
to uncover information identified tensions and difficulties for both the dying
patient and those caring for them when the truth was withheld (Glaser and
Strauss 1965; Timmermans 1994; Sokol 2006b).
Likewise, many attribute Kubler–Ross’s (1969) work on the articulation
of five psychological stages of dying that followed Glaser and Strauss, as a
powerful influence on prescribing new norms of death and dying (Timmer-
mans 1994; Seale 1998; Seale 1995; Seale 2000; Craib 2003; Seale and Geest
2004; Timmermans 2005; Kaufman and Morgan 2005; Charo Rodŕıguez et al.
2011). The work of Kubler-Ross (1969) on the stages of grieving situated the
(2011), counsels against dichotomizing east and west cultural differences in bioethics which
oversimplify and hide cultural pluralities. He argues against the sociological assumption of a
tradition of non-disclosure in Chinese medical practice and cites studies indicating a strong
preference from patients for knowing the truth.
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disclosure of a terminal diagnosis and prognosis to the patient as a critical de-
terminant toward the pathway of achieving a ‘good’ death. Full awareness of
impending death facilitated time for the patient to make sense of their death
and engage in shaping how their terminal phase is managed (Seale 1995; Field
1996). Medical practitioners who do not openly and directly disclose a termi-
nal diagnosis to their patient could be positioned through this lens as doing
grave harm by denying the patient the opportunity to prepare for a good
death.
The trend towards open awareness of terminal diagnosis since the 1960s
also parallels unprecedented technological advances in medicine. With ageing
populations increasing, along with life expectancies, end of life treatment de-
cisions are diffusing into a broader range of medical disciplines and frequently
complicated by existing co-morbidities e.g. renal dialysis treatment for an
older person with dementia (Grönlund, Dahlqvist, and Söderberg 2011).
Shifts in technological advances that evolve into new medical specialties
mean the scope of specialties are further refined and narrowed by higher lev-
els of specificity, for example oncologists that specialise in surgical oncology
or radiation oncology (Detsky, Gauthier, and Fuchs 2012). The impact of
specialisation can mean multiple physicians can be engaged in the disclosure
process with a patient. Detsky, Gauthier, and Fuchs (2012) highlight how
specialisation can mean the patient is seen less as a whole person as they
become compartmentalised relative to the specialty. Good (1994, p. 80) of-
fers a more global description of the impact on both the patient and medical
practice where disease is now the “object” and the person is the site of the
disease. No longer the “narrative agent” the focus has shifted away from the
patient’s world to what has become known as “routine, rational medical prac-
tice” (Good 1994, p. 80). Here, the patients’ experiences of their illness are
often subordinate to the physical manifestations of the disease and become
the singular focus of the diagnosis process.
Shifting Boundaries of Death
Seale (2000) attributes the effect of these technological, demographic and epi-
demiological shifts to a constantly shifting definition between potentially treat-
able to no-longer treatable conditions. For example, a diagnosis of cancer still
typically scares people, but with the increase in successful treatments it is no
longer considered synonymous with a terminal diagnosis (Seale 2000). Im-
pending death, when it is determined by a diagnosis, is in some instances able
to be a controlled and possibly slow death (Krisman-Scott 2000; Seale 2000).
Sokol (2006a) claims the shift in cancer disclosure is less attributable to
ideological changes on the part of physicians and more because of medical
advances in diagnosing and treating cancer from the 1950s onwards. Others
concur, arguing rapid medical advances have offered greater power to change
the conditions of dying and increased the range of options clinicians can offer
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patients to treat potentially life-limiting illnesses (Callahan 1993; Field and
Copp 1999). With more options available for treating pain and the disease
processes of terminal illnesses Field (1996) argues more medical practitioners
are willing to talk openly with patients about their diagnosis and prognosis.
In effect, rarely is there nothing more that can be done for the patient. Even if
curative intent is no longer possible, physicians can refer patients to palliative
specialists where a further range of palliative treatments become available.
Schofield et al. (2006) see this as a consequence of the increasing effectiveness
of medical intervention in that the disclosure conversation can be mediated
and softened with an extension of treatment options used in a palliative sense,
moving from cure to symptom control for as long as possible. They describe
this as a blurring of the traditionally “sharp transition point” from curative
to palliative care (Schofield et al. 2006, p. 398).
Timmermans (2005) points out that palliation becomes quasi-curative with
the use of hormone treatments, radiotherapy and chemotherapy in some ad-
vanced cancers such as breast and prostate that can be used to delay death
or keep it at bay. Correspondingly, constantly improving statistics of survival
rates change the disclosure conversation. The expectation of a good prognosis
from an initial cancer diagnosis maintains the focus on treatment options for
the disease rather than the impact this has on the patient’s life.
Clinicians are able to draw on discourses from hopeful anecdotal and sta-
tistical evidence of other patients’ survival. Willig (2011, p. 899) draws on
her own experiences being diagnosed with cancer, identifying how “military
metaphors” are used, appealing to patients and professionals alike to fight the
battle against disease “courageously and valiantly” to the end.
Craib (2003) also references the social and cultural scripts of dying that
have emerged, presenting models of idealised dying such as the heroic and
brave, living life to the full until the end, to the peacefully reconciled and
orderly, good death. In all of these scripts lies the notion of death with
dignity. Yet, Nuland (1994) in his book, How We Die reminds us the very act
of dying requires letting go of control over physiological systems as a “series of
destructive events that involve by their very nature the disintegration of the
dying person’s humanity” [p. 17]. He suggests the dignified death discourse
reinforces ideals of our own death, and the deaths of others we may witness
and learn from as romanticised moments of cleanly and calmly, slipping away
(Nuland 1994). The myth is perpetuated in our attempt to deal with the less
comfortable reality that death is rarely dignified (Nuland 1994).
For some patients, the plethora of palliative treatment options available
to where possible delay death may make the disclosure of a terminal diagnosis
easier but also increase expectations that their dying trajectory will be slow.
Schofield et al. (2006) caution new norms derived from the examples of other
patients who go on for years, can be inadvertently set up as the optimistic
message of a new hope; not a cure, but as many years as possible to death.
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Faith in Medicine for Salvation From Suffering
Lupton (2012, p. 7) reasons that in western societies trending toward increas-
ing secularization and individualism, survival is increasingly dependent on
medical progress and “faith in medicine is a creed”. Similarly, Good (1994,
p. 86) attributes medicine with not only influencing what we have come to
know as suffering but also as the mechanism for delivering salvation from that
suffering. Good (1994, p. 86) develops the claim that in a civilization “deeply
committed to biological individualism” the devotion to maintaining life and
reduction of physical suffering have become paramount. The conflation of
these widespread beliefs of human agency taming the powers of nature and an
avowed sanctity for life produces a powerful mandate for physicians. Charged
with salvaging life from death’s icy grip positions medicine and medical prac-
titioners as the intermediaries between life and death in the literature (Good
1994; Nuland 1994; Callahan 2000).
According to Chapple (2010) this produces a moral imperative for patient
and physician alike to preserve the sanctity of life against the enemy of death.
Simply accepting death is considered to be a rejection of modern medicine and
therefore a rejection of the value of human life (Chapple 2010). Good (1994)
argues this translates into clinicians needing to act whenever they can and
patients expected to accept their actions, in the medicalised fight to salvation.
In doing so, Callahan (1993, p. 89) positions medical science as integral in
distancing society from death by focusing attention single-mindedly on the
causes of death and “fostering the illusion that mortality can be eliminated
by eradicating lethal disease”.
This imperative for action underpins medical professionalism and to not
act could risk legally and morally contravening the Hippocratic Oath. In
the research for this thesis a key theme was physicians desire to preserve the
patient’s hope and alleviate suffering. Even when patients were moments from
death, physicians talked of intervening to lessen the symptoms of dying. To
not intervene could be considered giving up and having nothing more to offer
their patient, when they considered there was always something more that
could be done. To this end, what we have come to know as natural death is
medically managed as the good death; peaceful, pain free and welcomed when
the time is right (Shim, Russ, and Kaufman 2006).
However, Callahan (2009) positions death in this context as contingent and
isolated to the individual, such that the patient will die because of misfortune;
a biological accident, or individual failing rather than as an inevitable outcome
of being mortal. As a result the ongoing belief in the power of medical inter-
ventions is not threatened because death can be explained as individual and
isolated events (Chapple 2010). Thus, Chapple (2010, p. 81) argues in a death
denying society the contingent death of others provides distance from our own
death; “it is a problem only for those immediately affected by it, rather than
for the society at large”.
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Furthermore, death remains controlled and contained within the medi-
cal paradigm. Timmermans (2005, p. 1000) argues the range of ideal deaths
that has proliferated seemingly tailored to “specific dying situations” such as
hospice care, sudden death, and even assisted suicide are “now firmly under
medical control”. Managing the potential threat of new and alternative dy-
ing movements, he claims medicine “colonises” and absorbs competing scripts
from these movements into orthodox practice; with the more “radical edges
smoothed out” in the process (Timmermans 2005, p. 1000). Palliative care,
as one example is often referred to as “a movement” informing an alternative
ideology, with its attendant ethics and morality, on “how best to die” (Mc-
Namara 2004, p. 936). McNamara (2004, p. 936), views the hierarchy of care
in palliative care organisations, where medical responses to the physical care
of patients has prominence, as a way of offering “certainty and control to an
uncertain process”. She concludes decisions practitioners made on whether to
intervene or not in the patients’ dying are not only “rooted in science, but
are overlaid with decidedly moral imperatives to change the circumstances of
their patient’s lives, and ultimately, their deaths” (McNamara 2004, p. 936).
Blurred Boundaries of Truth-Telling
In the literature on disclosure, the decision to withhold information from the
patient of the extent of their illness is frequently referred to as lying (Grassi
et al. 2000; Hagerty et al. 2005; Sweeny, Shepperd, and Han 2013). Telling,
or not, becomes moralised as lying or truth-telling and the literature positions
physicians as good or bad depending on what position is advocated (Sokol
2006b). However, other authors more generously see the physician’s hesitancy
as a less sinister attempt to “soften the blow” and not take all hope away from
the patient (Timmermans 2005, p. 152).
Alongside this, some authors challenge the notion of direct and full disclo-
sure with arguments based on degrees of truth-telling (Hak, Koëter, and Wal
2000; Krisman-Scott 2000; Anderson, Kools, and Lyndon 2013). Running the
gambit of outright lying to withholding some information or details about the
future trajectory of the end of life process, it is suggested that some physicians
may consider they are telling the truth, even though this has been somewhat
modified or indirectly discussed (Miyaji 1993).
Lutfey and Maynard (1998) provide examples of an unspoken collusion to
avoid talking of death directly from three episodes of doctor-patient interac-
tion. Although the focus of the conversation was on the patient’s terminal
illness and prognosis, the words ‘death’ or ‘dying’ were never used but only
indirectly alluded to. Similarly, in a study conducted in 1997 of 365 American
doctors predicting survival in 504 cancer patients the subtleties of telling begin
to emerge. Here, it was found doctors withheld prognosis from a quarter of
patients, and for the remainder were less likely to provide their own beliefs of
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the actual prognosis, instead providing an overly optimistic estimate to many
patients (Sokol 2006b, p. 635).
Timmermans (1994) sees this as a gradation of the awareness contexts orig-
inally provided in Glaser and Strauss’s (1965) seminal work. In this context
open awareness is distorted to an “uncertain open awareness” where clinicians
remain the “gatekeepers” of information but hold back on the full account or
soften the information to maintain the patient’s sense of hope (Timmermans
1994, p. 332). Hodkinson (2013, p. 108) also looks at the blurred boundaries of
truth-telling arising from the demands on the clinician to balance professional
and legislated obligations to provide information to patients while ensuring
patients are protected from harm and distress. However McNamara (2004)
identifies another clinical situation where disclosure is potentially more com-
plicated. Citing the hospice model ideal of the patient being openly aware of
their dying, she identifies how palliative practitioners are increasingly chal-
lenged by discourses of patient autonomy and consumers of healthcare where
patients can decide if, and how much they want to know. The decision to
disclose a poor prognosis in this instance is removed from the physician but
this can be difficult to negotiate when families and loved ones want to know
and when seeking consent to treatment, particularly palliative sedation.
Some physicians also find it difficult to negotiate the transition from cu-
rative to palliative care. Broom et al. (2014) in their study of Australian
medical specialists engaging patients in the referral to palliative care found
broader social contexts for the variability in how this was negotiated. For
many patients, palliative care was equated with imminent death and along
with a loss of hope; they experienced a loss of the therapeutic relationship
that had developed with the specialist (Broom et al. 2014). The process of
referral had to be negotiated with care, patience and sensitivity in the context
of uncertainty about how long their patient may live (Broom et al. 2014).
A number of specialists spoke of the discussions as difficult and drawn out
when they sought ways to minimise distress (Broom et al. 2014). Viewed in
the context of specific patient biographies, some specialists cited examples of
young patients dying as reasons for wanting to maintain treatment for as long
as possible, particularly as young patients offered the greatest resistance to
palliation (Broom et al. 2014). For many, tactics emphasising palliative care
specialists as “more capable” were employed to assist patients and their fam-
ilies to come to terms with transition and get them the specialist palliative
care needed to support them (Broom et al. 2014, p. 158).
The key issue germane to this research is the judgement lies with the clin-
ician for whom the “burden of proof for the appropriate use of this privilege”
still rests (Hodkinson 2013, p. 129). These debates bring into question how
physicians experience the disclosure of a terminal illness in the context of ex-
pectations from society that the ‘right’ behaviour is to provide a direct and
full disclosure and their professional ethos is to do no harm.
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Medical Culture
The process of professional socialisation as integral to the making of a doc-
tor is articulated in a wide body of literature (Becker 1961; Haas and Shaffir
1982; Becker 1993). Medical students own agency in adopting, aspiring to,
and constructing professional meanings of being a doctor is considered in
the literature as part of the socialisation process (Charmaz and Olesen 1997;
Kasket 2006b; Kasket 2006a; Arráez-Aybar, Castaño-Collado, and Casado-
Morales 2008). The influence of medical culture and socialisation on how
disclosure is enacted is integral to this thesis. Learning how to judge what
to say to a patient, and when, I suggest, can be traced to the very first
stages of medical education. Here, medical students learn and adopt strate-
gies to appear competent as medical professionals. Managing their emotional
responses to situations few lay people witness to ensure their clinical effec-
tiveness is not compromised is critical. However, tensions can emerge with
the all-consuming demands of medical practice, professional expectations and
the needs of patients. Thus, examining the literature on medical culture situ-
ates the physicians’ experiences of disclosure analysed in subsequent chapters
within a powerful professional context.
Medical Socialisation
Haas and Shaffir (1982) claim the process of successful socialisation to the
medical profession is facilitated by a separation from the lay world. Drawing
on Goffman’s (1959) theories of impression management they argue learning
the language of medicine, adopting medical scripts and wearing medical attire
replete with tools of the trade separate the doctor from lay people and support
the performance of appearing competent (Haas and Shaffir 1982). Developing
a “cloak of competence” they claim, is all encompassing for medical students,
co-opting their time, social lives and belief systems as they strive to deliver a
convincing performance of their medical and professional competence (Haas
and Shaffir 1982, p. 84). Facing the potential criticism, shame and embarrass-
ment from their audience, be that patients, peers and/or senior clinicians, the
pressure to appear competent is immense (Haas and Shaffir 1982).
Coined the “hidden curriculum” by Hafferty and Franks (1994, p. 865), the
term refers to the medical training outside of the formal medical curriculum
students are exposed to, in particular how explicit cultural and ethical values
of right and wrong within the medical profession are internalised. Hafferty
and Franks (1994, p. 865) consider the cultural influence on medical training
that is in part a response to social and professional expectations that doctors
will react differently to what they see and what they think, than lay people
do.
From the cadaver dissection to the disdain from senior clinicians toward
emotional involvement and expression, a number of authors have written about
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how medical students learn to adopt strategies of emotional detachment to
maintain neutral affectation (Parsons 1951; Hafferty and Franks 1994; Kasket
2006b; Arráez-Aybar, Castaño-Collado, and Casado-Morales 2008).
Parsons (1951) referred to the act of dissection as a rite of passage in
medical training that he saw as not only a tool for learning anatomy but
”. . . a symbolic act, highly charged with affective significance” that estab-
lished young doctors relationship with death (Parsons 1951, p. 445). Pa-
tients are viewed as “victims of disease, objects for learning and subjects for
research. . . transformed into objects of work and sources of frustration and
antagonism” (Hafferty and Franks 1994, p.865).
Strategies of managing emotions to align with what is deemed profession-
ally appropriate for the young doctor begin to emerge and can be seen at play
in the disclosure of a terminal diagnosis or prognosis to a patient.
Emotion Management Strategies
Shaw, Brown, and Dunn (2013, p. 247) suggest some doctors distance them-
selves from the patient through the presentation of biomedical information
in order to block the patient’s emotional response and avoid feeling uncom-
fortable themselves”. In addition to communication skills, they identify other
factors that contribute to how a clinician discloses a terminal diagnosis or
prognosis including the emotional impact on them and how this may interact
with their psychological characteristics and more broadly, their working con-
ditions such as work-load and the structure of clinical care (Shaw, Brown, and
Dunn 2013).
Results from their research supports the work of Loge, Kaasa, and Hytten
(1997, p. 881) that “contrary to what many physicians believe, clinical com-
munication skills do not reliably improve from more experiences”. The reason
for this is largely because some doctors rely on coping strategies formed very
early in their medical training to reduce their own feelings of stress associ-
ated with early disclosure experiences with patients (Shaw, Brown, and Dunn
2013). Where these strategies have proved successful in reducing anxiety for
the clinician, Shaw, Brown, and Dunn (2013), found they are likely to be
adopted in the future, despite the potential negative impact on the patient.
They also cite a “culture of invulnerability” many of the clinicians in their
research referred to as influencing how they responded to the disclosure pro-
cess (Shaw, Brown, and Dunn 2013, p. 245). In this culture doctors did not
discuss their feelings with their colleagues and intellectualised the disclosure
process to prevent any emotional experiences interfering with their objectiv-
ity, although some admitted doing this as a “self-preservation” technique to
control their emotions (Shaw, Brown, and Dunn 2013, p. 246).
Hochschild (2003) in The managed heart: commercialization of human
feeling identifies the characteristics of professions where workers are expected
to provide emotional labour to generate particular emotions in others, par-
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ticularly in service industries. She uses the example of flight attendants who
are trained to control passengers’ emotional responses to perceived danger,
such as turbulence, by suppressing their own emotional reactions (Hochschild
2003). Medicine is another profession Hochschild (2003) identified requiring
emotional labour. Patients seek comfort, care, support and understanding
from medical professionals. Medical professionals are expected to respond
empathetically to all patients and suppress their own emotional reactions to
conform with patient and professional expectations (Hochschild 2003).
Drawing on the work of Hochschild (2003), Kasket (2006b) attributes the
socialisation to medicine as a vocation as a key influence in how clinicians
learn from the earliest moments of entering the profession the rules of emotion
management. These rules are premised on putting the patient’s needs first
and ensuring they operated with clear-sighted clinical effectiveness (Kasket
2006b). Research suggests, clinicians’ fear of losing control of their own feelings
and fear of the reactions of patients and family when breaking bad news
to terminally ill patients is sometimes a barrier to telling (Friedrichsen and
Milberg 2006; Johansen et al. 2012). Kasket (2006b) identified strategies
some doctors adopt such as selecting specialities where death is less likely to
be encountered regularly, or deflecting their own feelings from the encounter
through focusing on the patient’s feelings or even blaming the patient in an
effort to avoid emotional engagement.
The Voice of Medicine
Barry et al. (2001, p. 479) draw on Elliot Mishler’s concept of the “voice of
medicine” used to describe the rational, purposeful and scientific attitude of
the clinician reflected in conversations with patients that are dominated by
medical interests. In contrast to the voice of medicine, is the “voice of the
lifeworld” which refers “to the patient’s contextually-grounded experiences of
events and problems in her life”(Barry et al. 2001, pp. 487–489).
They cite the clinical encounter as a context where the voice of medicine
can seek to colonise and silence the voice of the lifeworld to achieve the ra-
tional, purposeful outcomes of medicine (Barry et al. 2001, p. 488). The en-
counter is dominated by the clinician’s objectives and the patient’s lifeworld
is effectively blocked from the conversation by focusing on symptoms, disease
and treatment (Barry et al. 2001). In some instances, speaking predominately
in the voice of medicine is effective, particularly when the patient is also seek-
ing the same information. However, when the patient wants to include the
context of the illness in their life in the conversation, such as the effect of
treatment on their future ability to work or care for family, and the clinician
speaks only in the voice of medicine, they can feel alienated and dehumanised
(Barry et al. 2001).
Yet as Kneebone (2014) points out, clinicians are socialised to speak to
each other with precision and clarity about the patient’s anatomy, physiology
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and pathology. Medical students craft their skills at editing and orating the
patient’s narrative of their illness. Called upon to demonstrate in medical
rounds their ability to identify, diagnose and communicate the physical symp-
toms of the case history demands information is succinct, precise and detached
from the patient (Kneebone 2014). Kneebone (2014, p. 1179) describes this
technical voice as highly effective but limited because it has been “filleted of
emotional content”.
In an analysis of clinical interactions where physicians disclosed bad news,
clinicians’ deliveries were often factual and abstract which encouraged recipi-
ents’ to reciprocate with “emotionally distanced” responses (Maynard 2003, p.
154). Shim, Russ, and Kaufman (2006, p. 17) describe this as a language that
“forces objectivity and decisiveness,” redirecting emotional responses toward
rationality and control. Medical language, McNamara (2004) poses, can only
speak of death in the context of “action, survival and effort” (Bauman quoted
in McNamara 2004, p. 935). Consequently, disclosure of a life-limiting illness
can quickly avert to focusing on treatment options rather than the possibility
of dying.
Taylor (1988) identified in her research with seventeen breast cancer sur-
geons and 118 disclosure events, three phases of telling used by the majority
of the surgeons. First, the conversation began with a “preamble” to “set the
stage”, leading to the “confrontation”; in this case the confirmation of the
breast cancer diagnosis, followed by “diffusion” where to lessen the impact of
the diagnosis, discussion shifted toward medical interventions (Taylor 1988,
pp.116–117). Interestingly, although many of the surgeons considered they
communicated an accurate prognosis to their patients, Taylor (1988, p. 116)
categorised only ten percent of the events as this. In only fifteen percent of
the events did the surgeons admit to being uncertain of the best way to treat
the cancer and in the majority of events (45%), Taylor (1988, pp. 116–117)
identified techniques of evasion, such as referring to general statistics where
the correct technical response would indicate a poorer prognosis.
Friedrichsen and Milberg (2006) warn of the risks inherent in disclosure
conversations where the emphasis is on engaging the patient in dialogue on
treatment, particularly in the transition to palliative care. While they agree
providing information is critical, along with emotional sensitivity and the will-
ingness to talk about prognosis, the concern is patients can misunderstand the
intent of the conversation and interpret their illness as treatable (Friedrichsen
and Milberg 2006).
Lupton (2012) points out that clinicians too have their own lifeworld they
bring to the clinical encounter that infuses with their voice of medicine. As
such, Jutel (2009, p. 279) views the medical encounter as “a relational pro-
cess with different parties confronting illness with different explanations, un-
derstandings, values and beliefs”. In this way, Lupton (2012, p. 9) argues
clinicians are not neutral observers in the disclosure process but are agents
in re-orienting their patients to their new future through translating medical
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knowledge to create a shared understanding of what this knowledge means for
the patient. Barry et al. (2001, p. 491) suggest the reliance on the voice of
medicine is necessary to some extent in any medical encounter and consider
the voice of medicine is “not in itself inherently bad”. Though they conclude
there is a need for doctors to be more open to discussing the concerns of the
patient’s lifeworld, this too is contextualised to a medical system where time
is limited, and doctors are trained to elicit patient information following a
structured format of medical questions (Barry et al. 2001).
In contrast, Frank (2004, p. 78) warns against the medical voice that speaks
in a monologue about the person with disease rather than to the person who
is before them. However, the literature points to how, through the language of
medicine, spoken with social and cultural authority, patients and their families
come to understand directly and intuitively not only what is expected of them,
but what to feel (Timmermans 2005; Shim, Russ, and Kaufman 2006).
Medical Time
The impact of the economic value accorded to medical professionals’ time
on the disclosure of a terminal diagnosis cannot be underestimated. Physi-
cians’ time is a high-value commodity that must be managed accordingly in
the context of increasing demand for health-care and diminishing budgets
(Frankenburg 1992). The imposition of structured medical care means dis-
closure conversations are contained to the time available in clinics or patient
rounds.
In contrast to the physicians’ immersion in medical culture, for many pa-
tients how time is structured and prioritised to the tasks of the medical project
unfolding can be bewildering and antithetical to their experience of being un-
well. Laranjeira, Leão, and Leal (2014, p. 14) highlight the contradiction
between the patient’s need for a more flexible rhythm when “clock time” and
routine is disrupted by illness and a health care system with an emphasis on
“hectic turnover or throughput of patients and an ever increasing pressure
to discharge early”. Similarly, Frank (2004, p. 139) highlights how “being ill
slows our pace” and yet rather than attune to the patient’s needs, “institutions
expect everyone to speed up”.
Shim, Russ, and Kaufman (2006, p. 8) define the role of time in the medical
system as “the marker for things health professionals think should happen and
for things that must get done, and it weighs heavily on everyone”. Time is of
the essence in the battle to hold back death, leading to what Chapple (2010,
p. 89) describes as a “ritual of intensification” clinicians use to “redouble”
their efforts, justifying the use of corrective interventions in the moral and
ethical fight against death. Notably, Mosenthal, Lee, and Huffman (2002,
p. 76) report in their research on surgical culture where death can be seen
as failure, aggressive curative intent dominates the goals of care are “often
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focused on procedural endpoints, morbidities, and mortalities, rather than
patient-oriented goals or quality of life”.
Even in the transition to palliative care, decisions to continue treatment
are presented not just as a way to alleviate symptoms but also to “buy time”
and hold off death for as long as possible (Chapple 2010, p. 70). However, the
irony of “hospices hope work” as Chapple (2010, pp. 100–101) points out, is
that patients must give up the expectation of “more time or more therapy”
in the acceptance of dying and hope of a good death. This peaceful, good
death informed by the death revival movement can only come when “hope
for recovery is to be officially abandoned” (Chapple 2010, p. 187). She asserts
that clinicians express satisfaction when dying is on time and without surprises
so that family and loved ones are in attendance and physical symptoms are
seemingly controlled (Chapple 2010).
Communication Skills
Studies indicate the way disclosure of a terminal diagnosis is communicated
and managed can positively influence how well the patient makes the adjust-
ment from treatment to palliation (Schofield et al. 2006). As a response to
a mostly negative evaluation of medical practitioners’ communication skills,
there are a range of models outlined in the literature developed for physi-
cians to use when disclosing negative or bad news (Meier, Back, and Morrison
2001; Baile et al. 2002; Boyle et al. 2004; Sweeny and Shepperd 2007; Legg
and Sweeny 2013). These are designed to fill the gaps that have not been
addressed in medical school training and professional development. However,
the critique of clinicians’ performance is ongoing, which brings to question
both the validity of focusing on communication skills and the efficacy of these
models to address it (Hagerty et al. 2005).
This focus on communication techniques, styles and models for “break-
ing bad news” is so frequently discussed that in some medical journals it is
simply referred to as the acronym, “BBN” (Barnett 2002; Shaw, Dunn, and
Heinrich 2012; Shaw, Brown, and Dunn 2013). Many of these techniques
are designed to support and guide clinicians to disclose the diagnosis to their
patients with emotional acuity and sensitivity. Equally, as with any communi-
cation management technique, they can be strategically deployed, not always
intentionally, to modify how disclosure is communicated but not necessarily
change the intent of what is being communicated. Good et al. (1994, p. 858)
identified what they termed “narratives of immediacy” used by oncologists to
explain and justify the focus on immediate actions and interventions (p. 858).
They observed oncologists “deflecting” discussions of prognosis by “drawing
patients back” to discussions on treatment where “endings are rarely made
explicit and progression is measured in calibrated bits, even though disclosure
is considered to be the norm, a patient’s right in American medicine, and
frankness is valued” (Good et al. 1994, p. 858).
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Kasket (2006a) reflects on the research interviews she conducted with
physicians and noted how the process of deflection was frequently used with
her. She found it difficult to move the conversation away from communication
skills issues in order to get the physicians to talk more about the emotional
processes of telling patients and families a poor prognosis. She describes this
as though the physicians had “so thoroughly and strongly internalized feel-
ings about not feeling or expressing personal emotion about patients that
they found it difficult to comprehend that I was asking about this aspect of
experience” (Kasket 2006a, p. 394). This resonated with my own research ex-
periences where the theme of the research project was most often interpreted
by the physicians I interviewed as a focus on communication styles and how
best to disclose a terminal diagnosis or prognosis.
A Single Moment of Telling or a Process Unfolding?
Diagnosis is integral to the system of medicine providing legitimacy and au-
thority to present an ordered account of the disordered set of symptoms which
bring patients to the clinical encounter (Jutel 2009, p. 278). In this way, diag-
nosis frames and focuses the clinician’s view of their patient. In the clinicians’
narratives from this research, diagnosis is the starting point; where the possi-
bility of disclosing a life-limiting illness begins, and sometimes ends. Diagnosis
is inextricably linked to disclosure; “the foundation from which sense-making
and experiences are crafted” for the patient and clinician alike (Jutel and
Nettleton 2011, p. 794).
In the process of diagnosis, both patient and clinician must navigate the
structure of medical care, often fragmented by medical specialisation and as-
sociated professional boundaries (Jutel and Nettleton 2011). For the patient
the often multiple diagnostic events leading to the disclosure of a terminal
diagnosis or prognosis can allow time for contemplation of treatment fail-
ure. However, this is in stark contrast to the clinician for whom the testing,
diagnosis, consideration of treatment options and management of palliative
care might evoke a sense of routine, with less acute boundaries (McManus
2012). These diagnostic processes and treatment regimens can provide a level
of predictability and back-stage preparation for the clinicians’ disclosure per-
formances (Goffman 1959). However, I argue that over the course of the illness
trajectory the physician is required to do more than disclose the outcome of
the diagnosis. Rather, there is a careful negotiation with the patient to seek
their ongoing trust and commitment to the pathway of medical care and sal-
vation from suffering (Good 1994).
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The Centrality of Diagnosis to the Physicians’ Experiences of
Disclosure
Diagnosis, is described by Brown (1995, p. 39) as “the language of medicine”
and by Jutel (2009, p. 288) as “the fulcrum of the medical narrative” situ-
ated at the intersection of the patient’s lived experience of an illness and the
clinician’s medicalised version of their story.
Learning to identify and present this medical narrative, is according to
Kleinman (1988) based on the medical student developing a scepticism for the
patient’s story. The patient, Frank (1995) claims, is expected to surrender
their narrative to this process when seeking care so the true facts of the illness
can be determined. In return, diagnosis provides access to what Parsons
(1951) described as the sick role for the patient; legitimising permission to be
unwell and authorising an exemption from the responsibilities of day-to-day
life.
In a study of medical residents conducting admissions interviews, Dav-
enport (2011, p. 873) analysed their “diagnostic storytelling” to identify how
they determine the answer to the most fundamental questions of “what’s going
on here?” Working in a short period of time from first encountering the pa-
tient to presenting their case history to other physicians, residents habitually
employed “narrative templates” to determine how to organise what facts are
relevant based on their medical knowledge of disease, treatment, outcomes and
what they have learned of the patient from their records (Davenport 2011, p.
874). Without applying some form of “organizing filters” Davenport (2011, p.
875) reasons physicians would be overwhelmed by the amount of information
in patient’s case files and in their narrative.
Leder (1990, p. 18) draws on hermeneutics and a narrative analogy, de-
scribing diagnosis as an interpretative process whereby the patient presents
with symptoms of bodily events that the physician reads as a text in order to
take over the authorship and transform the story, so that they can “wrest the
story from its malignant author and write a happier conclusion”. Interpre-
tation is aided for the physician from reading secondary texts. He identifies
these as the narrative text, or case history, the physical examination and the
instrumental text such as diagnostic tests and scans (Leder 1990, p. 11).
Reading these texts commences from the earliest encounter with the patient,
informing what information the physician chooses to seek and prioritise from
the patient’s narrative and the instrumental texts (Leder 1990, pp. 16–17).
However, Leder argues that medicines’ claims to “purified objectivity”
have led to a “flight from interpretation” with physicians seeking to “free
themselves from the patient’s restricted perspective and the subjectivity of
their own perceptions” toward a much greater reliance on instrumental texts
(Leder 1990, pp. 20–21). Nevertheless, these seemingly objective texts are
also subject to interpretation, and therefore misinterpretation. For example,
Moskowitz (2010, p. 127) cites a retrospective study of mammography re-
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ports that showed significant discrepancies in the readings of radiologists and
their treatment recommendations. Nevertheless, the instrumental text is of-
ten referred to in disclosure conversations as scans and x-rays are presented
to patients and their families as proof and at times independently from the
physician’s diagnosis (Rosenberg 2002). The attention on scans and test re-
sults can also act to deflect attention away from the emotional responses to a
poor prognosis or diagnosis toward the management of the physical disease.
In the literature on the sociological analysis of diagnosis, the identification,
classification and naming of disease is considered in the context of its central-
ity both to the system of medicine and in creating social order (Rosenberg
2002; Jutel 2009; Brown, Lyson, and Jenkins 2011; Jutel and Nettleton 2011;
McGann and Hutson 2011). Diagnosis provides a framework for organising
illness, determining treatment options, predicting responses to treatment and
explaining disease (Rosenberg 2002; Jutel 2009; Brown, Lyson, and Jenkins
2011; Jutel and Nettleton 2011; McGann and Hutson 2011). Rosenberg (2002,
p. 256) concurs stating that even if the expectation of a diagnosis cannot be
met in the clinical encounter, the process of diagnosis is still “socially effica-
cious” because “anxiety and mystery can be ordered, if not precisely allayed”.
How disease is categorised and diagnosed is contextualised more broadly
by Brown et al (2011) who consider the interplay of economic, political and
cultural structures on diagnosis. They point to diagnosis as a social process
beyond the individual to disease within the wider population. Multiple actors
such researchers, government agencies, commercial entities, social movements
are seen as contributing to an understanding of disease.
Jutel (2009, p. 278) positions diagnosis as a “powerful social tool” rein-
forcing the authority of medicine and its practitioners in the identification
and explanation of illness and disease. Even in the context of greater pa-
tient autonomy and engagement in medical care, it is clinicians who can use
their discretion to decide on their patient’s behalf if further investigation is
warranted (Jutel 2009). This is viewed as an element of the doctor-patient
relationship that has survived from the paternalism of days past where the
clinician “remains the key arbiter and thereby still holds significant juris-
dictional authority” (Jutel and Nettleton 2011, p. 796). Furthermore, it is
through the process of diagnosis that insight into the organisation of medicine
and the “interplay between medical care providers and professional territories”
is revealed (Jutel and Nettleton 2011, p. 799).
Rosenberg (2002, p. 256) alerts the reader to the assumption of diagnosis
as a “discrete act taking place at a particular moment in time” even though
it is frequently a “collective, cumulative, and contingent process”. In research
by Salander (2002) cancer patients’ narratives of the disclosure of their diag-
nosis were analysed. It was found patients generally talked about a longer
process, from their first contact with clinical staff and ending with conclusion
of treatment, therefore arguing the focus is never on a single moment.
Schaepe (2011) also supports the concept of disclosure as a process but
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then goes on to describe three circumstances patients recall being told their
diagnosis, suggesting there is a moment at some point in the process patients or
their families remember as significant. In the first of these situations patients
were in an emergency department and did not recall hearing the diagnosis
although their caregivers did “feel the full force almost immediately” (Schaepe
2011, p. 916). This contrasted with the primary care setting where patients
were told during a visit to the doctor and then faced having to tell loved ones
after, in what was described as a “two-stage trauma”(Schaepe 2011, p. 916).
In the final setting patients were diagnosed with a secondary cancer that had
developed or recurred a year or so after the first diagnosis. This too, seemed
to be both a process of diagnosis that culminated in a moment of disclosure,
the impact of which was recalled by some patients using metaphors such as
“a blow” (Schaepe 2011, p. 916). The reference to metaphors of violence with
the news of disclosure is also referred to in Gordon and Daugherty (2003)
Hitting you over the head’: oncologists’ disclosure of prognosis to advanced
cancer patients. The use of such metaphors seems to indicate an immediate
reaction to a shock that is felt as an assault (Schaepe 2011).
Maynard (2003, p. 12) reports that for the patient, disclosure can be ex-
perienced as a “graphic moment”, often recollected because it is subject to
frequent rehearsal with the telling and retelling to family, friends, employers
in the process of sense-making and reorganisation of their lifeworld that fol-
lows. It is perhaps Willig (2011, p. 898) who offers an intermediary and more
workable position suggesting the “cancer journey” is a trajectory punctuated
by “crisis points” (Coward, quoted in Willig 2011, p. 898).
The Ongoing Negotiation of Trust
Following disclosure, Page and Komaromy (2005, p. 306) identified how pa-
tients and their loved ones lives are recast as “the time before, and the time
after” the diagnosis. The future must be re-imagined; the planning of what
comes next and goal setting projected into a medical future (Page and Ko-
maromy 2005).
Multiple consultations may be required in the process of determining a final
or resolute diagnosis, a process eloquently described by Jespersen and Jensen
(2012, p. 348) where each consultation “works as a form of folding machine:
it connects points that were previously distant in time and space”. Not all
consultations follow a predictable path and the time in between consultations
are also a significant but different part of the process for the patient and the
clinician (Jespersen and Jensen 2012, p. 348). In a study by McQueen (2009)
of patients waiting for a possible cancer diagnosis indicated many experience
acute distress and anxiety. Recipients reported experiencing a distorted sense
of time waiting for, and receiving bad news in the encounter (McQueen 2009).
Maynard (2003, p. 12) describes the distortion of time such that “one’s inner
sense of duration can expand or contract relative to clock time... it may be
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agonizingly long or startlingly short as breakdown of the taken-for-granted
occurs”.
This positions the physician as continually needing to renegotiate trust
and confidence in their medical expertise while possibly working with little
certainty of what the diagnosis may be, in effect, seeking the patient’s contin-
ued trust in the likelihood of further uncertain testing and treatment options
(Schaepe 2011). Schaepe (2011, p. 912) draws on research indicating that
“trust is an outcome of situational predictability”. For cancer patients and
their families/loved ones the need for stability and to be able to trust the sys-
tem and physicians were competent was high (Schaepe 2011). Hence clinical
encounters very early into the diagnosis process served as defining “trust-
building or distrust building experiences” where the staff and the hospital
were closely scrutinised (Schaepe 2011, p. 918). How effective these encoun-
ters were at building trust could determine how bad news and subsequent
medical interventions would be experienced by the patient (Schaepe 2011, p.
918).
For the physician, disclosure of test results and further prognosis can be
complicated when there is no clear indication ongoing testing and treatment
will produce the anticipated outcomes. Williams (2005, p. 137) notes that
ironically and paradoxically, the advances of medicine that sought to address
medical uncertainties, have indeed generated greater medical uncertainties
that impose significant strain on the clinician and their interactions with their
patients. Bradby (2009) also talks of how symptoms can infer a multitude
of causes, many of which can now be tested for, at a refined cellular level
previously unavailable. This may produce a clear diagnosis for some illnesses
such as diabetes, but for other cases, it can result in an ambiguous, sometimes
even contradictory diagnosis (Bradby 2009). When medical treatment fails,
disappointment and uncertainty emerges, for example when young lives are
lost or illness is debilitating and ongoing and there are few explanations to
offer meaning in these situations (Lupton 2012, p. 8). Yet, as Lupton (2012)
suggests dependence on medicine in times of ill-health continues.
Telling as a Rite of Passage
The influence of the medical practitioner on the disclosure process and the
dying role is deemed by some to extend beyond simply communicating a diag-
nosis or prognosis. Disclosing bad news has also been considered as a ritual,
representing the threshold to the liminality or transition between exiting one
social world; health, and entering another; illness (Maynard 2003, p. 11). In
this sense, diagnosis and disclosure are rites of passage to the transition from
health to illness that ends when the patient re-enters with a new status of
cured or dying (Little et al. 1998; Blows et al. 2012).
Boland (2013) describes liminality as characterised by disorder and a time
when the social order, or what we thought we knew, is questioned. In re-
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sponse, people withdraw from what they knew as the normal modes of their
lives. Correspondingly, during this liminal time of the ritual process Boland
(2013) is of the view there are traditionally more freedoms with fewer limits
on behaviour. To ensure behaviour is managed so the ritual is completed,
Boland (2013, p. 230) outlines the role of “masters of ceremonies” who are
often in attendance to guide the participants through the transition. In this
way, clinicians can be considered as masters of ceremonies guiding patients
through the upheaval of illness, ensuring they reassemble their experiences in
culturally and socially preferred ways (Boland 2013).
The risk is when patients refuse to enter the liminal transition or exit
unexpectedly; the ritual is not completed, leaving the clinician and patient
bereft and separated from the culturally sanctioned identities (Blows et al.
2012). With increasing survival rates for many cancers, Blows et al. (2012)
see patients and clinicians trapped in an extended liminality where the threat
of recurrence prevents a clean exit and holds both in confused state of health
and illness care in perpetuity.
Death-brokering
Timmermans (2005, pp. 993–994) draws on the analogy of insurance bro-
kers, arguing medical experts are brokering “the existentially frightening and
ambiguous aspects of death and dying” on our behalf. “Death-brokering”
according to Timmermans, expands the telling of death to the negotiation
of cultural expectations of the acceptable line between “curing or letting go,
achieving a ‘good’ death and avoiding ‘bad’ deaths, attributing legitimate re-
sponsibility for the death, and determining relevant lifestyle and therapeutic
changes to keep on living” (Timmermans 2005, p. 994).
Charged with managing and explaining death, Timmermans (2005) rea-
sons the authority of medical professionals is unquestioned and reinforced
through an ever-increasing dependency on medical experts’ involvement to
offer solutions to an ever-increasingly medicalised process of dying.
Guiding a patient toward the trajectory they have “brokered” requires a
skilful presentation of themselves as competent and caring medical profession-
als who can be trusted to deliver the agreed outcome (Timmermans 2005,
p. 995). Page and Komaromy (2005, p. 295) consider medical profession-
als’ behaviours with patients, families and staff in light of Goffman’s (1959)
metaphorical presentation of self as a dramatic performance of impression
management.
The patient’s perception of the clinician and their acceptance of future
management of their life-limiting illness are based on how well the clinician
can negotiate their trust (Schaepe 2011). This suggests in part, negotiating the
patient’s trust draws on the professional status of medicine in society and the
culturally and socially determined expectations of how medicine will manage
the care of dying patients (Page and Komaromy 2005). Clinicians’ enactment
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of “scripts” convey impressions of professionalism, particularly when there is
consistency with appearance, setting and manner (Goffman 1959, pp. 21–
22). Drawing on Goffman’s (1959) theories of impression management brings
into question how longer and repeated processes of diagnosis or the “temporal
length of the performance,” affect the physician’s experience of disclosure. In
addition the clinician is often performing in front of multiple audiences such
as the patient, their loved ones, and even multidisciplinary care teams (pp.
27,215) .
Doctor–Patient Relationship
The relationship between doctors and their patients has shifted and changed
as patient advocacy groups and the increasing rise of active health consumer
awareness has heightened social awareness of the traditional asymmetrical
nature of the doctor-patient relationship (Lupton 1996; Lupton 1997; Williams
2005; Thompson 2007).
Consumerism in health care assumes the patient is willing and able to
evaluate, select and voice complaints about health services; challenge medi-
cal decisions and “resist paternalism or medical dominance” (Lupton 1997,
p. 373). Access to health information and support from self-help and vol-
untary groups, alongside an abundance of health information available on
the internet have had a significant impact on the doctor-patient relationship
(Thompson 2007). The shift to a focus on chronic health conditions is cited by
Thompson (2007) as an example of the wider influences on health care. The
knowledge and contribution people with chronic conditions make to managing
their illnesses has led to their recognition as expert patients in health policy
(Thompson 2007). In addition there has been a shift towards “incorporating
patients’ perceptions, values and preferences into a more subjective medicine,
moving health care goals towards quality of life and patients’ perceptions of
health”(Thompson 2007, p. 1298).
Consequently expectations of the role of the physician have also increased
as they must now navigate the dynamic shifts in the patient’s role with a
profound emotional acuity and technical accuracy in the context of complex
medical uncertainties. Lupton (1997, p. 380) in her critique of health con-
sumerism discourse develops the claim that some patients may seek a relation-
ship of dependence on a paternalistic doctor, “even as this confounds expecta-
tions around ‘consumerism”. Furthermore, she holds it is possible to consider
the health consumerist movement evokes a “rationalist anti-authoritarianism
against an ‘other’ (in this case members of the medical profession) defined as
controlling” (Lupton 1996, p. 169). Yet when patients are seriously ill and
frightened dependency on doctors can increase and rather than see the doc-
tor as an authoritarian ‘other’ they are a welcomed and reassuring presence
(Lupton 1996, p. 169). Lupton (1996, p. 165) positions the exchange of care
between patient and clinician in the medical encounter as a commercial and
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professional transaction, based on duty and payment of fees with an expecta-
tion the patient will respond with “gratitude, docility and compliance”.
In recent shifts away from the more traditional paternalist relationship,
patient-centred medicine is upheld in public health policy discourses of con-
cordance; a concept developed from an investigation into the failure of patients
to comply with treatment regimens (Bissell, May, and Noyce 2004; Steven-
son 2004). According to Stevenson (2004) concordance is premised on the
patient and doctor working as equal partners in the negotiation of treatment
plans and a greater understanding of the implications of that treatment on
the patient and their lifestyle. Concordance also assumes a respect for differ-
ences discussed openly and rationally in the context of an equal partnership
(Stevenson 2004). Yet, Bissell, May, and Noyce (2004, p. 860) critique the
concept, arguing concordance retains a focus on changing the patient’s atti-
tudes, not the clinicians. In this way, they see concordance as another model
of patient-doctor relations that risks being used to impose medical views on
how patients should behave (Bissell, May, and Noyce 2004).
Conrad (1985, p. 25) stresses that not all people share their doctor’s view
as they “feel and act on symptoms in many non-medical ways” so that what
seems to be irrational noncompliance “may be a well-thought-out plan to avoid
medical and social ‘side-effects’ which might impair personal and work life”
(Brown 1995, p. 45). Field (1996) too, considers even the dying role may be
influenced by expectations of medical practitioners. Ironically it is the hospice
model, premised on supporting the patient to die the way they want, he cites
as an example of this influence. Underpinned by the happy, positive death
discourse, Field (1996) points out it would be very difficult for a patient to
resist and die unhappily with rage and anger in a hospice.
Patients come to the clinical encounter with their own lifeworld under-
standings, concepts and meanings, hopes and plans. These are shaped by
past experiences with medical professionals, other people’s experiences and
information from social media as well as patients’, class, gender, age, ethnic
or racial groups (Lupton 2012). Ultimately, however concordance could mean
negotiations may fail and in the end the patient and doctor agree to differ.
The question this raises for the disclosure of a terminal diagnosis or prog-
nosis is what it means for clinicians when patients resist, refusing to accept
the diagnosis or choose to walk away from the treatment and care clinicians
can provide.
Failure and Demoralisation
The pressure on physicians to perform in socially, culturally and professionally
prescribed ways when caring for dying patients can lead to a demoralisation of
medicine and medical practitioners. When treatment fails or patients choose
not to accept the treatment offered, physicians can experience feelings of frus-
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tration and failure. Little support is available for clinicians to express these
feelings with powerful professional norms influencing physicians’ ability to ac-
knowledge emotional pain. In addition, physicians must negotiate the care of
their dying patients within tightly managed allocations of their time by the
medical organisations for whom they work. As such they are challenged with
finding ways to manage the relationship with their dying patients so they do
not feel abandoned and alone. Yet, often physicians are siloed into specialities
that mean they rarely have the opportunity to care for their dying patients
to the very end or say goodbye. This brings to question the impact of the cu-
mulative exposure to at times tragic and difficult patient deaths on physicians
and what, if anything, can be done to change this.
Failed Performances
Nuland (1994) describes the need for control as a factor in the personalities of
many physicians he has worked alongside. He argues “when control is lost, he
who requires it is also a bit lost and so deals badly with the consequences of his
impotence”(Nuland 1994, p. 258). Failed performances in telling, brokering
and guiding in the disclosure and subsequent journey to the ideal cure or
peaceful death sometimes provoke anger, embarrassment or humiliation for
clinicians and raise suspicions of medical mismanagement if patients or families
feel wronged (Goffman 1959; Timmermans 2005).
Charon (2001, p. 1898) in her work on narrative medicine, positions med-
ical practice within a series of relationships, “between the physician and the
patient, the physician and himself or herself, the physician and colleagues,
and physicians and society”. She, like Frank (2004), considers how connec-
tions between these relationships can be improved through listening to pa-
tients’ narratives that “demand the courage and generosity to tolerate and to
bear witness to unfair losses and random tragedies” (Charon 2001, p. 1899).
However, others have critiqued her approach, warning of the additional and
possibly unrealistic expectations of “superhuman empathy” this establishes
for patients and doctors alike (O’Mahony 2013, p. 614).
Macnaughton (2011, p. 1941) from the Centre for Medical Humanities in
Durham, cautions against thinking feelings such as empathy can be taught.
She stresses the suggestion it is actually possible to feel what another person
is feeling is both dangerous and unrealistic because “we cannot gain direct
access to what is going on in our patient’s head”. She concludes: “a doctor
who responds to a patient’s distress with ‘I understand how you feel’ is likely
to be both resented by the patient and self-deceiving” (Macnaughton 2011, p.
1941).
The dynamics of emotions at play are unpredictable but likely to be ex-
pressed by the patient with an intensity few others experience in their daily
work (Kasket 2006b). It is also likely that those emotions are sometimes
experienced as acutely by the physician. Meier, Back, and Morrison (2001)
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documented physicians’ feelings of inadequacy, frustration and failure as com-
mon responses to this situation. Yet, Grönlund, Dahlqvist, and Söderberg
(2011) identify expectations of physicians to operate largely independently
and alone. This creates a culture where they are often unwilling or unable to
have time with their equally busy colleagues to discuss the less medical aspects
of what their work entails (Grönlund, Dahlqvist, and Söderberg 2011).
Charon (2001, p. 1900) reasons because doctors “educate and police one
another” they also take on responsibility for their fellow practitioners “compe-
tence and conscience.”. Wallace (2010, pp. 7–8), in her research into mental
health and stigma in the medical profession talks of “the conspiracy of si-
lence” where physicians are reluctant to recognise or talk openly about any
psychological problems that might be due to their stressful working condi-
tions. Reinforcing normative behaviour and stigmatising deviance from that
norm, sets up the potential for substantial risks to the physician who dares to
disclose their own emotional pain lest it be considered irrational and an im-
pediment to their technical competence (Wallace 2010). Frank (2004) shares
this view articulating a particular aloneness that is in stark contrast to the
pretence of collegiality and membership in the medical profession.
Demoralisation and Burn-Out
It is not surprising that a theme in the literature is the burn-out of medical
practitioners in the face of the resilience they are expected to develop from
early on in their career (Ramirez et al. 1995; Meier, Back, and Morrison 2001;
Kuerer et al. 2007; Jackson et al. 2008; Guest et al. 2011; Roth et al. 2011;
Jasperse, Herst, and Dungey 2014; Shanafelt et al. 2014; Poulsen et al. 2015).
Where there is research on their personal experiences of emotional and ethical
difficulties, it is problematised and to some extent individualised indicating
that dominant discourses of rationality and stoicism in medical professionalism
may be threatened by narratives of mental illness (Cochrane et al. 1991; Wal-
lace 2010). An inability to sustain the psychological and physical endurance
expected, risks disrupting not only the professional norms but according to
Bradby (2009) also risks disrupting the social order of medicine that expects
a social good model of medicine to prevail.
Doctors adopting what is sometimes referred to as an “emotional suit of
armor” in the literature, to hide their real feelings and present the emotions
expected are at risk of losing touch with what they really feel (Aronson 1966
quoted in Kasket 2006, p. 139). As a result Frank (2004, p. 86) asserts doctors
and patients become isolated and estranged, no longer able to respond with
generosity toward each other, resulting in what he describes as a “demoral-
ization” of medicine.
It is the system of institutionalised medicine that Mildred Baxter holds
accountable for creating a sense of “alienation” from doctors and their patients
(quoted in Jutel & Nettleton 2011, p. 797). While Frank (2004, p. 27) too
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acknowledges there are many reasons why the practice of medicine is impacted
by how medicine is organised he maintains these reasons can become “multiple
alibis” to “truncate care”. Rather, he returns the focus to the individual,
arguing “in the interpersonal moment of practicing medicine, anyone can act
differently” (Frank 2004, p. 28).
Frank (2004) attributes the pursuit of curing illness and disease as a way of
buffering and distancing humanity from the incurable. Instead death is rarely
talked about and yet, as Callahan (1993, p. 129) states, “death is a universal
human experience, and it derives its meaning as much from this universality
as from the different circumstances of individual lives and deaths”.
Remoralising Medicine
When the focus on cure is no longer plausible, patients judge the physician
on how well they have conveyed a sense of comfort that might mitigate any
perception of abandonment by the medical system (Mast, Kindlimann, and
Langewitz 2005). Yet Back et al. (2005) found discrepancies between what
clinicians stated they did to avoid this and patients and families experiences.
Poignantly, Back et al. (2005) write of how clinicians rarely say goodbye to
their patient and families when it is unlikely they will attend any further clin-
ics. They suggest not saying goodbye risks leaving patients and their families
perplexed and although this may not be appropriate for all patients, acknowl-
edging the end of the therapeutic relationship can be “deeply meaningful”
and “a way of embodying the scope and power of one’s limits as a physician”
(Back et al. 2005, p. 684).
Gawande (2014, p. 293) in his book Being mortal: medicine and what
matters in the end critiques the medicalisation of death and dying and as the
title suggests reminds us that “endings matter”. He advocates confronting
the reality of dying with patients rather than pretending it can be beaten.
Gawande (2014, p. 306) argues this means there has to be an understanding
that ”there are times where the cost of pushing exceeds its value” in order for
the medical establishment to be able to offer the compassion that allows for
more humane ways to die.
Remoralising medicine, according to Frank requires finding ways to com-
bat isolation and connect with patients and colleagues to “restore generosity”
(Frank 2004, p. 137). This shift in approach recognises and seeks to include
the expression of emotional pain yet as Frank (2004) points out this is rarely
afforded to those giving the care. Kasket (2006a, p. 395) concludes in her pa-
per with two stories involving patients with horrific injuries and tragic death
told by physicians during her research. She is struck by the “carnage” and
confrontation with death physicians are often exposed to in their work that
few outside the profession would ever witness (Kasket 2006a, p. 395). Yet the
high potential for post-traumatic stress as a result is “scarcely apprehended”
(Kasket 2006a, p. 395). She too ponders how things could be different if expec-
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tations of doctors by others and themselves were questioned more frequently
and the stigma of physicians accessing psychological support was diminished
(Kasket 2006a)
Conclusion
The myriad of often conflicting views in the literature of how clinicians should
respond to patients, colleagues, and their own needs positions the process of
disclosure of a terminal diagnosis or prognosis within an array of critique and
expectations. In the literature, disclosure practices and processes are influ-
enced and shaped by the organisation of medicine and medical socialisation,
cultural and social expectations of medicine and the management of death and
dying and organisation of medicine and powerful narratives of ideal deaths.
Within this are theories and commentaries on the motivations of physicians in
the disclosure process and the degree to which they determine when and how
much information on a terminal diagnosis or poor prognosis is communicated
to a patient and their loved ones. Situated within a complex realm of narra-
tives in the literature that both glorify and demonise the medical profession,
the physician is asked to negotiate the pre-conceptions and expectations of
the patient to deliver a message that confirms their death is imminent. The
clinical encounter is viewed by Charon (2001, p. 1900) as the site of a com-
plex interplay of individual needs and socially constructed responses where
“granting tonic authority to its physicians while regarding them with chronic
suspicion, the public commands physicians to understand and treat disease
while doing no harm”. How this resonates with the experiences of clinicians
in this research engaged in the practice of disclosure with patients is explored




In the five biographies that follow I have written of the characteristics of each
clinician emerging from their narratives based on the interviews conducted.
Experiences they shared often served to illustrate their values and beliefs which
were apparent in the way they practice medicine. Focusing on the disclosure
of a life-limiting illness to their patients they revealed a broader contextual
landscape from which to understand how the clinicians’ experiences were often
markedly different.
Each clinician came to medical school with their “lifeworld” experiences
and the completion of at least seven years of medical education was followed
by further specialisation. Consequently, in their own unique ways they have
learned to speak with the “voice of medicine” (Barry et al. 2001, pp. 487–
488). However, socialisation to this culture has been experienced differently
and integrated to varying degrees with their own lifeworld values. How each
clinician experiences the disclosure of a life-limiting illness to their patients, it
could be argued, is an indication of how successfully they have been socialised
to the culture of the medical profession.
Some of the clinicians recalled early career experiences that speak of being
witness to situations where patients were ignored or abandoned by senior
clinicians. The complex and nuanced process of disclosing a life-limiting illness
to their patient occurs within the clinical encounter that is embedded within
and shaped by, the cultural contexts of medicine. It is a culture that has
influenced and informed how each of the clinicians has learned to ‘tell’. They
all recalled being taught some form of communication skills in medical school.
For Dr Z, the oldest of the clinicians interviewed, there was little emphasis on
this whereas Dr X, the most recently trained, talked of specific modules on
“breaking bad news” in medical school that was a feature of her specialisation
in general practice.
There is a sense that for some, despite the vast amount of research that
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informs models and medical school curricula of teaching communication skills,
including “breaking bad news”, experience on the job has continued to be the
primary and most valued source of learning. Their narratives of experiences
as medical students infer for some a resistance to the normative behaviour
of other medical practitioners. The process of ‘cherry-picking’ is recalled as
a way of selecting the good from the not so good, of how to behave with
dying patients. Some clinicians recount their reactions to significant formative
situations. They are experiences that have informed how they wanted to be,
not only because the behaviour they witnessed was antithetical to their values
of how people as patients should be cared for, but importantly, because of
how they, at the time chose to respond to the situation that unfolded.
How they negotiate and attempt to resolve the conflict in their values
experienced in these encounters conveys how they practice medicine today as
senior clinicians. Embedded within this dominant culture, narratives of their
learning, particularly where the collision of lifeworld and medicine occur, have
significance in their experiences with dying patients.
Dr X
Dr X had a period of twelve years working when she left high school, followed
by nursing training then medical school. Now qualified for thirteen years, Dr X
works in two medical roles. Dr X drew on formative experiences from nursing
and medical school; a primary feature of Dr X’s narrative was the power
dynamic inherent in the way medicine is structured. As a student nurse asked
to sit with a man who was near death, she felt unprepared and unsupported.
Unsure what to say to this man estranged from family and dying alone, Dr
X faced a personal and professional dilemma. New to both Christianity and
nursing, Dr X sought to comfort her patient. She said to the unconscious
man, “Do you know god loves you?” At once his breathing eased, he opened
his eyes, looked at her, and with a sense of peace prevailing, died.
“But yeah I think that was one of the most powerful things that
first taught me about how important it is about being ok, about
trusting your unique self to do what you feel you need to do and
follow through on that. . . ”
It was a powerful and significant experience for Dr X and symbolic of the
tension, uncertainty and discomfort she experiences when her values jar with
the often contradictory discourses of medical professionalism. On another
occasion as a junior doctor in the emergency department, a woman in her
forties who was having difficulty balancing and was “banging into things in
the supermarket” was admitted. The woman was sent for a head scan and the
results reveal she had brain metastases from lung cancer. The disclosure of
the diagnosis was handed to Dr X:
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“. . . it felt wrong because I think that I felt like other people had
opted out. I tried to do it in the best way that I could but it was
like, yeah, it was like she seemed to have no warning that this could
be coming and then anybody who would have more experience in
delivering this information than me was not going to be part of
that, and yeah, it was left to me to do it.”
Dr X’s early experiences influenced how she strives to communicate bad
news in her own practice, ‘ ‘so I think when I’ve had the opportunity to do it,
I’ve wanted to do it well but at the same time it’s not necessarily a comfortable
thing to do with people.” Despite feeling “there’s a lot of uncertainty attached
to it,” Dr X accommodates this in an acute awareness of her inner self; an
intuition she draws on to guide her actions and inform her sense of right and
wrong. Her courage to trust and act from her own values is sometimes counter
to the medical model:
“The medical model, it’s just very much about symptoms, have you
got this, have you got that, and not really about the how and why
and the curiosity to find out the whole picture about someone. I
think if you do that you’ll find that what people want to know is not
what you think they want to know. I think you have to let yourself
be vulnerable to not knowing anything sometimes.”
Dr X evaluates her choices of how she communicates and cares for her
patients, compared with her colleagues. It is a system she is at times outside
of, and othered by:
“In your work as a general practitioner too, you really work on
your own so you’re not really sure how other people do things so
you never quite know where you sit in the continuum of all those
kind of things.”
Dr X references experiencing how tenuous life is for her patients, where
she is acutely aware bad news is constituted in many forms particularly for
vulnerable elderly patients:
“. . . I see all these things as bad news, delivering bad news, like
it’s just not ‘oh well you’ve got a terminal illness.’ It’s like, ‘you
can’t drive anymore’ and to me it feels like bad news because I feel
sometimes really powerless in how to help people because everything
seems to become much more difficult when people get old.”
If Dr X feels powerless to help this does not prevent her from trying hard
to navigate a healthcare system that “could be a lot more smooth running in
delivering things for people.” Guiding Dr X in her practice is a determination
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to never let her patients feel there is nothing more that can be done for them,
least they feel abandoned; “I have the sense that instilling hope in people
is a really core thing of my values.” Her effervescent style, evident in the
passion with which she shared her experiences, saw her frequent laugher spilled
into tears and back to joy. She was very comfortable in her ‘uncomfortable’
experiences. She consciously accommodated the discomfort inherent in her
assessment of her own and other’s actions. That this might wake her in the
night is not hidden in her narrative, but brought forth as part of how she
dynamically made sense of her world:
“I find I wake up in the night quite frequently, that’s the time. . . I’m
not quite sure how you necessarily do anything about that because
they haven’t been conscious in the day time but clearly there’s
subconscious processes going on sorting, you know, trying to sort
things out.”
Throughout her narrative, Dr X reflected on how medicine is organised,
practiced and taught, often questioning how this is so, and how it could be
better. She meets her patients as people, seeking to consciously care for them
as autonomous and knowledgeable participants in their journey with her:
“I think in terms of my expectations of myself and trying to feel
conscious of being able to, not being all things to all people, because
clearly you can’t do that and I know that, but feeling like you’ve
had, or hoping that the other person has had an experience which
is beneficial and uplifting for them, because that’s important to me
and I don’t know if I get it right or I don’t, but certainly that is my
intention. And I don’t know whether being really conscious makes
your life harder or not. Sometimes it feels like it does (laughs).”
Harder or not, Dr X was comfortable with the ambiguity and uncertainty
her self-reflective practice of medicine facilitated in a way that was uniquely
her own.
Dr K
Dr K’s pathway to palliative medicine unfolded after a number of years in gen-
eral practice offshore. Many of his patients were elderly so he was diagnosing
and managing a lot of terminal illnesses. Dr K was doing continuing medical
education to enhance his skills in this area, particularly because there were
no hospice services available. Taking on an additional role supporting the
development of a hospice ward in a nearby hospital, Dr K realised how much
he enjoyed this work, “it’s quite a rewarding area to be in; also, when you’re
in a palliative care team, you’re never carrying any of this stuff by yourself.”
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Relocating to New Zealand he undertook specialist training in palliative
medicine and is now medical director of an urban hospice. Palliative medicine
is a place where Dr K feels he can make a huge difference by managing
patients’ symptoms so they and their families can focus on “the meaning-
making. . . growth and development that can happen in the terminal phase.”
Although he is acutely aware that his job is “to sort of get out of the way; it’s
not really about me. . . it’s not really about my god like powers as a doctor; it’s
really creating the conditions for that stuff the patient and family have to do.”
Advocating for palliative care, Dr K cites the challenges he faces in the
medical profession with an emphasis on curing and eliminating disease. He
talks of his mantra, “palliative care is active care” informed by his belief that
“there is always something more that can be done” for a dying patient. At
times it is an almost contradictory context he navigates, when in some situa-
tions colleagues resist palliative care involvement and in others, his specialist
knowledge means patients are readily handed over when a cure cannot be
found.
“Sometimes our recommendations are welcome and sometimes peo-
ple get stroppy. There’s a lot of relationships and you have to be
collegial. . . . But I have heard that they don’t want to deal with
palliative care. . . And we are in fact as specialist palliative care
providers, we by definition, get the ‘too hard basket’ for a lot of
other practitioners, that’s part of the point of our speciality.”
Anticipating patients will want to talk about dying with him because he
is the hospice doctor, Dr K is often disclosing not just a prognosis, but what
dying will likely be. Sometimes it is in the privacy of a patient’s bedroom
when alone with a patient they ask “the ‘How long have I got, doc?’ question,
that’s often, they don’t want to ask that necessarily in front of their family.”
Then because his practice extends beyond the patient to their family and
loved ones, he will suggest to his patient they talk about those issues with
their family afterwards.
He cites studies showing “if somebody dies peacefully and the family are
supported, there’s less depression downstream, there’s less complex grief.” Dr
K considers this is a measurable outcome for palliative medicine. In the uncer-
tainty of death, Dr K finds it reassuring for him and his patients, to anticipate
what could happen and have a plan A, plan B and plan C. This process gives
back some control to the dying patient faced with the wearying experiences
of losses, “chipping away” at their life. Much of what Dr K seeks to do is try
to re-frame the loss, as new achievable goals.
Dr K believes to work in palliative care “you have to reflect upon your own
mortality.” Experiencing the death of his older brother before he trained as a
doctor is to this day something Dr K says is “quite front and centre for me to
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think about things.” He shares the poignant story of his father, who was also
a doctor, being told his son was dying:
“The doctor who was looking after my brother came in and started
to talk to my dad, because my dad was a doctor, she started to
talk all the medical stuff about what was happening and my father
stopped her and said, ‘I don’t need to know, I know he’s going to
die, I don’t need to know this’. That stayed with me a long time,
well till now. So I now I feel I can ask patients and families ‘how
much do you want to know about what is happening’ because if they
want to know, they will tell you.”
In his teaching with junior doctors, Dr K talks of the centrality and in-
escapability of death, reminding them they will come across dying patients in
every rotation. He challenges how death and dying is communicated; a staunch
advocate of clear and unambiguous language, he implores his students, “If you
mean die, say die or dying; please don’t say ‘pass away’, ‘move on’, ‘time is
short’, ‘things aren’t looking good’ or whatever the million euphemisms are.”
Language and words are also an important part of Dr K’s meaning-making.
Creative media are referred to often. For example, he talks of music shared
with dying patients at the hospice and embracing the way other cultures deal
with dying:
“And the music that happens around here is also amazing because a
lot of music happens, Māori-Pasifika usually. Somebody Samoan
is here, choir comes in, they’ll stand around singing, it’s lovely,
everybody loves it, patient, family, patient in the next room, fam-
ily down the end of the corridor, staff, everybody loves it when it
happens. It’s never intrusive it’s always pleasant.”
He sees music as a very safe way for people to talk about death; “everyone
can think of a song that means something to them and they get tearful about
this and that song, but it’s all kind of ok if it’s a song.” What began as a
self-reflective process; a way of “dealing with things naturally” grew into a
way of communicating this message to a wider audience. A couple of years
ago he organised a public event, with live music selected largely from African-
American music he grew up with. For Dr K the lyrics of the songs he selected
spoke of hopeful transitions in the dying trajectory:
“For me, it’s my music and the songs about dying and grief and
loss and healing and that was the important theme I wanted to get
across in that concert that I organised was the trajectory to healing
‘when the doctors give up, the healing begins’ . . . ”
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When I asked what he would do if he was not doing his current role, he
replied instantaneously he would do another concert, in America, and this
time he would get funding to make a documentary of it. Dr K exemplified
a vocational and personal commitment, fuelled by crusading enthusiasm for
palliative care.
Dr Z
As a senior radiation oncology specialist practising in the same city over the
course of his extensive career, Dr Z’s patients can span generations of the
same family. The joy of the job for him is the relationships he has with his
patients and their families. Making connections across families can be an
opportunity to give back to patients and is a hallmark of his practice. On
one occasion while looking at a patient’s family tree, in a consultation with
a woman concerned she was carrying breast cancer genes, Dr Z identified “at
least a dozen names” of people he had treated. His “peculiar brain” meant he
could recall for his patient particular memories of one relative whom she had
only met once, facilitating a connection she greatly appreciated. Although he
has a strong belief in the very good public health system, now working in a
private clinic Dr Z feels he is able to offer a greater continuity of care, compared
with the potential for disconnect in the public system where patients may be
seeing different registrars at each appointment. Because of this continuity he
feels his patients “get to have a relationship that is almost like friends with a
professional boundary thrown in.”
“They know a bit about me, I know quite a bit about them which has
nothing to do with their actual cancer journey but actually helps
form a relationship so that . . . you can talk often a little bit more
easily about bad news or a change that might be bad news, because
you know a bit more about the patient or in particularly you know
a bit more about the patient’s support systems and family.”
Despite a significant shift in survival rates from cancer illnesses during the
course of his career, Dr Z still has many patients at any one time who are dying.
With people living longer now and cancer more of a chronic illness he is always
“balancing the co-morbidities of the other illnesses in terms of [your] ability
to withstand orthodox treatment of that particular cancer.” When patients
are dying he if often having to delicately discuss early on treatment decisions
to determine when interventions would be appropriate; something Dr Z finds
easier in the context of a well-established relationship with his patient:
“. . . you can have talks around, ‘I wouldn’t artificially resuscitate
you if had a cardiac collapse and you were in the last week or so
of your life unless you specifically said you wanted to be.’ ‘Oh
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thanks, no, of course I don’t.’ ‘But if you had an infection and
I could treat the infection and get you back to the quality of life
you had before the infection that meant that you’re daughter can
get back from London or something, it would be sensible to do that
wouldn’t it?’”
Forming these relationships is facilitated by Dr Z’s comfort communicating
with people from diverse backgrounds. He attributes this to his formative
experiences from his upbringing and his pathway to medical school:
“I think that’s one of the harder things for young doctors now
because I was of that era where you had the holiday jobs and things
like that which were for want of a better description, ‘working-
class’ jobs, and we could get them. So I had five years in the
freezing works, had a year off, a year at Certified Concrete, got
landed in the territorial army. . . and I played a lot of sport so you
come across all sorts of people . . . So I think that really, really helps
and I wasn’t bright enough to get straight into medical school so I
did a science degree first, so I was probably a couple of years older
as well . . . so I’d done a bit of growing up beforehand so it was a
little bit easier.”
Similarly, limited access to diverse “working-class jobs” as holiday work
for today’s medical students concerned him. Dr Z is a strong advocate of
the interpersonal skills needed to successfully treat patients, and suggests
that even though today’s medical students are “much, much, brighter” they
are not necessarily the “most rounded” having “never mixed up against the
common man or woman.”
Dr Z’s learning experiences as a young doctor came from working alongside
the “grumpy old surgeon who might have been a bloody good surgeon but was
absolutely useless at talking to patients.” Interestingly, Dr Z has now treated
some of those surgeons, one of them even thanking him for “mopping up after
him at the end of the ward round after me doing the wrong thing.” To which
Dr Z replied:
“Well, you were shy; I could tell you were shy. He was the third
generation of surgeons all with the same surname and my mother
who was a nurse describes his father as exactly the same, grumpy
and imperious, he was probably shy too, probably went to a posh,
private school and didn’t get taught any communication skills.”
He acknowledges medicine can be a tough profession where doctors put
a brave face on their pain and grief because this was “what they signed up
to do.” Dr Z talks of his own experiences of this when as an oncologist
he is dealing with bad news most days. Characteristically, he believes the
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“gifts from patients being grateful or friendly or pleased to see me” more than
compensate and are more than many other specialists receive. He is not
nervous talking about bad news or sad situations. He feels he is able to
do it so that most of the time it’s a positive experience for the patient and
their family, often resulting in getting a hug from everyone on their way out.
There is a cumulative grief he feels from these situations, but Dr Z considers
he copes because he has been able to contribute to helping his patients in
their acceptance of dying and the meaning-making that can come from that
for them and their families. No less emotionally expressive with age, he is
comfortable showing sadness in front of patients and alone:
“I still cry about lyrics and poems and bits and bobs and things like
that, and that helps me cope with my day-to-day job when I can
feel a bit moist eyed about something. But its okay, the true hurts
gone because I’ve acknowledged what it means.”
Dr Z receives gifts from patients, though he gives much in return. His care
and abiding respect for his patients connect him to their humanity. He meets
them as people and seeks to offer the best care he has available to nurture
them through their cancer journey.
Dr B
Dr B is a surgeon at an urban public hospital. He estimates up to seventy
percent of his non-emergency operative work is in breast cancer surgery. For
the purposes of the interview he selected to talk about his experiences dis-
closing life-limiting diagnoses to patients with breast cancer. His career as a
surgical specialist has evolved alongside the growing trend toward medical spe-
cialisation in New Zealand. He considers this shift toward sub-specialisation
is reflected in most international metropolitan areas and has emerged from
the perception that “the more you’re dealing with a given disease process the
better you get at it.” This context has facilitated Dr B orientating his surgical
work toward an area of medicine that has aspects he likes:
“There’s a lot of interplay with other departments, there’s a fairly
high level of patient contact. . . and the other thing which is ap-
pealing is that for the majority of people, particularly with screen
detection of the disease, the long-term results are relatively good.”
Dr B reflected on whether he has gravitated toward this speciality because
the interaction he has with patients suited his personality:
“I think by the average surgeon’s standards I have pretty reasonable
communication and interpersonal skills. And so therefore, is it
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pure chance that I’ve ended up doing an aspect of surgery that has
a pretty significant amount of patient interaction?”
Describing the disclosure of a breast cancer diagnosis to his patients as a
“pretty natural conversation” he strives to communicate in a straightforward
and non-condescending manner the information he would want to know in the
same circumstance. Uncertain how this can be taught, he considers learning
how to disclose bad news to patients in medical school came at a time when as
a student he had limited exposure to patients. Instead he referred to learning
how to communicate on the job, ‘cherry-picking’ from the good and not so
good styles, of senior clinicians, a mode of learning that continues with his
current registrars.
“I think they [registrars] do pick up by osmosis and when I look
back on my training, I think you definitely get influenced by certain
individuals, you get influenced by and you ‘cherry pick’; you see
things that that person does quite well and that person does quite
well, they don’t do this so well. But I think a lot of the training in
terms of that sort of thing is probably by observation. Obviously
personalities are different and there are some people who are better
suited to the certain aspects of medicine than others.”
He quips that in medicine for “anybody from aspergers to extroverts there’s
a job you can do and everywhere in between,” but despite perceptions “sur-
geons who can’t talk their patients aren’t generally going to be very effective in
their role.” Dr B believes people want a quality consultation with him, where
they leave the consultation comfortable that they have “a good handle on
what the problem is, what the options are, and what the pros and cons of those
options are from somebody who they think knows what they’re talking about.”
Appointments offer only a short space of time to achieve this, generally twenty
to thirty minutes for a first consultation and ten minutes for subsequent clinic
appointments. Dr B must be able to convey a lot of information to his patient
so that he can move them toward a decision on the treatment options they
are most comfortable progressing.
The pressures on these appointments mount when statistically the prob-
abilities of survival are stacked in favour of early detection and treatment.
Moreover, subsequent treatment such as surgery and radiography must be
scheduled into a system that can become rapidly over subscribed.
Although rarely emotionally affected by the disclosure of a breast cancer
diagnosis to his patients, Dr B says he no longer has the buffer of youth that
helped him as a young doctor. He too has aged and is more conscious of his
own mortality:
“When you’re fifty-three and you’ve got a forty-two year old with
breast cancer, you start thinking. I was sitting at a multi-disciplinary
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meeting the other day and I was looking down the page at new can-
cer diagnosis and I made the observation that I was about median
age of the women we were discussing and you think [hesitates]so I
think it changes.”
Although he has a lot of “stop and sniff the roses moments,” he is mindful
of the need to have clear boundaries between work and home:
“I think the other thing is too when you’re driving home from work
at the end of the day then you have got other things, work is part
of what you do but for me I’ve got kids to get fed, homework done,
bathed and into bed, school lunches ready for tomorrow or what-
ever, you’ve got other family issues or other things. I think if you
take it home with you then you’re a time bomb waiting to go off.”
Dr V
As a doctor specialising in hospital-based palliative care, Dr V’s experiences of
death and dying are extensive. He now heads up the palliative team in a public
hospital that provide advisory services to a broad constituency of patients and
staff. Although in this capacity, he is often not the frontline person who is
formally tasked with disclosing a terminal diagnosis to a patient, he is the
person who frequently has to re-communicate the ‘bad-news’; exploring what
the reality of that diagnosis means for the person and their loved ones. He is
also charged with leading the teaching, support and advice to staff handling
death and dying.
“So we see people on surgical wards who’ve got surgical problems,
who’ve got medical problems, who’ve got cancer related problems,
non-cancer related problems, we see people who are in their teens
to people who are in their hundreds; well early hundreds. . . we see
people in intensive care, we see people in the emergency department
or just on the regular wards.”
The service provided is largely advisory, meaning Dr V and his team are
called in to assist and work alongside other medical teams:
“So they’ll say, ‘Dear palliative care team, please could you see this
patient that we’re looking after who has got some pain because of
their cancer and is also struggling to come to terms with what’s go-
ing on and can’t make decisions about the future,’ or ‘the family is
fractured and falling to pieces, can you please help give support?’”
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This is a shift in how dying patients have been cared for in the past and it
is relatively new to have a palliative care team in a hospital as “hospitals have
been a bastion of cure-based treatment and always doing something to try and
stave-off disaster.”
Working in this area long-term, Dr V’s insights and experiences have
shaped his meaning-making of seeing both patients and staff act as they do
in the face of imminent death. He considers the praxis of his own beliefs
in how he supports patients and colleagues. His narrative is temperate and
philosophically informed.
Dr V was conscious and expectant of death as a natural outcome in
medicine, though he found little support in his training that enabled him
to extend the physical manifestations of dying to the emotional realities for
patients and their families. At the end of medical school and a few years
working as a general physician, Dr V decided to train in palliative medicine
offshore and in New Zealand.
He believes people usually die much as they have lived. For some “that
sense of who I am, of meaning, of meaning-making, of trying to put things
into context’ ’ is extraordinarily important and for others “it’s just not.” He
has witnessed many people dealing with their imminent death:
“Some people will have conversations that lay things to rest and
patch-up wounds and patch-up rifts. Many people won’t. This idea
that you approach death in the same way and that it’s necessar-
ily healing or transforming or forgiving or whatever, I think that
they’re hopes and wishes that society put on for us to see that
there’s some good that comes out of dying.”
For him, striving for the good death may be the goal of many, or the need
of society, but the reality he sees is that many patients experience “a good
enough death.” The experiences of working with dying patients can be many
things for Dr V:
“. . . it can be uplifting, it can be sad, it can be depressing, it can be
engagingly interestingly, fascinating. There’s a range of things and
it’s often a mixture of a lot of that. And it can be confronting. It
can be motivating for you to kind of think about your own issues.
It can be challenging as you try and work out what your issues
are and what actually are the professional issues which I think is
a core piece of work that needs to be done if you’re going to be in
this work.”
He is concerned for his colleagues who suffer when they are unable to
express or share the grief they feel from continuously dealing with difficult
deaths. Dr V believes this can lead to clinicians detaching the patient as
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person and ultimately to their own burn-out. He practices mindfulness; trying
to be in the moment and stay aware of his own issues coming up from what is
happening for his patients. He cautions that without this self-reflection, many
clinicians risk treating patients based on what they would want for themselves
or their loved ones and not what is necessarily best for the patient. Dr V is
aware of the pressures inherent in the medical system which contribute to
clinician’s feeling more intensely a sense of duty to leave things behind at
work. The challenge is to work out how:
“I guess part of who I am is a doctor; part of who I am is a family
man and a lover, a person who has an unhealthy interest in good
food (laughter). That is who I am so I can’t pretend that the times
where who I am is not the doctor part of me but on the other hand
I can leave behind my feelings that I constantly need to be there or
that I am constantly responsible which I think was difficult when
you first start with many clinicians because you think it’s your
duty. So there is a duty but the duty does not interfere with your
right to have privacy, to be able to leave it behind and say, ‘I’m
not responsible anymore.’”
Leaving work each day, Dr V often touches a pounamu at the entrance of
the hospital “to just leave my hospital self behind in that act, so there’s almost





“Diagnosis remains a ritual for the disclosure: a curtain is pulled
aside, and uncertainty is replaced-for better or worse-by a struc-
tured narrative”. (Rosenberg 2002, p. 255)
I began this research wanting and expecting to hear what it was like for
clinicians to tell their patient they had a terminal diagnosis or prognosis. What
I learned in the process was the experience of disclosure for clinicians was less
distinct. In the initial analysis of the clinicians’ experiences of disclosure three
themes emerged that provided a critical context to further analysis. All of
the themes resonated with the literature regarding the ongoing debate about
truth-telling by medical practitioners.
The first of these was locating the act of disclosure within the clinicians’
narrative. When I asked the clinicians how they experienced disclosing to a
patient that they had a potentially life-limiting illness, their initial responses
revealed how indistinct the act of telling can be. Some responses appeared
diffuse and were conditional on where they were positioned within the struc-
ture of specialisms in medical care, if other medical practitioners had or had
not already disclosed a diagnosis, if they consider it was their role to tell, and
if the patient had understood what the disclosure meant.
Initially I mistook this as an evasive response to discussing death and dy-
ing. However, all of the clinicians were unequivocal in providing patients with
the truth about their diagnosis or prognosis. It became clearer in the analysis
this process of orientating the ‘telling’ to a specific situation was indicative
of the context within which disclosure occurs. Some of the clinicians’ experi-
ences reflected a blurring of the boundaries evident in the research literature,
such that it was not always clear to them who was responsible for telling the
patient, or when they would receive the diagnosis and when they did, how
quickly to disclose this to their patient.
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For example, Dr X recalls when a radiologist phoned her with the results
of a mammography report for a patient that “wasn’t really mine.” When
she enquired who was going to tell the patient a lump had been detected, it
seemed no one was taking responsibility for this:
Dr X:“Then the mammography people rang another doctor, not
me and said, ‘There’s a lump under this woman’s arm.’ And this
doctor passed it on to me and I’m going, ‘well are they are going to
amend the mammography report or are they going to write a letter
about that?’ No. So this information wasn’t told to the patient,
came to me via somewhere else and then the thing was well . . . I’m
like this is so strange, what do you do with that?”
Similarly for Dr B, some of his patients were told the results of a needle
biopsy for breast cancer by their GP, however he could never be certain how
the disclosure was communicated:
Dr B:“Yes, what you’re never quite sure is with their GP how the
diagnosis has been couched. What I would hope is that if they got
a biopsy identifying cancer then the GP would have told them they
had cancer but I think occasionally it gets couched in slightly fluffier
terms to just ease them in gently to the diagnosis.”
Experiencing other clinicians struggling or avoiding telling patients clearly
and unambiguously their diagnosis was life-threatening was commonly cited
by the clinicians. Dr V offers an explanation for this that empathetically
situates this sense of avoidance within a context of the clinicians’ fear they
may hurt their patient:
Dr V:“And so I’ve gone from, ‘Oh gosh, if only they’d done it this
way’ to just acknowledging we’re all human (laughs) and that’s just
the way it is and these are hard, hard conversations for people to
have and to deal with, that people don’t want to do this, they feel
that they’re going to hurt someone by giving the news or they’re
going to take away their vestige of hope in the future, that they’re
going to damage them in some way and so these are protective,
maternal instincts that kick in.”
The risk of harming a patient as a barrier to full disclosure along with the
fragmentation of medical care into bounded specialities, these examples from
the clinicians’ experiences are commensurate with the literature on the com-
plexities of what is truth-telling. Contextualising the clinicians’ experiences
within these complexities highlights how judgements of clinicians’ as lying or
withholding the truth can be misinformed.
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The second theme was the centrality of the process of diagnosis to the
clinicians’ experiences of disclosure. I had expected the technical diagnosis
to be a cleaner and bounded platform from which the experience of telling
their patient would begin. However the analysis brought forward narratives
deeply embedded and entwined in diagnosis as a temporal process influencing
the professional presentation of disclosure. In this way, working from their
“medical narrative” diagnosis was often the starting point for the clinicians
telling me their experiences of disclosure (Brown, 1995, p.39).
Closely aligned to the process of diagnosis and the third theme prominent
in the analysis was the clinicians’ experiences of disclosure as a process rather
than a penultimate moment of telling. Of interest is what appears to be a
contradiction in this position when single moments of telling can be identified
in the clinicians’ stories. This suggests the intermediary position offered by
Willig (2011, p. 898) of “crisis points” which punctuate the “cancer journey”
may be a more helpful depiction for patients and clinicians.
In this chapter I present three clinicians’ stories of their experiences disclos-
ing a potentially life-threatening diagnosis to their patient. Using narrative
analysis I consider these stories as illustrative of the themes outlined above.
All three stories provide an insight into the centrality of diagnosis to the clin-
icians’ experience of disclosure as a process within an anticipated trajectory
of medical care that would follow the disclosure. However, what also emerges
from these stories is that within the process of disclosure lies the potential for
the act of telling to be difficult to locate in the fragmentation of medical care.
The first story from Dr K tells of a “textbook” diagnosis of pancreatic
cancer and the disclosure to his patient. Dr K’s diagnosis narrative depicts
how disclosure can be indistinct within a patient’s medical journey despite his
own determination to always tell the truth to his patients. Following this is the
second story from Dr B of diagnosing and disclosing breast cancer to patients.
In this story the impact of improved survival rates can be seen to influence
the disclosure experience. With confidence breast cancer detected early can
be successfully treated, the disclosure of the cancer diagnosis is focused on
the treatment actions to follow. In contrast to the more clear-cut diagnosis
and disclosure in the narratives of Dr K and Dr B, the final story from Dr X
speaks of the uncertainty of diagnosis and the dilemma of when and how to
tell a patient the results of their biopsy.
Analysing the clinicians’ experiences of disclosure in this chapter I also
identify themes explored more fully in Chapter 5 such as the impact of the
organisation of medical care on the experience of disclosure for the clinician,
the intensification of time with the focus on treatment following a disclosure
and the expectation of patients to respond positively to the treatment offered.
In this way, the narratives of diagnosis that follow provide a foundation for the
analysis presented in Chapter 5 of how the clinicians’ experiences of disclosure
are influenced and in part managed, by the culture of the medical profession.
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Narrative 1: Dr K
When I arrive down a sweeping driveway for the interview, Dr K greets me,
guiding me outside to take me on a tour of the hospice. It is an impressive
site nestled within lush grounds. I notice balloons swaying and tinsel glint-
ing from a modern building nearby. Dr K tells me they are celebrating the
opening of the building today, the result of a long battle to provide rooms for
art, music and counselling therapies. He proudly leads me through the build-
ing, introducing me to staff and hospice volunteers, telling them he is being
interviewed. Leading me back into the main building, we traverse further site
works as he explains the extensive retrofit underway. Eventually we settle into
the library, seated at an antique table over cups of herbal tea.
Dr K speaks rapidly as his voice undulates with intensity and animation.
He is passionate about the palliative care movement. It infuses the experiences
he speaks of and is a place he returns to frequently in the interview. During
the interview he determined that the central theme of my thesis was communi-
cation. He actively sought to reframe and re-position my research responding
to questions with narratives on communication skills and techniques:
Dr K:“So my own teaching now, it’s like, you know, it’s. . . . lead
with your big, your first message, don’t beat around the bush. Lead
with your first, well ask what the patient wants to know, then lead
with your first message and then stop talking.”
While I agreed this was important, it was as if we batted the ‘experience’
question back and forth. I sought his opinion about the experience more
indirectly, referencing literature that discusses the patient’s experience of the
moment of being told the diagnosis as the beginning of other processes.
The Textbook Diagnosis
We talk about the diagnosis process and Dr K tells this story of his experience
of what he describes in the opening line as a “classic” medical case:
“Dr K: I had a classic,
out of the book,
probably my third day in general practice when I took over from
this retiring GP.
Fifty something year old guy comes in,
he was a professor at the University.
Patient: ”My wife says my skin is turning yellow.”
Dr K: ”Oh do you have pain?”
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Patient: ”No”
Dr K: Now in my textbook
painless jaundice equals cancer of the pancreas
so in thirty seconds I’m thinking he has cancer of the pancreas,
and I need to do these blood tests
and I need to check and get an ultrasound and you know, things. . .
so I have to address that with him, I say, look at him:
“Actually your skin is turning yellow; this is the list of possibilities”
Again it’s not a definitive diagnosis right?
He’s got these symptoms,
I’m telling him this is high on the list of possibilities, cancer of the
pancreas,
but to him, that’s sort of a shock
and I don’t remember that he was particularly upset or distressed
or shocked,
- he wanted the plan.”
Dr K enacts this story as a scripted play, a feature of his narrative and
story-telling throughout the interview. Choosing to tell this story largely as
a dramatic presentation has the effect of collapsing time as if the diagnosis is
happening in the present (Riessman 2008, p. 109). Employing the genre of
performance, Dr K gives lines not only to himself but to his patient (Riessman
2008). The use of direct speech is a narrative feature that Riesman suggests
“builds credibility and pulls the listener into the narrated moment” (Riessman
2008, pp. 112–113).
Dr K describes this medical case as a “classic” and I wonder why he uses
this term. Is the case an exemplar of pancreatic cancer or does this evoke a
sense of a routine, conventional diagnosis? Perhaps it represents the medical
story ingrained from medical school, where students learn to determine what
counts as valuable information and how to present that convincingly as the
case history and differential diagnosis (Becker 1993). Dr K’s narrative is or-
dered as a medical story and as he knows I am not a doctor, he provides a
lay person’s description of the symptoms. The almost immediate diagnosis
conveys skills learned as a junior doctor seeing patients with the same symp-
toms and over time being able to position them along a “continuum of illness.”
This knowledge is evident in Dr K’s reference to “his textbook” which offers
an additional mark of competence and demonstrates the integration of his
early learning from medical textbooks to his own body of knowledge.
As the diagnosis unfolds, there is a sense of urgency when Dr K, recognising
the symptoms of a potential cancer, propels his patient toward a life-changing
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diagnosis. Time intensifies his need to prepare his patient for the interventions
required to confirm the diagnosis, reminiscent of the “ritual of intensification”
Chapple (2010, p. 89) describes.
In an ‘aside’ to me, his audience, Dr K tells me this is not a definitive
diagnosis but is an example of how the disclosure of a potential terminal
diagnosis can quickly avert to the focus on treatment (Riessman 2008, p.
112). It is as if he has in effect “brokered” his patient’s part in beginning the
journey toward a medicalised future (Timmermans 2005, p. 993).
Dr K acknowledges this is a shock for his patient though he does not
recall his patient was upset or distressed. However, introducing their shared
identities as professionals into the narrative, Dr K seems to align them both
with the expectation of a rational, pragmatic response to the diagnosis. Dr K
is understandably anxious to facilitate confirmation of this diagnosis as quickly
as possible though it may be this focus on immediate issues is indicative of
research findings which demonstrate how this moves the discussion away from
acknowledgement of the possibility of dying (Anderson, Kools, and Lyndon
2013).
His patient wanted “the plan,” indicating emotional responses were neither
appropriate at this early point in the diagnosis nor helpful when there was a
fight to prepare for. Yet, the patient literature of the disclosure processes
that begin with those first initial references to cancer, can tell a different
story, illustrated graphically by sociologist, Ian Craib (2003), in his personal
experiences of the diagnosis of a brain tumour:
“From the moment that the words ‘brain tumour’ were used by my
GP to the confirmation of the diagnosis, I was all but paralysed by
what I would then have called intense anxiety. When the diagnosis
was confirmed, the anxiety took off its mask and revealed itself to be
abject terror, a fear I had not felt before and which has haunted me
ever since, appearing now and again despite my efforts to submerge
it in everyday routines (Craib 2003, p. 286).”
Was Dr K’s patient also paralysed with fear? It seemed he would not have
been expecting the likelihood that he had pancreatic cancer, nor may his wife
when she mentioned his skin changing colour. With the patient’s potential
anxiety in mind, I wondered if Dr K had considered waiting until diagnostic
tests had been completed before opening his patient’s world to the potential
for the haunting terror Craib (2003) experienced.
“Jo: So when you’re in that situation, a situation like that, the
options could be to not say anything and do the tests and then. . . ?
[Cuts across quickly]
Dr K: I would never do that!
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Jo: OK
Dr K: Never do that.
That to me flies in the face of good patient/clinician [. . . ]
I mean that’s early on in the piece for that man
and of course if he said, ‘How long have I got doc?’,
then it would not have meant anything because it didn’t have any
exact diagnosis
all the way along.
I think it’s really important to be clear
and assess the understanding of this person you’re talking to.”
The question prompted a vehement response. Dr K interpreted my ques-
tion as a suggestion that he withhold information from his patient who he had
assessed as being able to understand the diagnosis and what it may mean.
Dr K’s story continues on to describe the actions that follow this initial
diagnosis. He describes a series of events; tests, scans, operations and further
diagnostics to portray an evolving process of moments of disclosure leading to
a final confirmation of the disease as terminal. In the passage that follows, Dr
K summarises the possible ways, “the moments”, when his patient may have
come to an understanding of the diagnosis of pancreatic cancer that followed
his initial diagnosis:
“. . . but where in that process did he think,
or who had the conversation with him, that said,
‘You’re not going to get better from this’?
Wasn’t me;
probably was oncology that had that conversation with him
that there are no further chemos that we can offer or whatever.
But he would have had a conversation beforehand from oncology
which would have said,
‘We’re going to try this chemotherapy which has a fifty percent
response rate’
or whatever.
And then how much understanding did he have?
He was a scientist so probably he could understand
except it was him personally so maybe his understanding
wasn’t being so quite scientific
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when an oncologist talks about those kind of numbers and percent-
ages.
So probably it’s a long, drawn-out moment of realisation,
that actually this is not going to get better.
So in those studies that you’re reading what is being reported by
the patient?
Is it that moment that they figured it out?
Or is it the moment, and probably a variety,
but it could be that sort of,
this is not going to get better?”
In this narrative Dr K depicts the many junctures of diagnosis and possi-
ble disclosure moments leading his patient to a final terminal diagnosis. His
immediate diagnosis of his patient’s symptoms is removed from the sequence
of events. It is at these junctures of diagnosis moments where ownership of
disclosing the diagnosis to his patient shifts and is diffused by, the specialisa-
tion of medical care. The “ritual of intensification” is renegotiated in Dr K’s
story and the cultural scripts shift with a renegotiation of the goal of care.
Gradually care is reformulated away from the intense battle when hope for
recovery is abandoned toward “comfort care” (Chapple 2010, pp. 89,187).
Despite decades of open disclosure policies, and Dr K’s position of telling
his patient the truth, in the process of treatment he assumes the patient will
discern his own awareness. Dr K is unable to pinpoint a time when a medi-
cal professional in this illness trajectory told the patient he was dying. The
gradual awareness he anticipates his patient coming to, in figuring out over a
long drawn out process, he is dying, mirrors the gentle, managed and peaceful
acceptance of death and dying in hospice discourses. Dr K’s assessment of
just when in the unfolding process of disclosure his patient knew he was dying
speaks to the “gradation of the awareness contexts” Timmermans (1994, p.
332) identifies in his research. Here there seems to be an “uncertain open
awareness” where clinicians remain the “gatekeepers” of information but may
be holding back on the full account or softening the information to maintain
the patient’s sense of hope (Timmermans 1994, p. 332).
Dr K’s approach of advocating open awareness at the earliest moment of
his symptomatic diagnosis but not locating a moment of telling in any future
diagnosis appears contradictory. It seems his patient is returned to a mortal
being in the absence of a successful treatment and all responsibility has been
divested to him to “figure it out”. Chapple (2010, p. 89) suggests this is a
way to maintain our faith in medicine when it fails others:
“This effort preserves the integrity of the medical project as it rubs
up against the margins of death. The ritual maintains the illusion
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that death comes only as the accidental convergence of this partic-
ular set of circumstances. The rest of us might still be exempt.”
Later Dr K tells me he was at his patient’s bedside as he was dying sug-
gesting the continuity of the relationship with his patient is restored. In this
transition or liminal period, Dr K can be considered to have taken on the
role of “master of ceremonies” charged with guiding his patient to the closure
of the ritual, which ends at the deathbed (Boland 2013, p. 230). Patients
in hospice care also return to Dr K in their transition, or liminality, toward
death:
Dr K:“I had a patient who died of a pulmonary embolism, very
classic, she’d been on the loo, she said to the nurse ‘oh’, she felt
something change in her chest, not particularly painful, but she
suddenly said ‘I don’t feel very good at all’, so the nurse helped her
back to bed and called me and I came in. She looked at me and she
said ‘Am I dying?’ no she said, ‘Am I dying right now?’ and I
said ‘Yes, you’re dying right now’. . . and she died within a minute,
probably the whole thing was probably five minutes from being on
the loo to having died.”
In this account, Dr K provides a story of another “classic” case. His use of
the word classic in both stories emphasises it is the nature of the experiences
that stand out for Dr K and that is why they are important to tell. Both
stories make a point of Dr K’s unambiguous commitment to telling his patient
the truth, right to the end. Both stories are also told to highlight how Dr K
experiences disclosure as moments within a process of diagnosis and prognosis.
When it is deemed to be his responsibility to tell his patient he does but he
cannot determine how disclosure will be managed by his colleagues despite
his best efforts to improve open and full awareness in his own teaching and
practice.
Narrative 2: Dr B
In the next story a similar pattern of diagnosis as Dr K’s pancreatic cancer
patient is retold. However unlike Dr K, Dr B describes a hypothetical patient
and begins by orientating to the context of the diagnosis, so that it is clear this
is a patient he is seeing for the first time. This sets the scene for the clinical
encounter. He does not describe the patient but she is present as he elicits her
symptoms and information about family members. Interestingly, many women
Dr B sees have no symptoms but because of their age or other determinants,
they are assigned a risk profile and invited to a screening programme. In
this way, the categorisation of his patients is an example of the “pre-disease
identification” Jutel and Nettleton (2011, p. 795) describe in their research
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within the sociology of diagnosis. The effect of this is to blur the boundaries
of disease diagnosis, creating what they describe as “a temporal and spatial
fracturing” of the diagnostic category (and the diagnostic process).
The hypothetical story evokes a sense of routine and familiarity for Dr
B as he describes the clinical approach to getting to a diagnosis that will
announce the presence of breast cancer. Like Dr K, he is clear of his role in
the disclosure process and does not avoid telling his patients the outcome of
the diagnostic tests they have undergone. He too experiences disclosure as
a process which initiates the pathway of treatment and further testing that
follows for his patients. It is also in Dr B’s narrative where the impact of
significant shifts in survival rates for some cancers can be seen to influence his
experience of disclosure.
The Point Where You’ll Know
I met Dr B in the midst of a busy outpatient clinic of an urban public hospital.
He finds a spare room and ushers me in. It is not his office but a consultation
room. I have to remind myself I am not here to understand how his patients
might feel as I try to work out which of the chairs to sit in that are lined up
next to his desk. It is a tired interior and I find it hard to adjust my vision to
the stark fluorescent lighting overhead. I get the sense that time is precious
as I organise myself to begin the interview.
In this excerpt, Dr B describes a series of possible steps in the diagnosis
process which leads to the clinical encounter where he is communicating a
diagnosis of breast cancer to his patient for the first time. They are “newly
diagnosed” patients. He tells this in response to my interest in how he prepares
for the disclosure conversation with his patients.
“If I’m seeing them for the first time,
then I’d take the history in terms of what symptoms they’ve had
any risk factors they might have,
like a person in the family history with breast cancer,
normally I’d check out their relevant medical issues
that might be germane to management of the breast cancer,
do a physical examination,
show them the mammograms that they’ve had done,
pointing out what their abnormalities are
and then talking about the result of normally a needle biopsy
which has confirmed the breast cancer
and then with that
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run through what are the options.
So at that point they’ll know,
‘you’ve got breast cancer.’”
Like Dr K, the presentation of the patient to me as a case is integral to
the medical story in Dr B’s narrative. Disease is the ‘object’ and the person
is the site of the disease, not as a “narrative agent” of their illness (Good
1994, p. 80). The passivity of his patient is interpreted through the actions
he ascribes to himself. He sees the patient, takes their history, checks out
relevant medical information, does the examination, shows the mammogram,
points out abnormalities, talks about results, and runs through treatment
options. The results of this are two-fold; “the inattention to the lifeworld of
the patient. . . and what we know as routine, rational medical practice” (Good
1994, p. 80).
In the temporal ordering of this disclosure ‘routine’, announcing the di-
agnosis of breast cancer is only offered at the end of the consultation that
culminates in the mammography results as irrefutable proof. Dr B’s narrative
mimics the structure of disclosing a breast cancer diagnosis to women for the
first time that Taylor (1988) identified in her research. Dr B begins the con-
versation with a preamble to “set the stage”, leading to the “confrontation” –
in this case the confirmation of the breast cancer diagnosis, followed by “dif-
fusion” where discussion shifted toward medical interventions which Taylor
contends is designed to lessen the impact of the diagnosis (Taylor 1988, pp.
116–117).
This diagnosis is early into a trajectory of care delivered by Dr B with
“curative intent.” He cites statistical evidence of highly successful outcomes
when breast cancer is detected early such that the threat of the disease as
life-limiting is rarely considered and therefore overt emotional reactions from
his patients are unexpected. He experiences most of his patients’ reactions as
“appropriately upset or pragmatic” and it is “very uncommon to get people
who are not emotionally and psychologically coping with it.” Like Dr K, the
focus is on the plan of what next:
Dr B:“I think what people want is a quality consultation from some-
body who they think knows what they’re talking about, that they
trust and who talks to them in words they can understand. So that
they leave the consultation comfortable that they have a good han-
dle on what the problem is, what the options are and what the pros
and cons of those options are from somebody who they think knows
what they’re talking about.”
Again, however there is evidence in the patient literature that describes
the experience of being diagnosed with breast cancer that is absent in Dr
B’s account of his patients reactions. The possibility for much more than a
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stoic emotional response occurring for the patient is powerfully told in this
evocative description of one woman’s experience of receiving a breast cancer
diagnosis:
“I shut my eyes and saw absolute black, no lines of red or purple,
pure black. My agitation lifted me off the table and I started walk-
ing around the examination room in small steps, working off the
tension. I thought I might put my fist through the wall. And then
when I opened my eyes, I couldn’t see too well. Or hear too well
either (Rosenblum in Frank, 2004, pp. 14-15).”
The stark contrast of this story to how Dr B experiences his patients’ reac-
tions resonates with the literature that suggests patients emotional responses
can be influenced and redirected toward the rational and pragmatic by the
clinician’s approach (Kaufman 2006; Maynard 2003). Unlike the “graphic
moment” retold in this patient’s account, in his narrative, the main event for
Dr B is not the disclosure, but the application of his technical skills as a sur-
geon in the fight to eradicate the disease (Maynard 2003, p. 12). It is here
where he can offer the most help to his patient. In this respect when Dr B
delivers the diagnosis it is the preliminary to the “medical project” unfold-
ing in the next part of the narrative, in which he must broker the medical
interventions necessary to complete the project (Chapple 2010, p. 89).
Following disclosure his patients are engaged in decisions on treatment and
the surgical option they prefer. There is an intensification of time reflected
not only in the same fast tempo Dr B uses in the first story, but also how the
narrative is structured (Shim, Russ, and Kaufman 2006; Chapple 2010). Dr
B works from one action to the next suggesting a routine he performs in a
time-bound process to ensure his patients have the greatest opportunity for
survival:
“So it’s either going to be when I’m seeing them with their cancer
diagnosis,
there is nothing else to do,
there’s a discussion around treatment options,
there are no further tests that have to be done
and then I’ll plan to see them again in a week to ten days
to finalise what is their preference.
Or, ‘yes you’ve got a cancer
but there’s a few other loose ends we need to tidy up’,
get these further tests done
and see you back here with the results of those
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and then we have further discussion around treatment options,
so we then say, ‘This is the operation we’re going to do’
and then we go and do it.
So I see them obviously when they’re having their surgery. . .
and then I’ll be seeing them in the clinic normally about seven to
ten days later
with the result of the microscopic report on everything that’s been
removed.”
The patient’s voice is still absent though there are discussions of treatments
which lead to deciding what operation will be done. Dr B’s use of the pronoun
‘we’ is used when he talks of the journey the patient is on with him. He refers
to ‘we’ again when he talks of the operation that seems to indicate this is not
something he is exclusively responsible for.
He returns to the first person in the next two actions, when he will see his
patient at the time of surgery and in the future, following surgery. This next
clinical encounter is another moment of disclosing the diagnosis to his patient.
There are four times in this process where he is seeing the patient with gaps
of seven to ten days, until she receives the final diagnosis. For Dr B there is
a predictable process he can rely on to manage how and when information is
disclosed to his patients with consultations embedded within a series of other
consultations, similar to the “folding machine” described in the literature by
Jespersen and Jensen (2012, p. 348).
All of this activity is again leading to confirmation in the form of the
histology (microscopic) report, which offers a reading of the ‘fine print’ at
the cellular level of his patient’s body of “some indication of ‘what does this
mean?”’ This is not “what does this mean for you existentially” or “how
will this affect your lifeworld”, but what does this mean for how the disease
will be treated in an ongoing medicalised future. Focusing on “narratives of
immediacy” averts discussion of his patients’ lifeworlds away from the clinical
encounter (Good 1994, p. 858). Each time Dr B meets with his patients in
this schedule of consultations and treatments they are drawn back into this
“therapeutic housekeeping” (Good 1994, p. 858).
This is reminiscent of Heidegger’s use of the medical clinic as an example
of a technology that transforms its patients (and its professional workers) into
objects for inspection, “subordinate to the orderability of the clinic” (Frank
2004, p. 28). Dr B’s experiences of disclosure are mediated and distanced
by the patient’s trajectory of care. The overarching structure of the medical
system defines the time he has available for the diagnosis process and facilitates
control over the disclosure processes. There is the impression of how each of
the diagnostic actions he describes is arranged into a schedule of work tasks
repeated for multiple patients over a longer cycle of outpatient consultations
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and surgeries. Information is updated, incrementally at each stage allowing
time for Dr B to prepare how he will manage the encounter.
Narrative 3: Dr X
In the final narrative, Dr X retells the difficulties she experienced disclosing a
skin cancer diagnosis to her patient. Similarly to Drs B and K, Dr X’s narrative
points to the impact of the structure of medical care on the disclosure process.
There stories diverge however when Dr X is unable to know with the same
certainty as Dr B when she will receive the biopsy results and therefore be
able to plan for communicating these to her patient.
Dr X’s story also brings to the fore the power of the clinician as “gate-
keeper” to the disclosure of a terminal diagnosis or prognosis in that ultimately
the decision to tell, when and how much to tell, remains with the clinician
(Timmermans 1994, p. 332). This narrative depicts the dilemma of knowing
when to disclose information to a patient, particularly when the patient’s own
“lifeworld” is considered (Barry et al. 2001). In this way, the questioning of
the disclosure process by Dr X contrasts with the more indubitable responses
from Drs K and B and begins to open up the analysis to the tension of personal
and professional expectations of how disclosure is managed.
The Uncertainty of Disclosure
The interview with Dr X is at the public hospital where she works in another
role from her part-time general practitioner position. Within a few minutes
of my arrival, she emerges before me. My immediate impression is her clear
sense of self and defined style in contrast to the somewhat doleful institutional
environment she is located in. She leads me through smoke stop doors and
along a corridor into a secure part of the building. We enter her office and I
am immediately struck by the many disorderly piles of papers occupying much
of the long desk I am seated beside. Dr X folds herself onto an office chair,
tucking her legs under her, settling into the conversation that easily unfolds.
This narrative from Dr X’s interview came after she had shared experiences
of disclosing terminal diagnoses to patients as a medical student and more
recently as a general practitioner. Dr X describes her experiences diagnosing
and then disclosing to her patient that a lesion on her leg is a melanoma. She
begins this story relating her patient’s gender and age with herself and through
sharing these characteristics indicates the possibility of her connection to this
patient and a strong sense of ownership in what follows:
“I had a woman recently who was the same age as me
and maybe that brings up some sort of transference kind of thing,
you know?
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And she came with a lesion on her leg
and she told me it had changed over a couple of months
and I looked at it and I said, ‘I have no idea what it is,
doesn’t look like anything nasty but the only way we can tell is to
take it off.’
Anyway she books in, I think about probably a whole month later
to have it taken off.
She has it taken off
and it turns out to be a melanoma.”
Here, Dr X draws on the psychological terminology of ‘transference’ to
describe and possibly explain her emotional experience with the diagnosis.
Transference, or ”the unconscious redirection of feelings from one person to
another”, in Dr X’s narrative suggests a more direct acknowledgement of the
medical profession’s “signature rule” where emotional involvement with pa-
tients is against the rules (Sullivan 2009, p. 522) (Kasket 2006b, p. 143).
Orienting to transference early into the narrative offers a sense of Dr X’s
awareness and centrality of her emotional labour in the clinical encounter
compared to both Drs K and B. However, her concern that these feelings for
her patient may be against the rules is suggested in labelling them as a pro-
fessional transgression of ‘transference’. In this way, Dr X demonstrates her
internal “emotional supervision” of the professional norms and expectations of
her as a medical professional (Kasket 2006b, p. 130). A tension arises because
the emotional supervision is added to the story after it has happened, leaving
me wondering if on reflection Dr X felt she had been too emotionally involved.
On receiving the pathology results, Dr X considers how her patient will
feel receiving this news and is concerned she will have been waiting, in the
“absent times” between consultations to hear (Jespersen and Jensen 2012,
p. 346). Dr X situates the disclosure directly within the temporality of her
patient’s lifeworld and unlike Drs K and B, questions what her patient will
need and what it will be like for her hearing this diagnosis. There is no
contention from Dr X she was disclosing a life-limiting disease to her patient,
or that this would be experienced as a single moment of telling for her patient.
Although she knows it would be far preferable to see her patient and disclose
the diagnosis face-to-face, her attention to her patient’s lifeworld leads her to
immediately contacting her patient by phone. Anxious that it is the end of
the week, Dr X is conscious if she does not tell her patient immediately it
would be another two days before she would hear the results.
When Dr X rings she ends up talking with the woman’s daughter because
the woman has taken a holiday. Inadvertently she introduces herself as “Dr
X from the medical centre”, realising immediately that now the daughter may
tell her mother that she has called. Worried that if this happened her patient
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may not be able to get hold of her and would be more anxious, Dr X decides
she must now call the woman on her mobile and talk with her. She calls her
patient and advises her of the diagnosis. Later in the day, concerned that the
woman, having now absorbed the initial diagnosis may have more questions
for her she calls again. Dr X does not want her to have to wait until Monday
for answers. Despite her best efforts, Dr X feels she has failed:
Dr X:“I didn’t do a good job, well about the whole thing because
sometimes when you try and do something well it seems to be far
worse.”
In Dr X’s narrative diagnosis is performed through a similar process as
Drs K and B. The hermeneutics of her clinical interpretation begin with the
experiential text of her patient describing the changes in the lesion, followed
by her own reading of the physical text when she looks at the lesion. She is
unable to finish reading the text without referring to the instrumental text
(Leder 1990). Here, there is a similar distorted separation of the physical body
from the diagnosis that is evident in the needle biopsy Dr B refers to. Parts
of the women’s bodies are extracted for an examination that is independent
of both the clinicians and their patients, yet the women are still connected
to this process because the specimens from their bodies are present in the
reading of this text.
Similarly to Dr B, Dr X refers to the time of each diagnostic stage, from
her patient’s awareness of a change in the lesion over two months, to the
removal of the lesion a month after the initial diagnosis. In contrast, Dr X’s
initial diagnosis did not generate the “ritual of intensification” as it had in
the narratives of Drs K and B (Chapple 2010, p. 70). Retrospectively telling
this story, Dr X knows the lesion is diagnosed as a melanoma, so her emphasis
on the month long period before the lesion is removed shifts from the first
encounter where it seems there is little to be concerned about to an emphasis
on her patient’s decision to book in “a whole month later.” Dr X’s patient
had come to understand through the language of medicine what is expected
of her and how to feel when Dr X did not raise immediate concerns about the
lesion, other than as something to be removed in the future (Timmermans
2005; Shim, Russ, and Kaufman 2006).
Dr X does not say she removes the lesion, only that her patient booked in
again to have it removed which appears to distance her from the unexpected
diagnosis of a melanoma. This first section has set the scene for Dr X to
unfold the difficulties she experiences with this diagnosis process.
“And then that’s where some of my difficulty comes from
because then it’s like should I have done something different about
that?
If I’d suspected it was anything else clearly
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I would have suggested that she got it off earlier
but it actually turned out to be a melanoma.”
In this section Dr X opens out the difficulty she experiences when she
begins to question how she could have contributed to a different outcome for
her patient. In questioning her actions, Dr X reflects on the timing of the
removal of the lesion and her professional responsibility for contributing to
the delay. Unlike Dr K, the initial diagnosis does not lead to Dr X confidently
determining the likelihood of cancer and therefore being able to prepare her
patient for this possibility. Ultimately she cannot determine her patient’s
actions though there is definitely a suggestion that she thought she could have
exerted greater influence to have the lesion removed earlier. Seeking counsel
and support, Dr X discusses this with her colleague who provides another
perspective on her actions:
“. . . and then it’s like when I talk to my colleagues,
‘The thing is, it’s off, that’s the good news
You could have sent her away and said,
it’s nothing and you don’t need to do anything about it.’”
It is possible to consider this perspective has been offered to comfort or
console Dr X, suggesting she think positively about what she did by compar-
ing her actions to other alternative diagnostic choices available to her. Their
counsel offers a unique insight into the diagnostic autonomy available to clini-
cians who can use their discretion to decide on their patient’s behalf if further
investigation is warranted. It is a position that Jutel and Nettleton (2011, p.
796) suggest has survived from the paternalism of days past:
“Even in our contemporary era, where a greater emphasis is placed
on the lay person to play a more active role, the diagnostician in
the medical setting remains the key arbiter and thereby still holds
significant jurisdictional authority.”
However, it seems the guilt and questioning is not assuaged by the profes-
sional views of her colleagues. Dr X intensifies her efforts to get her patient
appointments with specialists:
“Then if it turns out to be something then that’s a bad thing
but it’s this whole sense of how comfortable are you in this whole
system.
What’s a reasonable amount of time?
So I was sending off letters saying,
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‘Please see this woman’ to the plastics department
and feeling a bit panicky myself about it and thinking,
‘Oh you know it fits in a criteria which could be nasty for her’
and I am just wanting to expedite this whole thing.
So I’m sending it off and sending off another one saying,
‘I’ve got blood tests and I’ve got this and that.’”
Dr X questions her comfort within the structured secondary care system
she is dependent upon to provide the next stage of care for her patient. Now
time becomes a critical feature of her narrative and having assessed the risk of
losing time in earlier passages, Dr X seems to want to make-up time or at least
ensure time does not further impact on her patient’s prognosis. She is both
within the system, as a general practitioner in primary care and outside of
this system, when her patient is referred to secondary care. There is a sense of
a tacit negotiation with others that transpires in her communications, as her
authority in this domain is diminished. The protocols of communication are
evident in the politely addressed letters of request. She must bid, on behalf of
her patient for the scarce resource of time in the system. Her experiences of
this diagnosis process portray the analysis of diagnosis by Jutel and Nettleton
(2011, p. 799) as a “means for casting light on the interplay between medical
care providers and professional territories“.
Dr X’s narrative offers a markedly different experience of time than in Dr
B’s account, where disclosure is scheduled in clinic time and offers him the
opportunity to draw his patients into the immediacy and certainty of “thera-
peutic housekeeping” (Good 1994, p. 858). Like her patient, Dr X must wait,
uncertain of when the results of the biopsy will come to her. This uncertain
timing limits her power to influence, organise, or prepare for the disclosure
to her patient. In this way, it is the times in between the consultation which
impose on Dr X’s experiences more than Dr B’s (Jespersen and Jensen 2012).
In the medical hierarchy of knowledge, Dr X’s knowledge of her patient
becomes subordinate to the opinions of other medical specialists, constraining
what actions she can take other than to broker her patient’s fast-tracked ap-
pointments (Johansen et al. 2012). Her impression management is critical to
the ongoing negotiation of trust in her relationship with this patient and as
such, her narrative unfolds differently to Dr K’s, yet they engage in the same
process of scheduling appointments and guiding their patients toward other
medical specialisisms.
Dr X returns to her ethical decision of when to disclose information to her
patient, contrasting it with that of a colleague in her general practice:
“I don’t know how they would deliver that news themselves
but I know that they wouldn’t be thinking about it in the night or
in the weekend
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whether their decision to not tell somebody that weekend
was the right or wrong thing to do.
That they just make that decision they don’t need to know that.
I’m not there to say that’s not right.”
The reintroduction of her colleague to this narrative provided another lens
to view her experience against. Her decisions are weighed up against what
she is certain her colleague would have done and it sets the scene for the
uncertainty she experiences in her decision to tell her patient when she did.
Her colleague by comparison is decisive and confident they are making the
right decision on behalf of the patient. Dr X does not judge them for this,
rather there is a sense she is contemplating this response as preferential to her
own; it is their comfort with their decisions rather than the actual decision.
They are not awake at night wrangling with the ethical dilemma that Dr X
experiences in the same situation:
“but to me I analyse all these sorts things,
if I’ve got the information have I got the right to withhold it from
someone
who may well be waiting and want to know?
And that’s what was going on for me and this whole thing about
this woman,
now I know.
I can sit with the discomfort of knowing except should I do that?
Do I have the right to do that?”
Dr X’s analysis introduces differences between herself and her colleague.
Her patient is central to this decision and she is aware of her power in their
relationship. In this respect, Dr X’s narrative is focused more on her patient’s
lifeworld than Drs K and B. The clinical facts are “not separated from the
person who experienced them” but embedded in her patient’s temporality
(Johansen et al. 2012, p. 576). She is prepared to take on the discomfort of
her decision to tell in the hope this will ease her patient’s discomfort waiting
for, and hearing, the diagnosis.
Dr X sets herself apart from her colleague because she questions the med-
ical authority bestowed on her that allows her to withhold information until a
more suitable time. Johansen et al. (2012, p. 576) suggests the continuity of
a GP’s relationship with their patients over a longer period of their lives can
command a deeper loyalty and greater opportunity for a “shared humanness”
(Johansen et al. 2012, p. 576). Dr X’s medical practice is grounded in her re-
spect and acknowledgement for her patients and her own lifeworld experiences.
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The continuity of her relationship with her patients is a source of enjoyment
and satisfaction and means she must also manage her “performance” over an
extended period of time (Goffman 1959).
Clearly it would be easier for Dr X to make an appointment for her patient
to disclose the diagnosis but unlike her colleague, Dr X determines in this
instance it is unethical because asking her patient to wait over the weekend
could intensify her anxiety.
“And therefore I felt like I wanted to tell her
and at least give her the option to come and speak to me that day
but as it happened it didn’t go that way in the end.
I feel though that in hindsight would I have been better to do
what my colleague would have done and said:
‘Well they don’t need to know this on a Friday’
Maybe it would have been better to do it on another day.”
Sitting with the discomfort of knowing evokes a sense that staying still will
be no more comfortable than the action of telling her patient. Time becomes
the catalyst for this dilemma.
Conclusion
Understanding the role of the diagnosis process in the clinicians’ experiences
of disclosure has emerged as a central feature in the often diffuse, complex
and diverse stories of when, where, why, what and how clinicians are “telling
bad news.” Disclosure of test results and treatment outcomes are present at
each juncture in the diagnosis process mediating and sometimes distorting
disclosure as a single moment and a protracted series of events.
All of the narratives portray a process that slices the diagnosis into steps
and stages, at times alienating the clinician as it does the patient, both of
whom are asked to wait ‘patiently’ for the final diagnosis. For Dr B’s patients,
this diagnosis time can be extended for years, as patients commence a five-year
outpatient’s programme, in a liminal state between treatment and cure, where
the threat of recurrence of cancer hovers in the biannual encounters with his
patients.
In Dr X’s narrative there are similar “temporal adjustments” thrust upon
her as she negotiates the timing of diagnostic procedures and questions tim-
ing of the disclosure moment for her patient (Jutel and Nettleton 2011, p.
794). Similarly, as the clinician’s narratives outline a process where their pa-
tients must negotiate the “order of professional boundaries and organisational
responses of formal care provisions” so to must the clinician (Jutel and Net-
tleton 2011, p. 796). Dr X’s narrative reveals the tensions she experiences
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navigating a system of health care on behalf of her patient that has become
“increasingly fragmented and specialised” (Jutel and Nettleton 2011, p. 796).
Routines of clinics, diagnosis and treatment provide certainty, predictabil-
ity and back-stage preparation for clinicians’ disclosure performances (Goff-
man 1959). In Dr B’s narrative an early detection of breast cancer diagnosis
was accompanied with an expectation of cure and survival. There was a
greater sense of an ordered and more certain diagnostic and disclosure rou-
tine. For Dr X the timing of the diagnosis and the reading of diagnosis created
uncertainty and an awareness of her experience of this as different to her col-
leagues. Uncertainty is not a feature of Dr K’s narrative of diagnosing cancer
in his patient, yet blurred boundaries of truth-telling emerge in the trajectory
of care that follows for his patient.
In their own unique ways, each clinician has in their sights the patient to
whom they are disclosing the diagnosis. Yet in each narrative, the clinicians’
experiences of the diagnosis process and the disclosure moment(s) are remark-
ably different. Dr B’s narrative is without emotion while Dr X is kept awake at
night worrying about how she has disclosed bad news to her patient. Dr K of-
fers nothing of his emotional experience but gives an impassioned performance
of his stand on telling patients at the earliest possible moment.
In each narrative the telling moments located each clinician’s identity along
a spectrum of professional beliefs and ideologies. A picture begins to emerge
from these three narratives of diagnosis of the broader social and cultural land-
scape in which they are situated. Death and dying are professionally managed
on our behalf and as long as there is always something to be done, there is a
moral imperative for clinicians to be doing and patients to be accepting.
The orderliness of death and dying in this system of care suggests certainty
and confidence in how disclosure is performed and experienced by clinicians in
secondary care. Only Dr X’s narrative offered a less routine and more uncer-
tain experience. This raises questions of how much the clinician’s experiences
and emotional management of the disclosure process is influenced and man-
aged by their socialisation to the medical profession. In the following chapter
I explore the significance of medical socialisation and the power of professional






Dr V:“. . . the fundamental truth is that it doesn’t matter if we cure
cancer tomorrow because the person whose cancer is cured will at
some later point in their life be struggling with the thing that can’t
be cured...and the underlying issue is that we’re mortal. And no
matter how good medicine or breakthroughs in science are, it’s not
going to help us address the absolute - which is we at some point
will need to contemplate our mortality and actually deal with it.”
It is through the diagnostic processes outlined in Chapter 4 that the socio-
cultural and professional dynamics of medicine surface in the clinicians’ ac-
counts of their experiences disclosing a terminal diagnosis or prognosis to their
patients. Clinicians are expected to perform in specific ways by patients and
peers. In this way the presentation of a diagnosis to their patients can be
considered from the perspective of Goffman’s (1959) metaphorical use of the
dramaturgical and the performance of medical professional. To deliver the
presentation with the authority required for the patient to believe the diag-
nosis is legitimate, there is little freedom to radically alter the performance.
Without the clinical environment, the medical tools and the pre-performance
of the waiting room, suspicions could be aroused about the profession. This
can be exacerbated if the clinician’s language, mannerisms and appearance are
inconsistent with expectations of the medical professional (Goffman 1959).
Clinicians strive to be open and honest with their patients while balancing
the needs of their patient. Ensuring patients felt they still had a sense of
control over their medical care and knew they were not being abandoned if
their prognosis was terminal was cited as a priority by the clinicians inter-
viewed. Alongside this is a belief there is always something more to offer their
patients often underpinned by the clinicians’ commitment to do no harm to
their patients Frequently premised on prioritising their patients’ needs over
their own this is strikingly evident in the clinicians’ expectations of manag-
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ing and expressing their emotions in front of patients and their families/loved
ones.
However as medical professionals they are subject to a system of medical
care and a hierarchy that significantly impinges on how their interactions with
their patients are performed. How “feeling rules” of the profession where self-
reliance, stoicism and neutral affectation are valued is interpreted in different
ways by the clinicians I interviewed (Kasket 2006a, p. 386 ). Dr K felt the
expectation clinicians do not show emotions had definitely changed but had
to be balanced with professionalism:
Dr K:“. . . you can’t go and blubber over them like an idiot, you
know, you’re the professional, you have your professional role, but
you can certainly be empathetic and show that it’s affecting you and
you know...Nurses, some of the nurses cry, some of the nurses go
to funerals. I tend not to go to funerals.”
I had wondered if the more home-like environments of hospice care, built
on the philosophy of holistic care, where patients are encouraged, and some
would say, expected, to express a full range of emotions would facilitate a more
equal confessional relationship between patients and clinicians. Interestingly,
the more overt expression of sadness and connection to family through their
presence at funerals is identified by Dr K as the domain of nurses, who it
could be argued in Goffmanian terms are the supporting actors to Dr K’s per-
formance (Goffman 1959). His comment suggests nurses are afforded a wider
range of emotional expression in the feeling rules and indeed may be expected
to provide this level of emotional labour as further assurance in the liminal
ritual of the good death championed by the hospice movement(Goffman 1959;
Hochschild 2003; Blows et al. 2012; Boland 2013). In contrast to Dr K, Dr Z
talked of having openly expressed his sadness with his patients:
Dr Z:“I have had a tear running down my face. I have to not feel
bad about that, I feel that that’s not inappropriate. I don’t hide
behind a desk, I’ve got out of my chair and hugged people when
they’re upset and I don’t think that’s inappropriate.”
Yet, Dr B’s position more rigidly adhered to the professional “feeling rules”
as he considered his patients did not expect or want to see his emotional
reaction to their diagnosis and it may also affect his clinical judgement (Kasket
2006a, p. 387 ):
Dr B:“By the same token, if you become emotionally involved with
the delivery of the information I‘m not certain that is a useful thing
from the patient’s point of view...I think you have to remain pretty
emotionally neutral to be maintaining efficiency as a good quality
clinician.”
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Clinicians are expected to maintain “affective neutrality” in their encoun-
ters with patients; a trait they are socialised to value and enact in their pro-
fessional identity “as it is associated with power, knowledge, and being above
the challenge” (Kasket 2006b, p. 143). Learning the “feeling rules” of the
profession as suppressing their emotion in the belief they would otherwise be
overly affected for the next patient is coined in the research by Kasket (2006a,
p. 387) as ‘There’s Always the Next Patient’ rule.
Time management becomes critical to medical specialists with competing
and multiple demands in their working day which can easily encroach into
night and weekend calls. This often demands that “doctors contain the extent
of personal interaction in favour of professional detachment, that patients are
treated as ‘cases’ rather than people” (Lupton 2012, p. 120). Dr B describes
how the pressure of clinic time affects and influences his emotion management
with patients:
Dr B:“The reality of clinics is that it’s busy. Its throughput; its
bang, bang, bang and you dealt with that consultation and there’s
another ten or twelve people to see. So I think you do get very
adept at switching off and switching on.”
Dr B’s ability to switch on and off, for the next patient, illustrates how he
has adjusted his emotional management to the expectations of his profession
and the structure of the clinic. There is a rationalisation of his own emotions
as subordinate to the demand of his profession to meet the needs of patients
for his unimpeded clear-sightedness. As Jespersen and Jensen (2012, p. 346)
suggest, the consultation “becomes doable because it can push surplus prob-
lems elsewhere, and because it can limit itself to a smaller contribution in a
larger course of events.” In the secondary care health system, Dr B is able
to describe with greater certainty the time it would take for his patients to
be diagnosed and treated. His experience of time is of a predictable time,
a schedule and routine. He does not express concern with these timeframes.
Time, though, is something that can bring comfort to clinicians’ emotional
experience of the diagnosis process. For Dr B, time mediates the emotional
impact of disclosing a life-limiting diagnosis. However, when diagnosis occurs
quickly and is unexpectedly terminal, the short timeframes of diagnosis, and
shortened lives of his patients, particularly young patients, exposes him to feel-
ing affected. Whereas, longer timeframes in the diagnosis process exacerbate
Dr X’s discomfort because she is already conscious of her patient’s experience
leading to this diagnosis and feeling some responsibility, seeks to avert further
harm to her patient, and to herself, by trying to expedite things.
In this chapter I present an analysis of narratives from the interviews with
Drs K and X, Dr Z and Dr B to illustrate how their experiences of disclosure
are influenced and informed by medical culture. In these narratives three key
themes emerge. Firstly the influence of medical culture on each clinician’s ex-
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perience and management of the emotions they feel in the disclosure processes
with their patients is explored. Intertwined with this and strongly resonat-
ing with the research presented by McNamara (2004), is the belief there is
always something more that can be offered to their patients. The ability to
offer patients other options and maintain their focus on treatment draws on
the literature on disclosure where awareness contexts are blurred with efforts
by clinicians to “soften the blow” and also block potentially uncomfortable
emotional responses; their own, their patients and their patients loved ones
(Timmermans 2005, p. 152). Closely related to both themes is the expecta-
tions clinicians’ have of their patients accepting what they can offer within
the medical model of treatment and care. These themes are enmeshed in
the broader interpretations of Mishler’s application of the technical, rational
“voice of medicine” illustrating the tensions and shifting flow of communica-
tion between the clinicians and their patients (Barry et al. 2001, p. 488).
The narrative analysis continues on from Dr B’s description of diagnosing
patients with breast cancer in Chapter 4 where he goes on to describe his
emotional response to the disclosure process. This is followed by excerpts
from Drs K and X in response to my question of what it is like when there
is nothing more that can be done for a patient and the implications of this
on their expectations of themselves. In the final narrative Dr Z’s story of his
experience with patients who chose not to accept the treatment he can offer
is presented to illustrate the significant emotional impact of this decision on
Dr Z when as a result he is left with nothing more he can do for his patients.
Narrative 1: Dr B
Approaching the emotion
In the next part of the narrative with Dr B he responds to my question about
how he prepares for the clinical encounter where he is disclosing a diagnosis of
breast cancer to his patient. He clarifies this in reference to patients who will
be “newly diagnosed they’ve got disease which they’re not ultimately going
to die of, so seeing people with whom there is intent to treat with curative
intent.” His response is then structured around his emotional experiences of
this type of encounter:
“So this is something you’re dealing with on a weekly basis.
So what is my approach to that?
Well realistically, it’s probably pretty pragmatic
and I think it’s very uncommon for me
to be emotionally affected by the consultation.”
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Dr B situates the disclosure of a breast cancer diagnosis to his patient
within his frequent exposure to the process and the expectation of curing them.
He speaks now in the first person; providing an ownership and individuality
to his approach and his response. He talks of how things really are, though he
qualifies his description of pragmatic with less absolute terms of “probably”
and “pretty”, and in the next line with “uncommon”. This alerts to the
possibility of other approaches and experiences, suggesting he is not always
emotionally unaffected.
Dr B returns in this passage to the curative intent scenario. He employs a
hypothetical patient; the average lady of sixty years, who can likely be cured,
as a contrast to the young mother, who will die. ”But I think I could honestly
say that my average, the average sixty year old lady coming in with a newly
diagnosed breast cancer these days I would be emotionally neutral about it
because you’re doing it every day.”
Dr B reasserts his response to these patient encounters as emotionally
neutral. Here too, there is an interesting shift to the first person, “my average”
that he corrects to “the average” in the second line. He repeats the attribution
of his regular exposure to this type of clinical encounter and also the length
of time he has been doing this, “these days,” to his emotional neutrality. His
emotion management suggests a temporality from earlier days, perhaps as a
medical student when he may not have been as adept at managing his feelings,
to the present, “these days” where he is in control of his feelings and regularly
exposed to disclosure situations. Socialised in overt and subtle ways over and
over again, as medical students and junior doctors, to aspire to being “an
affectively neutral technician” the “signature rule of the professional” is to
never become personally or emotionally involved with patients (Kasket 2006a,
p. 143).
Continuing the narrative, the rhetorical question is repeated. Dr B in-
troduces the risk that his approach could negatively affect his patient by his
experience of emotions in their encounter.
“So my approach to that,
and I don’t think you’d do the patient any favours
by being emotionally labile during a consultation
and I don’t think that’s what they want
and I don’t think that’s what they expect.”
Drawing on terminology borrowed from psychology, Dr B classifies emo-
tions within a paradigm of abnormalities (McGann and Hutson 2011, p. 22).
This is a feature of his narrative he also applies to his description of one pa-
tient’s ‘extreme’ reaction to a diagnosis of breast cancers as “pathologically
abnormal”. Constructing extremes of emotional responses allows Dr B to pro-
pose an unthinkable and irrational way to behave in a professional context.
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This duality of emotions from neutral and labile, however, effectively elim-
inates a myriad of emotions in between, some of which his patients may want
expressed and some that may better sustain him (Lupton 2012). As such, it
seems that he is denied the experience for risk that it will leak into the perfor-
mance of being a professional clinician. Studies have found that clinicians have
a fear of losing control of their behaviour and their patients reactions when
disclosing bad news (Friedrichsen and Milberg 2006). Dr B’s very genuine
concern that he could cause some harm to his patients were that to happen is
echoed in the research, suggesting suppressing emotions, rather than contam-
inating the clinical encounter with this unprofessional display, is a common
way of coping.
Struck by his unexpectedly candid response, my response prompts Dr B
to define an exceptional circumstance where he may be affected:
“Jo: Is it?
Yes. With the odd exception of, for example, that one we we’re
talking about;
that woman who was one week post-partum
with a three year old,
a one weeker
and a husband,
who was almost certainly
going to be dead
within twelve to twenty-four months.
It’s pretty difficult not to be affected by that.”
Dr B references a patient he had described earlier as an example of the
extreme end of the spectrum of patients in his care. She is unexpectedly
diagnosed with metastatic breast cancer after experiencing some back pain
while in hospital following the birth of her second child. A dualism of emotions
emerges; his emotionally unaffected response to seeing a patient with intent to
cure, and feeling affected when he has to disclose imminent death. In contrast
to the first section, Dr B does not use the first person, contributing to a less
personalised account. He has a central role in this disclosure also, but his
ownership is less noticeable than in other parts. Without the background
information it could only be assumed that this is his patient who he has
diagnosed with terminal cancer and he is directly affected by this.
Stenmarker et al. (2010, p. 482), in their research on paediatric oncolo-
gists breaking bad news, talks of how life-threatening conditions and death
in children “contradict the order of nature” and these difficult circumstances
often result in a continual grieving process for health professionals. Though,
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for Dr B, “happily this is not a common scenario.” He references it three
times in the interview, amplifying the significance this scenario had for him.
They suggest, that although the “existential provocation remains unresolved,”
clinicians managed by having a “carefully prepared view” of their central life
issues to risk “transmitting” their own fear of death to the patient (Sten-
marker et al. 2010, p. 481). Dr B employs clinical language with casual intent
to describe and possibly distance himself from this experience, though there
is also a sense of heightened drama of the intensity of this situation, as if his
emotional affectation must be explained by a justifiable cause.
The emotional labour demanded in medicine is offered without formal
external supervision, rather as Kasket (2006b, p. 139) suggests in her research,
clinicians engage in their own “emotional supervision” where an “awareness
of professional norms and of expectations from all sides might certainly make
a physician feel that emotional faux pas will be noticed and disapproved by
someone”.
Interpreting the norms of the medical profession is likely to also include
the stigma of mental illness which infuses Dr B’s categorisation of emotions
as “neutral” and “in control” or “labile”. Later in the interview I asked Dr
B if colleagues shared with him how they felt in difficult situations and his
response reflects the “conspiracy of silence” Wallace (2010, pp. 7–8) refers to
in her research:
Dr B:“Not with respect to psychological aspects of dealing with the
patients, it’s more with respect to a difficult management problem,
like patient’s got a complication and how do they deal with it or
they know a patients coming up with a particular surgical problem
and so it’s not feeling really upset because Mrs Robinson’s got a
recurrence of cancer.””
Testament to the hallmark of a “culture of invulnerability”, it is the fear
of making a technical mistake in the management of a patient more than the
experiences of disclosing a life-limiting or terminal diagnosis to their patients
that is considered a greater concern (Shaw, Brown, and Dunn 2013, p. 246).
This in part he explains as a result of the fear of reprisal from another audience:
Dr B:“Under-riding that is there is always a background fear, not
so much litigation in New Zealand, as HDC and complaints pro-
cess and things like that. I think that’s what generates angst for
practitioners not pouring their heart about the patient has a got a
bad disease process which is nothing to do with how they’ve man-
aged the patient and nothing to do with their ability to deal with
the natural history of the disease.”
The extent of doctors policing one another is apparent in this response
from Dr B and is exacerbated by the introduction of a higher authority with
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the power to publically bring to light any failed performances (Charon 2001).
It is not surprising then to find Dr B acts relatively independent and alone
with regard to the less medical aspects of his work (Grönlund, Dahlqvist, and
Söderberg 2011).
As a surgeon, Dr B must act with clarity, focus and precision. He must be
certain of his performance and cannot afford to lose control not only because
of the physical risks inherent for his patient but he also when he is in front of
an audience ‘performing surgery’. While the team support his performance,
they may also see if he falters. Managing his performance is an ongoing effort
to reinforce his status and professionalism as a surgeon. As Goffman (1959,
p. 40) suggests:
“. . . performers often foster the impression that they had ideal mo-
tives for acquiring the role in which they are now performing, that
they have ideal qualifications for the role, and that it was not nec-
essary for them to suffer any indignities, insults, and humiliates,
or to make any tacitly understood ‘deals’, in order to acquire the
role...in part to foster the impression that the licensed practitioner
is someone who has been reconstituted by his learning experience
and is now set apart from other men.”
I asked Dr B whether there were any specific things he consciously did
when shifting from work to home. Unlike Dr X in Chapter 4 he was not kept
awake at night worrying about how he has responded to his patients:
Dr B:“I don’t think so specifically with respect to dealing with the
breast cancer patients for example. If you’ve seen a particular bad,
somebody is in a particularly bad predicament with respect to their
disease I think you’ll think about that but it’s ... I don’t lose any
sleep about it, you’ll feel I don’t know if upset is the right word
necessarily because that it’s almost like you’re taking a stronger
personal emotional attachment, I think you’re ... I hate to think
that you would lose the ability to feel the person and where they’re
at but I think that’s different than being significantly emotionally
upset.”
Dr B’s approach to the disclosure of a breast cancer diagnosis to his pa-
tients in Chapter 4 and the emotion he experiences is evident of his own
emotional policing suggesting if he feels upset he has digressed the rules of
attachment to a patient. He is committed to the patient and their needs,
seeking to maintain his connection with where they are at but again returns
to the feeling rules to determine this is acceptable only when it is compared
with the more extreme response of “being significantly upset”.
As a surgeon, Dr B is generally positioned to be able to soften the blow
of a breast cancer diagnosis by offering a range of treatment options and in
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doing so, manage the emotional intensity for himself and his patients. Mostly
there is always something more he can do and in the following narratives from
Drs K and X, the significance of these offerings to patients and their families
is apparent in their emotional responses and expectations of themselves as
caring physicians.
Narrative 2: Dr K and Dr X
Dr K champions palliative care, repeating his mantra “palliative care is active
care” to junior doctors and senior colleagues alike. Unlike some of his medical
colleagues, Dr K does not believe there is ever a time to stop diagnosing and
treating a person who is dying. There is always something more that can be
done for a patient and he always has “plan a, plan b, plan c” formulated to
communicate to his patients, their families and loved ones and his fellow prac-
titioners. He acknowledges “dying is inherently uncertain” with an “inherent
lack of control” but works hard to anticipate and plan for what could happen.
There’s Always Something More That Can Be Done
I was surprised that there was always something more that could be done,
anticipating and assuming the hospice ideal of a good death was a quiet,
peaceful and natural retreat into death, without medical interventions. I had
also thought there would be situations where nothing further could be done to
stave off death and medical interventions would be inappropriate in the final
terminal phase. With this in mind I wondered if there were situations where
Dr K’s confidence in his mantra may not always ring true:
“Dr K: . . . the other phrase I can’t bear to hear is: ”There’s nothing
more we can do” because in my book there is always something
more we can do, always.




Jo: There’s never been a time when someone’s pain can’t be con-
trolled?
Dr K: You can increase the medication, you have to talk about the
side effects from increasing that medication ...your goal of care is
that relief of symptoms but it’s an infrequent thing.”
For Dr K to think, act or say “there was nothing more that could be
done” was “tantamount to euthanasia.” He defended the use of palliative
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sedation, outlining the rigorous consent process and rarity with which it was
administered. Without prompting in the interview Dr K raised euthanasia
many times, particularly with reference to it being “an act of killing, not an act
of medicine.” Dr K talked of the ways he and his team care for dying patients
in a holistic hospice environment where spiritual, physical and emotional care
are accorded equal prominence. Much of this is centred on “reframing hope”
for his patients as each loss chipped away at their sense of hope:
Dr K:“. . . the young mother who died last Sunday, who’s two daugh-
ters were here today, she wanted to get home for a period of time.
She knew she only had a couple of weeks. She was upset. They
hoped they could bring Christmas forward so she could have Christ-
mas with her kids. Well that happened. She was home thirty-six
hours and they had Christmas. That was her hope. So it’s re-
framing the hope.”
His response echoes that of Dr X who shared the view there was always
something that could be done for a patient expanding more fully on what that
might be:
“I think actually to say to somebody, ‘There’s nothing more that
we can do’ - I don’t think that everybody would be in a position to
break that kind of news because most of the time there is something
you can do and so part of it is how you frame that.
Like if there’s nothing more we can do,
does that mean to cure you?
Or does that mean to help you have the most satisfying life that
you have the potential to have?
And what does that mean to you?
Does that mean having some sort of therapy that prolongs your life
because that’s the thing that you want to have?
Or is it choosing that you want to have certain types of pain relief?
Or you’d like to go travelling and is that a good thing to do?
In some ways it feels to me like there’s always something you can
do
and part of what I feel about it is that there’s a responsibility,
I’m not sure if that’s the right word,
I have the sense that instilling hope in people is a really core thing
of my values,
for people to have a sense of hope.
Not necessarily a sense of hope that they’re going to be cured.”
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Both clinicians’ narratives portray the restoration and maintenance of a
sense of hope for their patients and their loved ones. Dr X explicitly con-
nects this to her “core values” suggesting this has been a driving motivation
for her call to the profession. Dr K also talked about being attracted to the
profession because he can help people. To some extent both have responded
to the social and cultural expectations of medicine as a helping profession and
their expectations of what they can offer their patients when a medical cure
is no longer an option extends to a broader interpretation of what that might
mean. Integral to instilling hope is always being able to offer something to
their patients even as physical illness and dying diminish not only what the
patient can expect to do but what medicine is able to offer. The gambit of
doing extends to beyond the realm of medicine to include offerings previously
unavailable in the biomedical model, such as art and music therapy, spiritual
counselling, palliative treatment and supporting families at home. In this re-
spect there is an “absorption” of what Timmermans (2005, p. 1000) describes
as potentially competing therapies into the control of the medical management
of death and dying.
However, this brings to question if always having something to offer pa-
tients is not only more easily achieved with technological advances in medical
care and the holistic approach to hospice care but as Field (1996) suggests also
provides the clinician with a way to mediate their disclosure conversations with
patients. Focusing on the next course of action, even if this is delivered by
another specialist or therapist continues to engage patients and their loved
ones in a medically framed future (Good 1994). It could also be argued the
process of engaging in hope restoration is restorative for the clinician also as
they face their patients’ physical and for many, existential suffering.
In contrast to the narratives of hope above, Dr Z offers a story from one
of a series of situations that he found distressing. In each of these situations
his patients had responded to his diagnosis and treatment with some form of
resistance, from denial of the prognosis he offered to rejection of biomedical
treatment. He referred to these situations as “sub-types” he found distressing
because; “I haven’t been able to care for them or get across where they are in
all this and how I can contribute to some extra life and above all their quality
of life.” The distress he experiences is counter to the gratitude and joy he
feels in most of the clinical encounters with his patients and their families.
Dr Z spoke with a modest pride of his ability to communicate bad news to
patients and most of the time be successful in “bringing them around” toward
an acceptance of his gifts.
Dr Z:“I think I’m quite good at doing it; most times I can do it so
that it’s a positive experience for the patient and the family. And
it’s often; if you’ve said to them that they’ve got a few months left
that you get a hug from everybody on the way out.”
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He describes this type of reciprocity as the “gifts” of gratitude he gets every
day from his patients that counter the cumulative battering from dealing with
“the numbers of people you would have seen and the numbers who did actually
die and the number of conversations that you had around, “’Look I’m sorry,
do you want to know where you are in terms of life expectancy?”’
Narrative 3: Dr Z
When I arrived for the interview with Dr Z, a radiation oncologist in private
practice, I wondered if I was in the right place. Walking to reception I passed
an empty waiting area, soft lighting and intermittent birdsong guided me to
a caring receptionist. Unlike my experiences waiting in public hospitals, I
felt immediately important and cared for. The contrast to public hospital
environments disturbed by jarring bangs, crashes, harsh lighting and beaten-
up furniture was striking. Dr Z immediately appears, greets me and we go to
his office. Although the room is furnished with a couch, he sits at his desk
and I select from the line-up of chairs adjacent to him.
Initially it is hard to read his demeanour, he offers little of the warm and
engaging professional which emerges as the conversation flows and I wonder if
this is part of his technique. His calm yet aloof approach begins by asking me
to tell him what I have learned so far in my research. As a senior clinician,
Dr Z speaks with a sense of confidence in the wisdom and insights he offers
from his vast experience. Quietly spoken, and at times almost inaudible, I
am physically and mentally drawn in closer. I am closely attentive to his
words and more intimately engaged. In this story, Dr Z talks about a group
of patients who reject the biomedical model and seek alternative treatment
which again, contribute to his cumulative feelings of grief and failure.
Die When They Could Not Have
“Another group of patients that you don’t come across that often
but can be very distressing are those few patients
who totally abandon your advice around orthodox medicine
and go for alternative medicine.
Now I have a fairly generous view about complementary therapies
compared with some of my colleagues, I just say,
”Actually you can spend a thousand bucks at the health food shop
but you’d be better off buying a pair of running shoes and walking
in them
because that degree of exercise is going to help with your immune
fighting
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and there’s evidence to back that up.”
“No I don’t think you should go to a clinic in Mexico.”
Bolivia is now the fashionable place.
There are sadly quite a lot of doctors who end up being quite fringe,
often general practitioners who see some sort of vibrant light and
say,
“Well I can do this, this and this.”
Once that gets in the way of a choice that could actually truly make
a difference
that is very difficult as a clinician who cares.
And they die when they could have not died.
You can’t guarantee you would have cured them with the orthodox
medicine
but you would have had a lot greater chance than what they took.”
Dr Z opens with positioning the patients he is describing as a group that he
does not see often, though this does not mitigate the distress he experiences.
The immediate orientation to his patients’ behaviour as irrational is apparent
and it is interesting Dr Z describes this as abandonment. In light of his sense
of rejection and failure as a result of these types of distressing situations, the
sense of abandonment suggests it is more personal than his patient’s rejection
of biomedical, orthodox medicine.
In this story Dr Z’s patients are not directly recognised as health con-
sumers who may have carefully and methodically investigated the medical
interventions available to them. The social and cultural scripts in Dr Z’s
medical management of patients with life-limiting diseases appear to exclude
their lifeworld beyond that which is considered medically amenable to inter-
ventions. In the fight against time against death, patients are expected to
accommodate the imposition of medical interventions with all the attendant
additional suffering in return for more life. Dr Z’s response to his patients’
choices mirror the literature on compliance and concordance, in particular,
as Conrad (1985) suggests, not all people share their doctor’s view and may
choose to respond in “non-medical ways” that can seem “an illogical form of
noncompliance” (Conrad in Brown, 1995, p. 45).
There is the presentation of a dualism between alternative medicines as
‘unorthodox’ and subordinate to the orthodox medicine Dr Z can offer which
can cure patients. This dualism positions medicine with life-giving and ex-
tending powers in the battle with death and more ‘natural’ therapies as an
alternative not only to orthodox medicine, but in these circumstances, to life.
Dr Z’s patient is again, non-compliant in refusing to accept the medical in-
terventions he offered and in this story, their beliefs and those of some of his
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medical colleagues is called to question. Describing some doctors, predomi-
nately GPs as “quite fringe” is illustrative of Dew (2000, p. 1792) research on
medical acupuncturists who are seen as deviant, possibly even fraudulent and
market-orientated. He suggests the use of alternative therapies by medical
practitioners creates an “uneasy tension”:
“For the medical profession, the problem of the use of alternative
medicine by medical practitioners has not gone away. The medi-
cal profession has struggled for decades to come to some form or
rapprochement with its members who are attracted to alternative
medicine. This uneasy tension between the profession and its mem-
bers has to some extent been settled today, with the New Zealand
Medical Council gaining powers through the Medical Practitioners
Act 1995 to assess practitioners and oversee quality assurance pro-
cedures. In addition, guidelines have been developed for all prac-
titioners who use alternative medicine to indicate where they step
over the boundary and defy the social norms of their community
(Dew 2000, p. 1792).”
This tension can be read in Dr Z’s story where alternative medicines are
acceptable as complementary to orthodox medicine only, and tolerated until
they do become alternatives and “get in the way of a choice that could actually
truly make a difference.” His belief in the power of medicine to make those
choices suggests a more paternalistic approach because he has defined for
himself what would make a difference for his patient and is distressed when
his patient does not share his view. The encroachment of alternative therapies
into the clinical encounter, renders Dr Z bereft of gifts. There is nothing more
he can do and his performance is not just disrupted but abruptly ended.
Dr Z’s experiences of his patients as active health consumers were echoed
by Dr B. Although he experiences most of his patients as “pragmatic and ra-
tional” and people who “listen to what you’ve got to say and make an informed
decision”, he describes with some frustration, the two or three patients he sees
each year who contest his advice and based on “misconceptions” request more
extensive treatment:
Dr B:“One of the issues I find is when people come in from the
get go... with very fixed ideas and it’s not necessarily from trolling
over the internet or whatever; it’s often from the girl next door in
the neighbourhood or Aunty Madge or whatever had breast cancer
and she had this done.”
He realises some patients will have a better outcome psychologically when
the treatment they request is more extensive than required, for example, a full
mastectomy even if it is not medically necessary, although considers it does
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not change the effectiveness of the treatment and their long-term outcome.
Dr B does not describe the same sense of failure with these patients; rather
he seems to express a more forceful response:
Dr B:“It’s trying to deal with those people, as a more common sce-
nario, or albeit happily not that frequent, but trying to knock down
preconceived misconceptions. The people who come along with the
raft of information from the internet are normally of a personal-
ity type whereby they’re going to be hard work anyway they’re a
certain type of person.”
Like Dr Z, Dr B appears to group these patients into a type, in a way that
appears to section them off from his more frequent experience with patients.
Referring to the group as a personality type seems to distance the opportunity
for feeling he has personally failed. Unlike Dr Z who is left with nothing
more he can do when his patients choose to seek alternative treatments, Dr
B remains actively involved in his patients’ medical journey and is able to
accommodate their choice in the orthodox biomedical management of their
disease.
Conclusion
Attracted to the medical profession to be able to help their patients and armed
with the medical arsenal of offerings which has extended beyond sophisticated
pain management to spiritual and emotional guidance, the clinicians act to
restore hope, dignity and control to their patients. However when patients
act to control their dying in ways that are outside of the expected response
to this model of care and treatment, clinicians can be left bereft of further
involvement.
The power of their socialisation to the medical profession is apparent in
the narratives presented in this chapter. Emotional responses to patients
are regulated by both an overriding desire to protect the patient from any
additional suffering the clinicians’ emotions may engender and professional
policing of appropriate emotion management.
Overarching this analysis is the organisation and structure of medical care
dominating, interrupting and also mediating the clinicians’ relationships with
their patients and their colleagues. Time with patients is managed and con-
trolled through the structure of medical care. Fractured into clinics, surgeries,
diagnostics, and referrals to other specialists, medical time dominates and can
subsume the patient’s lifeworld while routinising the disclosure experience for
clinicians.
The narratives bring to the fore questions about how always having some-
thing else to offer patients affect the clinician’s experience of disclosure and
if there is always something more that can be done for their patient, does it
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also assume the patient should always want something more to be done? This
leads to how disclosure experiences for clinicians are more than moments of
telling, in the context of open awareness and health consumerism, requiring
the clinician to negotiate or “broker” their patients’ entry to the trajectory of
medical treatment and care to follow (Timmermans 2005, p. 993). Position-
ing disclosure in this way facilitates an analysis of the clinicians’ experience




“Despite all our grand societies, our memberships, fellowships,
specialty colleges, each with its own annual dues and certificates
and ceremonials, we are horribly alone. The doctor’s world is one
where our own feelings particularly those of pain and hurt- are not
easily expressed, even though our patients are encouraged to express
them. We trust our colleagues, we show propriety and reciprocity,
we have the scientific knowledge, we learn empathy, but we rarely
expose our own emotions (Verghese in Frank 2004, p. 4).”
Disclosing a terminal diagnosis or prognosis is not always a clear-cut and
distinctly defined act. The experiences from Chapter 4 support the argument
that telling is often within a process of treatment, testing and further diagno-
sis. At times there is a sense of the ordinary and routine when patients and
their loved ones progress through a defined trajectory of medical care, falling
neatly within the specialisms of primary and secondary medical care and often
exiting with a successful outcome, be that survival or a good death.
Permeating these experiences are the powerful discourses of medical cul-
ture identified in Chapter 5; influencing and determining professionally and
socially acceptable responses from clinicians and patients alike to the disclo-
sure of a terminal diagnosis or prognosis. However if disclosure is a routine
process why does it continue to be widely debated in the literature and the
subject of so many models of patient-doctor communication?
Challenged by the more routine diagnostic response and with the sense
it was more than just telling a diagnosis in the disclosure experiences I was
hearing, I probed for situations beyond the routine, the generalised, the con-
trolled and manageable to get answers to my questions. I wanted to know if
there were times when disclosing a life-limiting diagnosis to their patients was
more difficult, than others, and if so, why. If the diagnosis was the “front-
stage” presentation of self, I wanted to know what the consequences were, if
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any, for clinicians when the “orderly social interaction becomes disorganised”
and what social and cultural scripts they drew on to navigate in uncharted
trajectories (Goffman 1959, p. 214).
In this chapter I explore the clinicians’ narratives that recall times when
the disclosure of a terminal diagnosis or prognosis has been difficult, and
as such, less routine for the clinician. These stories are presented because
they provide poignant glimpses “backstage” into the extraordinary experi-
ences medical professionals face in the context of what have become ordinary
expectations of the profession and society more broadly. The impact of these
expectations I argue is rarely considered from within or outside of the profes-
sion (Goffman 1959, p. 214). Building on the themes from Chapter 5, each
narrative illustrates specific pressures on the clinicians in the process of telling
or “brokering” their patients’ ritualistic passage toward the medicalised tra-
jectory of treatment and care (Timmermans 2005; Maynard 2003; Blows et al.
2012, p. 993).
Most noticeable is the patient’s voice; directly or indirectly through their
physical body; it is comparatively more present in these stories. The gener-
alities of diagnosis and disclosure previously discussed are less hypothetical
and in the presence of a patient and the voices from their lifeworld, fraught
with uncertainties. What emerged as a result were experiences that spoke of
frustration, distress, and failure for the clinicians and seem to interject and at
times silence, their voice of medicine (Barry et al. 2001).
It is within these narratives infused with a sense of failure and the potential
for demoralisation where I contend the imperative for change lies. I question
why clinicians who bear witness to so much suffering are so frequently unsup-
ported when in our society it is now acceptable for the archetypal masculine
hero, a former All Black, to publically champion mental health awareness from
his own experiences with depression.
I begin with a narrative from Dr B. Face-to-face with a non-curative diag-
nosis, Dr B is unexpectedly caught without time to prepare himself or his pa-
tient for the outcome. Unlike the linear progression of the diagnosis narratives
in Chapter 4, the immediacy of this diagnosis and disclosure is pronounced.
Correspondingly his narrative illustrates how expectations of treating with
“curative intent” and the structure of clinical work distance him from the
emotional effects of disclosure situations.
This is followed by Dr Z’s narrative, another story from a series of dis-
closure experiences and encounters with dying patients who are not wholly
complicit with the biomedical management of death. Patients are heard in
his narratives as health consumers exercising their right to decide on how
their illness trajectory will be managed. As such, the tension of brokering
his patients’ acceptance of orthodox treatment while respecting their rights to
manage their adjustment to their illness with integrity is striking.
In the final narrative of this chapter, the theme of always having something
more to do in the medicalised control of dying in Chapter 5 follows through
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in a story from Dr K. His relationship with dying patients in palliative care
is a negotiation with time and hope. Prognosis is infused with always having
a plan to address the inherent uncertainties of death. In this narrative, Dr K
retells the experience of trying to control and manage his patient’s unexpected
seizures with her loved ones at her bedside. He is caught in a situation he
is unable to control, denying him the opportunity to facilitate the ultimate
‘good and peaceful death.’ Unlike Dr K’s first narrative of the classic patient
diagnosis in Chapter 4, and his vehement commitment to always being able to
offer something to his patient, here he is left questioning what more he could
have done.
Rather poignantly in each story there is a resistance from the patient.
Although unintended in Dr B and Dr Ks’ stories, where the patients’ physical
bodies determine the success of their medical actions, the result is the same
as Dr Z’s patient who cannot be brought round to accepting the care he
can offer. There is an overwhelming sense of powerlessness and a deeply
embedded sense of failing their patient. To conclude, drawing on Frank’s
(2004, p. 86) work I look at the risk of “demoralisation” for clinicians when
the cumulative experiences of failure and ongoing pressure to respond with
stoicism is considered. With the risk of demoralisation present, questions
arise of what might be done differently to better support clinicians. These
questions inform the analysis of alternative narratives explored in the final
chapter (Frank 2004, p. 137).
Narrative 1: Dr B
The Christmas Patient
In this narrative, Dr B shares his experience disclosing a terminal diagnosis to
his patient. She is presented by Dr B as a close fit to the profile of his “average”
patient described in Chapter 4. In her mid-sixties and following seemingly
successful operative and radiation treatment five years earlier, his patient was
coming to the end of the follow-up programme. Attending a consultation
with Dr B prior to Christmas, she appeared “entirely asymptomatic”, but
as part of his routine examination he detected some suspicious hard feeling
lymph nodes in her neck. He ordered a needle test and scan which showed
his patient had metastatic disease related to the previous breast cancer. “She
had disease everywhere, brain, lungs, bones, liver.” Dr B described the extent
of her disease as a very unusual scenario which was “clearly incurable.”
In the following narrative Dr B continues on from a previous diagnostic
description of the tests that he ordered, the confirmation of the disease pro-
gression and the list of palliative considerations for further treatment he had
to talk with his patient about. He rounds this off with a return to the same
rhetorical questioning which is a feature in the story of diagnosis:
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“So, question of how do you approach that?
Well I think that from my point of view it’s certainly more affecting
than the person you’re seeing for the first time.
This is a lady I’d known for five years been seeing her,
operated on her and seeing her probably a couple of times a year
for five years,
she walked into the room looking her normal happy, bubbly, self,
entirely well,
no symptoms
and ten days later we’re seeing her with the results of her CT
which shows she’s got disease she’s going to die of.
I think that is... definitely...you...it affects you unquestionably
but the reality is that,
what I’d like to hope I’d do is
interact with that person in a compassionate way
and not like a cold fish”
For Dr B, his patient’s recovery seemed to be moving toward greater cer-
tainty as she neared the end of the five year programme. He described his
patient affectionately from the connection formed over many encounters. She
was “her usual bright, bubbly self,” suggesting an effervescence of life masking
his ability to immediately read the symptoms of a recurrence in the physical
text she presented to him. With the statistical likelihood of survival increasing
each year following the initial treatment each consultation over this time prob-
ably increased the reaffirmation of trust in their relationship. In many ways
his narrative is an example of the interpretative assumptions Leder warns of
in the clinical encounter:
“Almost from the moment the patient walks in, the physician is
generating provisional diagnoses which determine which questions
will be asked, what tests ordered. The physician must beware of
conceptual inflexibility: the text engages its reader in dialogue and
may at any moment explode one’s pre-existing interpretations (Leder
1990, p. 16–17).”
While Dr B enjoys the opportunity to get to know his patients better over
the longer period of regular follow-up consultations, and likens it to a GP
relationship, he has also experienced the failure of the diagnostic processes.
Furthermore, the follow-up programme positions Dr B to offer reassurance
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he knows could be undermined by an undetected recurrence. Dr B had spo-
ken earlier of how unreliable the physical examination can be because small
tumours were hard to detect and many women presented without any symp-
toms. When symptoms were present and tumours were detected by physical
examination, there was a less optimistic prognosis. Dr B describes this model
of care as “lacking scientific evidence” and understandably there is a sense
of failure and frustration when a recurrence is diagnosed in this context. In
this respect, Dr B is continually renegotiating his patient’s trust in continuing
with a breast screening programme when he can never offer certainty of their
survival (Schaepe 2011). If Dr B is unable to accurately detect recurrences
and is unable to treat with curative intent, his performance of disclosure is
threatened and may fail.
Unlike his diagnosis narratives in Chapter 4, where the disease was referred
to as independent of the women’s bodies it inhabits, here Dr B talked of
the disease, as belonging to his patient; “she’s got disease she’s going to die
of.” This type of disruption is one that Goffman (1959, p. 214) suggests
may have consequences “from the point of view of the social structure”. His
reputation, and the reputation of the efficacy of scientific medicine in the
fight against disease, may be weakened. Dr B’s patient represents a potential
disruption to this faith in medicine. Her terminal diagnosis is reflected as
contingent to an individual incident (Callahan 2009). This is an example of
what Goffman (1959, p. 31) describes as the socialization of a performance
where the performance represents an “idealized view of the situation”.
Dr B reflected on what his emotional reaction to this situation was and
as in his earlier narratives, moved to offer an explanation as if to justify the
emotions he is experiencing before concluding with how he would act. His
use of the word “approach” again refers to his emotional approach in both
narratives, rather than what he would specifically do or say. Similarly, he re-
ferred to an affecting emotion from “his point of view” which provided a sense
of ownership of the feelings he was experiencing. Emphasising his feelings
of being affected “unquestionably” reinforces the sense his response must be
defendable and without question as a medical professional. The emotional su-
pervision occurring in this situation suggests an ongoing internalising of what
is considered professional appropriate as “a product of the ‘latent curriculum’
of medical school, which continues on into the workplace” (Kasket 2006b, p.
146).
Referring to his experience I wondered how Dr B prepared for this en-
counter. In his response which follows the impact of the extent of the disease
that seems to have progressed rapidly is apparent. Bereft of the lengthier
diagnostic processes of his clinical routine in the first chapter and let down by
regular diagnostic screenings over the course of the follow-up programme, Dr B
is exposed to a clinical encounter with his patient that affects him emotionally.
His emotional neutrality and generally unaffected demeanour is threatened by
this sudden terminal diagnosis of a patient he has developed a longer relation-
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ship with.
“Jo: Using that example, before you see the patient you face your
day and you know ”Ok I’ve got that? Is that right?
Dr B: Well that lady she came back from her CT
and I literally saw her CT result
about a minute before I walked into the room
Jo: To see her?
Dr B: Yes, because she came back,
I knew she was back with the results of her CT scan,
flip up her CT scan and was like
‘Fuck, I can’t believe how advanced it is’
Jo: So you literally had a minute or two to prepare?
Dr B: Now sometimes you would have seen,
because a copy of the report would come through into my in-tray
but I think that one we got it all done fairly quickly
so I don’t think I’d seen her report when . . .
but quite commonly might have seen the result come through to you
a couple of days before the consultation,
on that occasion I hadn’t,
but either way in that particular situation . . .
and there’s some cases where you know they’re going to have a bad
scans
just because of the way they’re presenting,
the way they look,
symptoms and things like that.
Whereas that was in the context of
yes she had some obvious nodes in her neck
but she looked entirely well,
had zero symptoms whatsoever,
she had not noticed these nodes
it was just a chance finding by me at the clinic.
She went away and had this scan,
it was sort of dotting the i’s and crossing the t’s exercise
and the scan comes back showing she is riddled basically and
that was, sort of blew . . . ”
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Dr B returned to the timing of this diagnosis, perhaps interpreting my
question as a suggestion of some negligence on his behalf. His narrative began
to resonate with Dr X’s diagnosis narrative in Chapter 4 because the imme-
diacy of telling his patient was now central to the narrative. However, Dr B
was not faced with the uncertainty of when to tell his patient; the speed with
which the scan was conducted and the structure of his clinics determined that
for him. Unlike Dr X who was never certain when she will receive the diag-
nosis, Dr B talks of the ways he would normally have been prepared for the
diagnosis of a cancer recurrence. The system of communicating a diagnosis
between medical practitioners meant it might ordinarily have been delivered
internally to his in-tray. Knowing this information for a couple of days be-
fore the meeting with his patient would have provided some time for him to
prepare and adjust emotionally to the news.
On the surface it appears the crucial incident is the diagnosis leading up
to telling his patient but in context it has a different interpretation. It is the
surprise, as if science, statistics and her display of no symptoms had let him
down as a reliable source of information and he is now caught off guard in
what was supposed to be a routine consultation. The narrative peak is not
what might be expected, that the woman is told she is dying, but rather it is
Dr B’s reaction to the results of the diagnosis.
It has been suggested that for patients the uncertainty generated by the
possibility of a recurrence of cancer in the future “means individuals are ef-
fectively trapped between two social states: health and illness” that is likened
to a state of liminality persisting for the rest of their lives (Blows et al. 2012).
Dr B’s experience of this liminality is also marked with the uncertainty of this
recurrence. His role as “master of ceremonies” in the ritual is curtailed by
the structure of medical specialities. He can only preside over his patient’s
survival at the end of the five year period, not their dying which is passed
onto another specialist (Boland 2013).
Paradoxically, Dr B’s skill as a diagnostician and through examination,
“dotting his i’s and crossing his t’s” meant he had to tell this bright and
bubbly patient, at a traditionally happy time of the year, she is dying. In
the story Dr B tells, he seems unable to bring his narrative to a resolution,
and fades away on his last words, “it sort of blew...” This is possibly to
infer it “blew him away” as the ‘exploding’ of his pre-existing interpretation
(Leder 1990, pp. 16–17). There is a sense he cannot easily reconcile how this
terrible outcome has occurred during his watchful and extended diagnostic
process over the past five years. His story also supports how time ‘backstage’
is critical to how clinicians can prepare for, and recover from, the disclosure
performance (Goffman 1959). I wonder what might this mean for his registrars
who are “cherry-picking” from how he is with his patients as they are socialised
into the surgical profession?
In the second narrative, Dr Z’s experience of disclosure is not disrupted by
unexpected results he has to communicate, rather it is his patients’ responses
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to the diagnosis and treatment he offers. When Dr Z’s patients resist, he is
unable to guide them to the liminality of the dying ritual. It is as if they have
taken back their diseased bodies and refused the gifts Dr Z has offered. Their
refusal is experienced as rejection and failure by Dr Z.
Narrative 2: Dr Z
The sub-types of distressing situations Dr Z described fractured his sense of
reciprocity when patients did not share his views on accepting the diagnosis,
progressing with treatment and extending life where they can. In the follow-
ing story, Dr Z describes another of the sub-types of clinical encounters he
finds distressing and the effect of this on his assessment of how well he has
performed.
Denial and Anger
“Occasionally, it doesn’t happen that often but occasionally
you will have a patient who just actually does not want to know
and it’s often men.
His way of coping is to absolutely deny that he’s going to die
and then you, me; I’m painted almost as the enemy.
They don’t come along that often, but they take a toll.
Another one I remember like that was a man,
is a very well-known name, what a great guy he was, and he was,
but he had melanoma presented with secondary disease.
Three days before he died he berated me
for telling him that I thought he was in the last few days of his life
and shouldn’t his sister who lives offshore to come and see him.
Seventy-two hours later he was dead.
So that’s what I told him, but he was so angry with me.
That was really hard.
Now in fact to be fair, this is a good example
because it’s probably now fifteen to twenty years ago.
I occasionally see his widow around town
and she gives me a hug and basically said,
”It was just as hard for you as it was for me.”
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So he set her up for grieving for a decade before she could get her
life together
and that is really hard. Sort of two percent as hard for me as it
was for her,
but that two percent I still feel.
You don’t have many of them and I probably only have one every
two or three years
that’s as far on that pole
but that means I’ve had twenty of them and you can remember
every one of them.
I could just about recount the whole clinical course.”
This story opens with Dr Z orientating the situation as infrequent and
contingent to a category of patients who are mostly men, denying death.
Research suggests patients often find it very difficult to challenge doctors due
to the institutional power they have (Lupton 1997). Dr Z does not consider his
private patients’ profile with regard to wealth to be too dissimilar to those he
treated in the public system because health insurance schemes are more readily
offered by employers and prioritised by patients. The patients Dr Z describes
in this narrative however, suggest age, gender and possibly social class may
be factors in redressing the asymmetry of power in their relationship.
The patients he describes appear powerful and their sense of self undi-
minished by the fact their body needed for “being-in-the-world” is diseased
(Filc 2006, p. 240). Ironically these are patients who have taken up the so-
cially ascribed and medically facilitated challenge to fight for their survival.
They have chosen to ignore dominant discourses on the right way to die; their
meaning-making critical to a ‘good death’ is to never give up. Their self-
determined dying trajectory runs counter to the medically determined timing
of when to give up the fight and in doing so, inverts the role of the clinician
to passively having nothing more they can do. The journey is terminated and
the ritual transformation is incomplete (Zimmermann 2007). Dr Z describes
feeling ‘disempowered’ in these situations because he “hasn’t been able to get
through” to his patients.
Dr Z:“. . . it’s as though you’re speaking a foreign language. Whereas
I was brought up in xxxx; I learnt to communicate in the freezing
works rather than at medical school. I just speak plain language
and I have a reputation for that so it’s not that I did it behind
medical gobly-gook, it’s just that I haven’t been able to get the con-
cept across or the concept hasn’t been accepted because it’s been
rejected because of how that person sees the world and wants to
maintain their integrity as a person often at the expense of how
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the family will cope afterwards. So you feel sad and therefore you
assume some of the sadness, I think, you assimilate some of the
sadness.”
What is interesting in Dr Z’s subtypes of distressing situations is that he
has not blocked his patients’ lifeworlds from the encounter (Barry et al. 2001).
The relationship he builds with his patients could be considered empowering
because they make their own views about their health and some will share
these with him.
The refusal to accept the diagnosis and “gifts” of extending life Dr Z can
provide positions his patients as non-compliant with the preferred treatment
regime. Despite Dr Z’s ability to communicate effectively with a wide range of
people he cannot get this concept across. He hears their responses as rejection
of the awareness and acceptance that is considered integral to the concept of a
good death. However he acknowledges his patient’s right to control their own
dying as this is “how that person sees the world and wants to maintain their
integrity”. The tension in the shift to concordance in public health policy
is evident in this situation. This assumes a respect for differences discussed
openly and rationally in the context of an equal alliance but critiques suggest
concordance retains a focus on changing the patient’s attitudes (Bissell, May,
and Noyce 2004). Brought to a conclusion in this situation, concordance can
also mean negotiation may fail and in the end the patient and doctor agree to
differ (Bissell, May, and Noyce 2004).
Whether Dr Z’s response is borne from a paternalism and his “exaggerated
sense of wanting to do good” for his patients and their families is questionable.
There is definitely a concept Dr Z is trying to “get through” to modify his
patients’ beliefs but he is positioned within the medical management of death
on society’s behalf to do just this. He is left with few options but to try to
change his patients’ beliefs if not for them, then to ease the suffering he has
witnessed loved ones experience in similar situations. When he cannot achieve
this, Dr Z feels he has not done well and he is “letting that patient down or
letting that patient’s family down somehow.”
There is a cumulative account of the number of encounters over the course
of his career which reinforces the impact on him. He cannot forget each time
this happens:
Dr Z:“I think probably interestingly I often feel that I have failed
in that setting that I haven’t been able to bring that patient, person
around to an acceptance that was still maintaining dignity for him
or meaning but would have made it so much easier for his wife
and family. And very peripherally would have made it a hell of a
lot easier for me because interestingly your diastolic blood pressure
goes up five points every time you look and say, ‘Oh yes he’s coming
to see me tomorrow and I don’t know quite what he’s going to say.’
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Often there can be a bit of anger in that patient’s reaction, so yes
they want to know but don’t want to know.”
Dr Z spoke of his experiences from a position within, and across, the
span of his career as an oncologist. Dr Z has established his reputation in
the city he was born and raised in. He reflects on his differences to many
of his medical colleagues in a way that suggest it is a mark of pride. He
came to medicine from a different background where learning to adapt how
he communicated to people from all walks of life was essential to his success.
Unlike his colleagues who came from “posh schools” he has been able to use
his disadvantage of wealth and status to advantage; he does not hide behind
“gobly-gook” but faces his patients offering and receiving “gifts” his colleagues
may never receive.
Dr Z’s narrative style is as important to the analysis of the content because
it illustrates how he can be successful at “bringing people around.” Often
during the interview he would pose questions to me at the end of a sentence,
seeking agreement with the statement he has just made. He invited my assent
to his experiences, concluding with questions like, “. . . and it’s lovely isn’t
it?” and “...that’s really rather wonderful isn’t it?” It was impossible not
to concur that the feelings of love and appreciation he experienced from his
patients were lovely and wonderful. I realised at the end of the narrative how
effective this technique would be if I was a patient he was talking with and
began to understand how persuasive this was combined with his quiet voice
and confident but gentle command of the conversation. It also reflected how
this technique was integral to his performance and when the negotiation with
his patients fails how limited the scripts are for him to extend the care he
deeply wishes to provide.
Similarly in the final narrative of this chapter, Dr K is unexpectedly left
with little to offer his patient when he is able to control her seizures so she
and her loved ones can experience the peaceful death they may have been
expecting from hospice care.
Narrative 3: Dr K
In the literature on the medicalisation of death and dying Chapple (2010, p.
112) talks of the “derangements” to a good and orderly death when dying
occurs at the wrong place or the wrong time. Dr K’s narrative provides an
insight into the emphasis on control of physical symptoms inherent in the
“domestication” of dying assumed in hospice principles (Chapple 2010, pp.
110–111). For Dr K the responsibility to facilitate the good death weighs
heavily on him as dying is “a situation that has inherent lack of control on
the part of the patient and family and I feel that.”
“And there was nothing I don’t think I could have done
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I’ll never forget a patient who had seizures.
She had a brain tumour and she had seizures
and the seizures were under control with anti-convulsants
but then she had this huge seizure
and she died having a seizure.
Status epilepticus is the term, people die from status epilepticus.
And there’s just nothing that I gave in ten minutes
that stopped that seizure
and her partner was in the room,
she was a youngish woman,
and it was, it was, (motions body writhing in seizure)
and just foaming
and it was awful
and that was one where I absolutely stayed in the room
and the nurse, two nurses, were just running back and forth
and they knew exactly what I was going to order anyway
so, trying to get this seizure to stop.
And it didn’t.
She died having a seizure.
That was terrible.
And there was nothing I don’t think I could have done
. . . and I thought afterwards
and talked to my colleagues, ‘What on earth could we have done?’
The only thing if I could have maybe found a vein
and stuck in an IV and tried to do an IV
but even then,
it was only ten minutes,
it was over in ten minutes,
but it was a terrible ten minutes.”
He opens this narrative with a statement of the significance of the situation
he is going to describe; it is unforgettable, marking it as immediately distinct
from other more routine situations. Like Dr’s B and Z, this suggests Dr K
wants to ensure I know this is uncommon and therefore his presentation in
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this situation is acceptable. He allows me to see behind the scenes or at least
watch from the wings but not necessarily get backstage (Goffman 1959).
Dr K orients me to the scene with a summary of his patient’s symptoms,
the management of those symptoms and the event of her death. He rounds
this summary off with the definitive diagnosis of her condition, in Latin ter-
minology to emphasise the condition can be fatal. This sets the scene for his
actions and why he is unable to control his patient’s seizures. He introduces
two important features of this narrative; the temporality of his patient’s dying
and an audience, her partner is in the room. This follows with a return to
his patient who he recalls as being a youngish woman. As he moves on to
describe what was happening to her body he becomes animated, using his
body to dramatise the seizures and the detail of her foaming at the mouth to
illustrate the horror of what was happening before him.
In this and other situations where death is difficult, Dr K makes a point of
his decision to stay in the room, referencing an earlier conversation when he
talked of how it was often more likely to be the nurses who stayed. Again, this
signals it is an out-of-the ordinary encounter demanding his presence. He is
committed to trying to stop the seizures and now introduces more people to the
scene. His performance is assisted by the team; two nurses are working with
him and the tempo of his narrative increases as he describes them running to
get what they anticipate he needs (Goffman 1959). His description indicates
the hospice staff could be more accustomed to difficult deaths than Dr K’s
narrative suggests. He describes a scene reminiscent of the research conducted
by Page and Komaromy (2005, p. 304) observing the medical response to an
unexpected death where staff follow their professional scripts from “an affinity
with the moral obligation of the performance”. Dr K’s narrative describes
attempts to bring order to the chaos unfolding before him. His actions in
managing this difficult situation suggest it is an expected response by his
team to his patient’s dying process and as such, no matter how futile, he must
continue to intervene (Page and Komaromy 2005; Chapple 2010).
The action stops when unable to control the seizures his patient dies. He
repeats the outcome again from the opening summary. Unable to control his
patient’s seizures the scene Dr K describes is one of panic and horror. Her
body has defied his plans and he is unable to secure a peaceful death for her
and her partner who is watching. It is terrible. Like Dr B, he experiences a
sense of powerlessness. Dr K’s intense activity to stop his patient’s seizures is
indicative of the response to a failed good death script Page and Komaromy
(2005, p. 304) describe:
“. . . death is still viewed as awkward in some way and that it needs
meeting with the correct response and performance. In the western-
ised world this response is essentially medical and professional.”
The promise of a good death is unfulfilled and Dr K questions how he
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could have done something different to achieve this. He shares this with his
colleagues, and in ways not dissimilar to Dr B, this seems to be only about
the technical management of his patient’s physical symptoms. His return to
more medical interventions seems to be all that is possible for him to consider.
He concludes his narrative of the scene with his dying patient to a return to
the temporality of her death. The time seems distorted by the terror he
experiences; “it was a terrible ten minutes.” In Dr K’s stories of difficult
deaths I was struck by the assault on his patients’ bodies not only from the
seizures, the pain or the bleeding, but the medical interventions Dr K was
“throwing” at them.
I wondered how his patients’ deaths would be managed if they were dying
at home? I found it difficult to reconcile the “alternative script” of death
in hospital espoused by the hospice movement with the biomedical interven-
tions Dr K enacted (Page and Komaromy 2005, p. 295). I was reminded of
Chapples’s (2010, pp. 110–111) view on the modern day “deathwatch”:
“What was once called the deathwatch is uncomfortable for persons
accustomed to goal-directed activities. Pressure exists to minimise
one’s exposure to such helplessness.”
For Dr K despite the futility of further medical intervention his reflection
on these terrible moments indicates always having something more he can do
for his patients is firmly within the biomedical model as he considers how he
could have gone further and “stuck in an IV”. The question is how he could
do anything else when he is tasked with minimising exposure for his audience
to the “series of destructive events” in the body’s process of physiologically
letting go that is the act of dying (Nuland 1994, p. 17).
Demoralisation
If the dominant discourse of medical professionalism expects stoicism and ra-
tionality, what might the consequences be for the clinician who feels, expresses,
and is deeply affected by emotional responses to disclosing a terminal diagno-
sis? Conversely, what are the consequences if they don’t? An inability to bear
the psychological and physical endurance expected, risks disrupting not only
the professional norms but also the social order of medicine that expects a so-
cial good model of medicine to prevail (Bradby 2009). Reinforcing normative
behaviour and stigmatising deviance is the norm and sets up the potential for
substantial risks for the clinician. Few dare to disclose their own emotional
pain or reaction lest it be considered irrational and an impediment to their
technical competence as a doctor. This brings into question how clinicians
can sustain the increasing frequency of diagnosing, communicating and man-
aging their patients’ life-limiting diagnoses in this complex and dynamic social
world.
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From Dr B’s narrative there is no indication that he would see his patient
again and this abrupt end is not discussed in relation to how his patient may
feel after their five year clinical relationship is over though research on patient’s
perspectives confirms many feel abandoned, fearful, and isolated when this
happens (Kasket 2006b). The fragmentation of medical care into specialities
makes it difficult for practitioners to maintain continuity in their relationship
with patients and let alone, be in a position to acknowledge the end. Time
is rarely available for clinicians to visit dying patients outside of the hospital
environment and as death nears, many patients are physically unable to attend
clinics. Frank (2004, p. 86) contends how medicine is organised and resources
allocated, contributes to the demoralization of medicine so “who gets how
much of these is no longer organized according to the hypervalue that the
physician’s presence, in itself, can be healing”.
For some clinicians, this facilitates avoiding a difficult and possibly emo-
tional conversation with their dying patients but it can also be a deeply re-
warding experience which can assist with their grieving (Back et al. 2005).
However, this may be the last most important thing clinicians can do for their
patients that would bring comfort, closure and a chance to say thank you
(Back et al. 2005).
In a paper on physician grief, one oncologist described the sudden dis-
covery and subsequent disclosure, of one of his favourite patient’s cancer re-
lapses, as an event which triggered emotion and introspection that acted like
an “earthquake” reverberating through his holiday weekend (Shanafelt et al.
2014). Yet, the impact of this grief on the physician is rarely acknowledged or
expressed, often leading to burn-out, depersonalisation and emotional exhaus-
tion (Shanafelt et al. 2014). Dr B’s sudden discovery of his patient’s terminal
diagnosis is the defining moment in his narrative and one he returned to several
times. When he recalls the scene his thoughts are punctuated with hesitation
as he seems to search for the words to describe how he feels. He does not use
the first person throughout this narrative when he is talking about how he
felt, suggesting his feelings are externalized by a rigorous internal emotional
supervision where grieving is considered a severe breach of the rules (Kasket
2006b).
Dr B:“Well I think you get relatively numbed to it as would be my
experience. I don’t think that means that you lose your empathy
with the patient but I think ...Because this is what you’re dealing
with and this is what you do. I mean I think that for the average
punter coming in with their newly diagnosed breast cancer I would
think that in the overwhelming majority of the time, in terms of
how I internalise it, that I’m emotionally neutral and in the over-
whelming majority of cases, completely unaffected by it. There is
the occasional case which you’d have to be personality disordered
not to be...the lady who was a week post-partum; you’d have to
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be sub-human not to be affected by that but happily things of that
nature are very rare.”
Dr B’s narrative suggests there would never be a situation where his emo-
tions are not carefully managed and if he was troubled, it would be inappropri-
ate to discuss this with other medical professionals; mirroring the “conspiracy
of silence” Wallace (2010, p. 7) refers to in her research:
“The tendency among many impaired physicians and their col-
leagues is to believe that the physician will either work it out or
the problem will somehow disappear. Out of loyalty and respect,
colleagues will often feel they owe one another the opportunity to
resolve the situation on their own.”
In contrast to Dr B, Dr Z talked about the “cumulative battering” he
experiences from dealing with dying patients most days. Alongside the cu-
mulative battering, Dr Z talks of experiencing a “cumulative grief.” For the
most part it is grief he can cope with, with the exception of the few times
with patients “where I feel as though I’ve not got through and therefore I
should have done better somehow.” He talks of “assimilating the sadness”
from these situations but it is the relationship with his business partner and
colleague that is a source of mutual and informal support. He questions if
other oncologists really are coping or if this is more about maintaining “the
brave face in the milieu that doesn’t allow you to say, ‘I’m grieving’ or ‘I’m a
bit battered’ without getting a seemingly ’Chopper Reid’ response back.”
Similarly, Dr V talks of the “vicarious distress” that he sees in medical
colleagues from “sublimating distress, sadness, your own issues around suffer-
ing” as a factor in clinicians detaching from patients and no longer recognising
them as people. Closely positioned as a trusted advisor, he is able to see from
the outside his colleagues’ responses to patients that are dying and is con-
cerned that without being able to talk about their own feelings of sadness and
grief, the care of the dying patient can be compromised:
Dr V:“So people in ICU or people on crash teams that deal with
cardiac arrests, I’ve had many conversations with people here about
how hard it is for them to stop ventilation or to continuously walk
away and not talk about it, and it gets hard to the point where you
detach or you don’t think about the person as a person anymore.”
He also thinks it is important clinicians give themselves permission to know
that sometimes they won’t succeed, to know that “sometimes there are things
that just aren’t flexible, sometimes there is no thing that’s going to make it
all go away.” His views echo those of Frank (2004, p. 6) who asks “how do we
accommodate our lives to what we can never cure, ultimately death?”.
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This is sentiment that Dr X also shares, saying there is an expectation
that clinicians must appear as all-knowing to their patients but she thinks it
is important for both the clinician and the patient to show some vulnerability
in the process of disclosure:
Dr X:“. . . and I think really it’s a reflection who delivers it rather
than anything else. I don’t think it’s even about not caring about
the person they’re delivering it to; I think it’s more about how
somebody feels ok in themselves. Whether they’re comfortable,
whether they feel ok about being challenged, whether they feel ok
about somebody bursting into tears in front of them. And clearly a
lot of people don’t feel ok about that and maybe that’s something we
need too. I don’t know, maybe some people would disagree, maybe
some people would say that we don’t need to feel ok about that, but
I think that you’d find that a lot of patients would prefer it if people
showed their sense of vulnerability more in the conversation.”
Finding support within the dominant medical culture to take risks and
show vulnerability is not easy. It brings to mind a theme from the literature
where the system of institutionalised medicine is charged with alienating the
doctor from their patient. As Frank (2004, p. 4) offers, “Too many people in
medical settings, patients and staff both, are isolated from one another even
as they work, suffer, and hope in the most intimate synchrony”. Dr K speaks
of this when he compares his experience of working in palliative medicine with
previous experiences as a GP:
“Dr K: That whole concept of safety, you know, people, practition-
ers have to feel safe to be able to expose their vulnerabilities
Jo: So if you didn’t have that feeling, in other places that meant
that if you weren’t sure; it perhaps wasn’t safe to say?
Dr K: Yes, you would feel much more, isolated.”
Dr K’s response to the need to feel safe to express vulnerabilities high-
lights the sense of risk inherent when clinicians choose to act in ways that
challenge their socialisation to the medical profession’s expectations of what
is acceptable in the disclosure process. Dr B talked of the overarching fear of
a formal complaint because of medical mismanagement yet Dr Z shared with
me that in his experience as a member of the complaints board a large number
of complaints were directly related to how clinicians had communicated and
interacted with patients. The question is how can clinicians be supported so
the fear and risk of acting with generosity and expressing vulnerabilities it
seems almost abnormal to suppress are excised?
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Conclusion
Understanding the particular; the details of specific clinical encounters clini-
cians shared with their patients, these narratives moved the clinicians’ expe-
riences of disclosure beyond the generalities in Chapter 4 to the challenging
terrain of their own and their patients’ lifeworlds. Unlike the diagnosis nar-
ratives, their patients were present, and as such, introduced the uncertain,
the unpredictable and the resistance silenced in the front stage presentation
of the routine diagnosis. These difficult experiences seemed to overshadow
the clinicians’ successful routine encounters with their patients when a life-
limiting illness is diagnosed, a prognosis offered and the hope of a meaningful
and good death extended. This is the risk that clinicians seek to manage
each time they are with a patient in these situations. Controlling medical
uncertainty is what they are trained to do, however when the uncontrollable
happens it is problematic and carries a toll.
There is an emotional impact and no matter how well they are buffered
by the diagnosis process or endless medical interventions, or their powers of
persuasion, it is palpable. Understandably, all of clinicians are vulnerable to
the cumulative battering, as small numbers of difficult situations mount up
over the course of their careers. Awareness of the risk of burn-out from assim-
ilating the distress seems to offer little resistance to the dominant discourses
of stoicism their vocation demands. It is hard to imagine the resistance it
would take to choose to respond to dying and death differently in a medical
culture not immune from bullying and isolation. If clinicians are constantly
surveying themselves and other colleagues what opportunities are there for
them to stop and listen to how their dying patients are really feeling? Yet,
in the midst of demoralising systems and practices in medical care are stories
from the clinicians who did just that and as such, provide the impetus for the
narratives of generosity in the next and final chapter.
Chapter 9
“Remoralization”–narratives
of risk and generosity
Introduction
“The traditional idea of medicine is to offer more than treatment.
The hospitality that exceeds treatment welcomes the sick person
without qualification. Medical hospitality invites the ill to feel less
stigmatized and isolated. According to the ancient ideal, those who
make medicine their work are to find their consolation in being the
kind of people who offer such hospitality”. (Frank 2004, p. 3)
Reading the clinicians narratives in the preceding chapters the distance
between “the traditional idea of medicine” and the experiences they retell is
not one of intent but rather of people who have sought to make a difference,
within a system of care and profession responding to expectations of staving
off death, always having a medical response and managing dying so it meets
the ideal of the good and peaceful death; a concept more reconcilable to those
of us yet to face this than the largely undignified disintegration of physiological
systems Nuland (1994) described.
From the analysis of the clinicians’ narratives it would be plausible to
conclude this thesis with a summary of how disclosure of terminal diagnosis
or prognosis is more than telling and how clinicians’ telling is influenced by a
powerful context of cultural, social and professional expectations. However, in
the midst of the routine disclosures, the suffering, the frustrations and failures
I heard other narratives I could not ignore or discount. These narratives
were more pieces of the stories, rather than the plot, offered with humility
and an abiding respect for the people involved; be they patients, families,
colleagues or employers. They speak of risk, vulnerability, humanity and an
unmistakable generosity. Collectively their pieces of stories build connections
to a way forward where clinicians are supported to be the kind of people
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they were when they embarked on a journey to help people and offer society’s
hospitality to the sick (Frank 2004, p. 3).
Drawing on the work of Frank (2004) I present these narratives of risk and
generosity as insights into how clinicians and their patients’ experiences of
disclosure of a terminal diagnosis or prognosis can be remoralised. I conclude
this final chapter of the analysis with some thoughts informed from the clin-
icians’ narratives on the broader social responsibilities and opportunities to
extend generosity to those we ask, on our behalf, to bear witness to so much
suffering.
Care That Connects
Frank (2004, p. 84) argues remoralisation requires a “medicine that does not
isolate but connects”. But what does that really mean for clinicians and their
patients? How can clinicians know they are connecting with patients and
how is this different to the care they might otherwise provide, or the care
they witness peers and superiors providing? In response to these questions I
found pieces interwoven into the clinicians’ experiences of disclosure that speak
of a connection to the shared humanity and possibly mortality between the
clinician and their patients. I begin with Dr X who recognises and positions
her patients as people; in doing so, she affords them an equitable capacity to
be able to judge when care is authentic. These excerpts are followed by Dr
K’s story of learning another way to connect from watching nurses caring for
their patients. The last narrative of this section is Dr Z’s poignant stories
offering final reassurances to his patients.
People Can Tell
From the beginning of the interview Dr X’s narratives of her disclosure expe-
riences were characterised by her sense of injustice when the rules of medicine
dictated how dying patients were treated and how she felt powerless as a med-
ical student to challenge them directly. Yet, Dr X does take risks, and acts
from a strong value and belief system to extend care and empathy to patients
when others have abandoned them:
Dr X:“So I went and talked to this woman because everyone was
shut off from everyone and she was just on her own and I had
a real sense of again, this doesn’t feel right to me to come and
what seemed like a matter-of-fact presentation of, ‘Actually you’ve
got something nasty and you’re going to die’ kind of idea. . . but
thinking, ‘Oh I can’t just go and pretend I haven’t heard it.’ I
don’t even mean that, it’s more like I couldn’t leave, something
in me would not let me leave because I felt like this woman needs
somebody to at least engage . . .
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But interestingly I got in trouble for that. . . because someone said
to me ‘What makes you think that it’s your job to do this?’”
Dr X also talked of a big expectation to “know lots of stuff” but ques-
tioned the validity of this from the perspective that doctors are “not really
encouraged or allowed to be in the position where you feel comfortable about
not knowing things.” She suggests this contributes to why doctors deliver
bad news “standing up at a bedside without a heck of a lot of compassion or
bedside manner.” For Dr X really getting to know somebody requires think-
ing beyond asking the questions she has been trained to do in the focus on
symptoms and try to really engage with people:
Dr X:“. . . ask what your inclination is, where does your mind take
you about these kind of things? And I think that you end up finding
about who a person is and what they want or what they need in a
situation rather than the catch all six out of eight or whatever.”
However she recognises the omnipresent medical culture can mean tak-
ing risks to be able to engage with patients this way, particularly when the
technical voice of medicine is given much greater authority:
Dr X:“But I don’t think the system so much allows you to be that
way and so I do think that you have to be brave or whatever, that’s
my sense to speak out because it’s a far more rational kind of
thing.”
The rational, pragmatic voice of medicine is challenged by Dr X who seeks
to infuse her own lifeworld values into how she communicates with her patients.
Communication is not just a set of techniques to elicit specific responses rather,
for Dr X it is finding a way to connect with her patient and also be open to
what their response may be. Unlike doctor-patient encounters where the voice
of medicine dominates and patients quickly learn what responses are expected
and affirmed by the clinician, Dr X is comfortable with the uncertainty of how
her patients wish to respond. As such, she credits her patients as an audience
with insight into the authenticity of her performance and in return experiences
their generosity of forgiveness if she does not always perform perfectly:
Dr X:“I think a lot of it is that people can really tell whether or
not you’re genuine in the way that you deal with them and I be-
lieve that’s a really important thing and I think that people can see
through that really well so I think people are forgiving.”
Forging connections with patients so medicine does not isolate them, Dr
X talks of trusting her “unique-self”, being both “brave” and “curious” to
question “why this might be the way it is?” Her narrative resonates strongly
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with Frank’s (2004) concept of remoralisation for patients and clinicians alike.
Sadly, in her experience this takes bravery to risk others’ reproach so she can
still be her “unique self” and a clinician.
Touch
Communication techniques are afforded a dominant place in the literature on
how to break bad news to a patient. Much of this literature however assumes
techniques and models of communication will be successful no matter who the
audience is. In this way, the status of the voice of medicine remains intact
because techniques offer pre-determined scripts to manage and control difficult
conversations without premising how unique the experience is for the patient.
Notwithstanding guidance on how to communicate to patients is critical and
at least allows medical students and clinicians the opportunity to reflect on
what the purpose of their communication may be in disclosure moments.
As a strong advocate for the utility of communication skills training and
techniques, Dr K talks of how much he has integrated into his interactions with
patients so he can facilitate conversations about dying patients are reluctant
to have with others. He provides many hypothetical examples of how this
would work; however it is when he is sharing a story of an experience with a
patient that his commitment to connecting openly and honestly with them is
so apparent. In this narrative Dr K talks about how he learned the importance
of touch:
Dr K:“The other thing that’s real important in communication
skills that I had to learn with time, and I learned a lot from what I
observe in nursing and what nurses say is that physical touch is a
hugely important way. That distance between clinician and patient
disappears and patients ask things when there’s touch involved that
they wouldn’t ask necessarily when there’s no touch involved. So
nurses will say that here when they’re doing physical care, they’re
giving somebody a bath or a wash, stuff comes out from patients
about what they’re worried about, what they’re upset about, you
know. . . ”
His story is a refreshing inclusion to the repertoire of verbal communication
techniques and a compelling example of how patients as people, can be reached
without words:
“I’ll never forget this patient, a year ago or so;
woman came to an outpatient clinic here from work.
She was single, great career, she lived in Turkey and Italy and New
York and all these places all over the world.
She had advanced cancer and she continued to work.
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She came in here for an outpatients clinic and she sat like this
(arms folded across chest)
and she was giving me her story
and I was doing the doctor thing, talking ra, ra, ra
and I said: ‘I need to examine you.’
I took her round to the examination room,
sat her on the edge of the bed,
put the blood pressure cuff on,
I had the stethoscope in my ears and I was doing her blood pressure
and she said: ‘I just want to die.’
So it was just when I was touching her,
I was just doing the blood pressure, wasn’t even undressed right?
So it’s. . . like ‘tell me what you’re thinking’ or ‘what’s that about?’
Or whatever, exploring from right then because it was the touch.
When we weren’t touching
it was very much the resolve, you know,
professional to professional really.
But the moment of touching was (intake of breath). . . ”
Interestingly in this narrative Dr K again orients me to his patient’s iden-
tity as a professional; an identity he shares with her. His description of where
and how she works builds a picture of her self-reliance and stoicism in the face
of advanced cancer. This picture seems to show not only a connection with
her but also an admiration of her. However there is also a sense her emotional
response is permissible because she ordinarily would respond as a professional,
suggesting when she does respond as a patient with advanced cancer who is
feeling overwhelmed, it is a surprise.
Dr K’s orientation builds the case of the power of touch. Not only can
this physical connection break down her stoicism and expectations of how she
should behave as a professional it also enables her to move beyond an intellec-
tual response to talk about how terrible she is feeling. What is important is
how Dr K responds to her. Identifying as a professional he could have contin-
ued doing his doctor thing, returning her attention to her physical symptoms
and effectively closing down the passageway where they can connect (Frank
2004). Rather, Dr K stops doing - it is critical to his story and remarkably
different to his other narratives of his experiences with patients dying. He has
the courage and humanity to explore her response, opening the space for her
to share what he intuits from her body language is being tightly held within.
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It is understandable that for many people with life-threatening illnesses,
the expectation to find the words to express what they are feeling in the face
of adversity is too difficult, particularly if there are no words to describe this
meaningfully to another person. Furthermore, their sense of aloneness and
isolation can be exacerbated when the expectation is they speak only words
of bravery and a valiant struggle rather than acquiescence. The connection to
things beyond the intellectual can sometimes only be accessed through touch.
The same could also be said for clinicians.
On saying goodbye
There is a greater sense of intimacy and affection in Dr Z’s clinical relation-
ships. He talked of going to visit patients in their home or hospice when death
was near and recognised the comfort this brought to them and their families
as well as the healing he felt. He finds it tough when patients are suffering
existentially and offered a recent example of visiting one patient in hospice
who was angry:
Dr Z:“. . . it’s harder if they’re suffering existentially
so that’s the tough one.
A recent example perhaps
a lovely man, very well-read, we shared books to read and that sort
of thing
and I know I helped him a lot just cope with everything,
and he’d been a bit depressed on and off over his life
and that sort of stuff.
Well I saw him actually in the hospice a couple of days before he
died
and he was quite angry. But all he was angry about was,
”How much longer do I have to be like this?”
And when I said, ”It’s not going to be much longer, you don’t have
to endure this very much longer.”
And it wasn’t pain it was just suffering,
”I feel useless I can’t even do anything, I can’t even read anymore”,
that sort of suffering.
And I gave him a hug and said,
‘it wouldn’t be very much longer.’
But all he was angry about was, ‘How much longer do I have to be
like this? And when I said,
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‘It’s not going to be much longer, you don’t have to endure this
very much longer.’
And I gave him a hug and said it wouldn’t be very much longer.
He died two days later.
His wife rang up and said, ‘He said to me Dr Z said I could go,
it’s okay now’
and she said, ‘Thank you’.
Well again, getting that back takes away three months of cumula-
tive grief I’m very privileged because I have bits of people’s lives
and I get bits of love from lots of people
so that takes away most of the cumulative stuff I think.”
In the narrative above Dr Z takes time to connect with his patients and
their loved ones even in difficult moments when they are suffering and dying
is not peaceful. He is aware his presence can bring comfort and his words
as one who has witnessed so much suffering, can ease his patient’s burden.
His generosity is reciprocated with a call from the man’s wife thanking him
and affirming his efforts to relieve his patient’s suffering. Dr Z’s experience
exemplifies Frank’s (2004, p. 99) assertion that “identification with the ill is
not a burden added to what physicians already bear; it lightens what they
must bear”.
In response to this story I asked Dr Z if there were situations where he
may actually be saying goodbye to someone. He describes how endings he can
participate in assist his own preparation for the loss he may feel:
Dr Z:“Yes, that’s right and that’s pretty tough. I guess I tend
to see people, this may be some of the differences that you asked
right at the very beginning between public and private, my public
colleagues will say it’s because of numbers of patients, but I used
to do it there. If things were going wrong and Iife expectancy was
relatively short, I would still see those patients, they would still
come back to a follow-up clinic with me even though I might have
obviously got palliative care involved and the GP and things like
that. So I’ve got a lot of patients at any one time who actually
are in the last weeks of their lives but they might be seeing the GP
one week as arranged between the GP and myself, and me the next
or something like that. Basically that’s just part of the process of
caring and so to some degree, it’s a bit like getting the patient home
before the eulogy, to some degree I’ve said goodbye as we’re going
along rather than I’ve heard about the death or read about the death
in the notices in the newspaper. Which can otherwise be so telling
– I do look at the funeral notices and then every now and then if
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I hadn’t known somebody was declining and I see it, I’m probably
more affected than the ones I knew were because I’m less prepared
for that one, whereas I’m prepared for the others.”
Endings matter, yet few clinicians talked specifically of saying goodbye,
even Dr K who at the very end with his patients never explicitly talked of
this as part of what he was doing for them as they died (Gawande, 2014). In
Dr Z’s narrative feeling he has said goodbye prepares him for the loss he feels
when a patient dies and there is sense of closure for the work he has done
to help his patient and also the end of their therapeutic relationship. His
narrative reflects a more modern version of the traditional care Frank (2004)
refers to where he may not have the time for an extended death-watch at his
patient’s bedside but he recognises his presence alone can be deeply reassuring
and healing.
Dr Z:“There’s a point where I would lose that contact because it’s
just inappropriate to bring them in because they’re more bed-bound,
I quite often visit people at home and families just love that. I’ll
visit somebody in the hospice or if it’s somebody at home. I guess
what that’s done is that its helped me, there’s probably quite a lot
of personal healing going on by doing that because a family is so
chuffed that a doctor’s going to call past and just say hello and sit
on the end of the bed and hold somebody’s hand, you don’t have to
spend a long time there.”
Dr Z’s narrative is testament to the reciprocity generosity brings and how
important opportunities to acknowledge endings are to his ability to keep doing
what he does. When asking how we as individuals act to restore generosity,
Frank (2004, p.137) contends responses “risk becoming lost in elaborations
of institutional complications and menacing possibilities”. Dr Z’s response
is by contrast elegantly simple. There is still something more that can be
done as a clinician and that is to honour the relationship he has with patients
by recognising they mattered enough to him to face them as people and say
goodbye.
The Way Forward
If, as Frank (2004, p. 1) suggests, “Medical generosity sets a standard for the
rest of society, because illness is a universal form of suffering” then who is re-
sponsible for ensuring the standards are set? Is this the sole responsibility of
those who practice medicine? If so, how can the medical generosity described
in this chapter infuse the medical socialisation of every medical student? Or
are there broader connections to be made where society supports and recip-
rocates medical generosity, recognising not only the universality of illness but
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the needs of those charged with caring for us? In response to these questions
I present in this final section two excerpts from interviews with Drs V and
K because they connect the generosity depicted in the clinicians’ narratives
above with a reciprocity within and outside the medical profession.
Reflecting Generosity From Within and Outside the
Profession
Dr V’s role as a palliative care consultant in a large urban hospital extends
beyond patient care to provide support to other medical practitioners. His
insight into the suffering many witness in their daily working lives and the
difficulties expressing the feelings this brings up is evident in his description
of how he may support them:
Dr V:“We are often sitting down and listening and working it
through, and acknowledging it and we’re working at that level with
our colleagues. We’ll get asked to go and see someone for pain
control and go and sit down with a colleague and say, ‘So what
are the issues?’ ‘Well the pain’s not under control and no matter
what we do we can’t help and it’s so frustrating and it’s really sad
because they’re young and I don’t know what to say’. And sud-
denly it’s not about the pain, it’s about them and their feelings and
how confronting this is for them and so that’s a large piece of our
work.”
Responding without judgement, Dr V extends a generosity toward col-
leagues who he has over the course of his career come to see as “good people
doing the best job that they can and everyone’s intention is to do the best
by the patient.” He understands difficult conversations may not always go
perfectly but informed by his experience over his career and the concept of
mindfulness he generates a context of kindness and acceptance toward them:
Dr V:“I’ve never come across someone at this stage who doesn’t
just want to do the best and so sometimes it doesn’t work out that
the person’s heard or understood because it’s a factor to do with
them or their family and sometimes it’s to do with the way the
news was delivered but I think that’s just how life is.”
His perspective is a distinct and refreshing contrast from the literature
critiquing clinicians for how they disclose a terminal diagnosis or prognosis.
He is aware of the decisions his colleagues face and how hard it can be to
communicate these when it feels like this will hurt the patient:
Dr V:“That’s a huge part of what we do in our service is supporting
colleagues who are having these difficult conversations and who are
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having to make difficult decisions and one’s that don’t sit easily
with them because they don’t want to hurt someone or give up hope,
or someone’s young and they feel that it’s not right that they should
die so young and we need to do an extra bit whatever that might
be. And of course there is no extra bit really because if someone’s
going to die, they’re going to die.”
However, Dr V also offers a generosity to what is expected of clinicians
caring for patients who are dying. There is no “extra bit” that can stave
off death and in reminding his colleagues of this allows room for mortality,
their own and their patients, to be considered. It is an approach Dr V does
not forcefully present but rather offers as his own awareness of the suffering
inherent in his profession. The potential for how Dr Z influences the culture
and medical socialisation of the junior doctors he teaches with his approach is
in my opinion a powerful response to Frank’s (2004, p.1) challenge to “increase
the generosity with which we offer the medical skill that has been attained”.
In this next example from Dr K the generosity he describes is from outside
of the medical profession and offers a sense of the connection he feels when
the care he and his team offer to those who are dying and their loved ones is
reciprocated by others:
Dr K:“But another thing I find sustaining is where yes, society
denies, but there’s been a number of things, that young man with
the horrible tumour on his face, his mother works at Pak n Save,
she’s a cashier at Pak n Save. Pak n Save said to her: ”Don’t
come in to work, stay with your son”. They continued to pay her
salary. I don’t know how many months they paid her, not great
salary she’s a cashier but they paid her salary. No expectations
that she would come in. I’m sure it wasn’t part of a contractual
arrangement but they paid her salary for her to be at home with her
son and it went on and on and on. That’s the kind of story which I
find really inspiring. I think the Warehouse does that same sort of
thing. And that’s nothing to do with the hospice. We also hear the
awful stories of employers who sack people and some people come
and they have no income and we have to negotiate with Work and
Income to get the supports and da,da,da but we also hear employers
who keep the income going. That keeps me going when I hear that
sort of story where communities support the dying person.”
The generosity extended by this employer exemplifies our shared humanity
and responsibility to offer hospitality to those that are ill. Dr K is sustained by
these responses from communities and “feels a part of it” indicating how con-
necting the work of medical professionals to society is integral to the remoral-
ising Frank (2004) advocates. Hospice care is one vital link to communities
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and in this respect more easily accommodates the flow of generosity between
the medical profession and society. There is a higher level of visibility as a
result, facilitating an opportunity for lay people to witness the complexities
of caring for dying people clinicians must navigate every day. Although for
privacy reasons he is unable to publically acknowledge the company for what
they have done he can respond with a letter of thanks. What matters most
to Dr K is that “as long as we are acknowledging to somebody in their chain
that this is a really, really important and good thing.”
Other Tangents. . .
Combating isolation, failure, fear of reprisals from patients, colleagues, senior
clinicians and complaints authorities and becoming emotionally numb in clin-
icians who are tasked with disclosing life-threatening illnesses or prognosis is
a challenge. I contend it is a challenge not just for the medical profession but
for westernised society as a whole to face what death really is, understand
what we are asking clinicians to do on our behalf, and find ways to forgive
them and ourselves–the ultimate act of generosity (Frank 2004).
A significant step toward this would be to acknowledge what it is clin-
icians are being tasked with when they disclose a life-threatening illness or
terminal diagnosis. If we accept disclosure is more than delivering a diagnosis
to a patient and consider disclosure as the critical rite of passage to bringing
people around to accepting the trajectory of medical care to follow, then it
changes how clinicians can be supported to do this. Understanding disclosure
as nuanced with social, cultural and professional expectations of clinicians
managing patient responses to their newly altered future demands different
responses. Firstly, repositioning clinicians as equally susceptible to emotional
suffering as their patients, albeit cumulatively, presents a challenge to domi-
nant discourses of stoicism and self-reliance. This raises questions of why the
emotional well-being of clinicians is not granted the same primacy as it is in
other models of professional supervision and competence such as psychiatry,
psychology, and palliative care.
Dr Z suggests that if medical professionals are supported in “letting the
cumulative and the occasional frustrations out, your competence is proba-
bly going to be enhanced anyway isn’t it?” Strategising on how this shift
could happen in the medical profession, Dr Z pointed to the acceptance of
the concept of palliative care in medicine and in particular how palliative care
specialists are provided with professional supervision.
Dr Z:“Sorry another tangent but the palliative care bit is interest-
ing. That might be the way to make it more generalised because if
we’re saying palliative care means the quality of life aspects of all of
the chronic illnesses that we live with more because sixty-five per-
cent of all of the people who ever got to sixty-five are alive today,
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then having supervision across all of the disciplines in medicine
that care for patients as opposed to diagnose might be actually
pretty damn sensible.”
Dr Z’s suggestion seems rational, pragmatic and logical, given the increas-
ing complexity and blurred boundaries of life-threatening and chronic illnesses
he identifies as a significant change in how clinicians care for patients. Given
the influence of technological and demographic shifts, Dr Z is alert to the
likelihood of more clinicians facing disclosure moments across a wider range
of medical specialities. Applying Dr Z’s logic suggests there is an opportunity
for emotional competence to be commensurate with other requirements of the
continuing professional development for clinicians’ recertification:
Dr Z:“You could say that, ‘We think supervision is important and
we’d like evidence that you attended at least five sessions a year.’
Or something like that. I don’t think that would be that outra-
geous.”
Affording an equal status to emotional well-being would go a long way
to challenging the stigma of mental health Wallace describes in her research.
After all these somewhat outmoded and unhelpful expectations of medical
professionals reinforces discriminating discourses of mental illness as an in-
dividual failing. There is an inherent contradiction present for a profession
who is charged with caring for those with mental illness but cannot extend
the same understanding to their colleagues. In this respect, despite all the
technological advances in medicine, the profession appears to one of the few
remaining bastions of the “stiff upper lip” mentality.
It also follows that how clinicians are trained and supported to break bad
news could encompass their own as well as their patients’ responses to grief
and loss. This is not to suggest clinicians must always have an emotional
response or connection to their patients when disclosing a terminal diagnosis
or prognosis but rather to allow space for it to be possible. It is as likely there
are patients who they do not connect with, who frustrate and enrage yet it
is equally important they can discuss this without feeling guilty or uncaring
also.
Conclusion
Ultimately, from the clinicians’ experiences in this chapter, it is developing an
understanding that at times such as disclosure and imminent death it is the
power of connection which can heal both patients and clinicians. Learning
how to connect beyond the prescribed models for breaking bad news requires
the bravery evident in the clinicians’ narratives, to sit with the discomfort of
not knowing what to do, of making mistakes, of not always having something
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medical to offer, of understanding the value of stopping, holding a hand, being
silent and not “miss the face” (Frank 2004, p. 116).
To achieve any of these things requires we who are not medical profession-
als to also act with bravery and face all of what death and dying is without
expecting this will always be peaceful and always be good. Shifting our own
expectations of death we may offer a generosity toward medical professionals
so we are not asking them to tell the truth but mask the reality by always
having something medically to offer. Clinicians may often be positioned as the
intermediaries between life and death in the work they do but they are also
the intermediaries in the cultural and social demands for managing death and
dying. In this respect, we have a shared responsibility in how we ask them to
do this and what can change.
All of the clinicians in this research cited the opportunity to have conti-
nuity in their relationship with patients as significant to their experiences of
disclosure. This resonates with the literature on patient experiences, specifi-
cally not feeling abandoned during the transition from cure to palliative care.
Yet medical care is increasingly structured into specialisms which fragment
doctor-patient relationships and the opportunity to connect at such critical
times. There are a multitude of reasons why changes to the structure of med-
ical care is not possible but this does not mean it cannot be modified to allow
time for clinicians to continue to see patients who may be under another clini-
cians care. What it requires is the value of the healing presence of the clinician
to be included in the commodification of clinicians’ time. Above all else this
could facilitate the opportunity for disclosure of a terminal diagnosis or prog-
nosis to be a point of connection for clinicians which can continue across the
journey of their care to the end.
After all in the context of open awareness it seems illogical and disingen-
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